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SUMMARY AND NEW TRENDS 
The year 2005 was the first year of the implementation of the National Drug Policy Strategy for the Period 
2005 to 2009 and the Action Plan of the National Drug Policy Strategy Implementation for the period 2005 to 2006. 
The Action Plan contains a total of 144 tasks which are mostly aimed at ministries. They are divided into 43 goals 
which relate to seven drug policy fields: (1) primary prevention; (2) treatment and aftercare; (3) harm reduction; (4) 
drug supply reduction and law enforcement; (5) coordination and funding; (6) the field of information, research, and 
evaluation, and (7) international cooperation. 
The most significant system changes in the field of drug policy in 2005 involve: 
• Adoption of Act 379/2005 Coll., on Measures for Protection from Harm Caused by Tobacco Products, Alcohol, 
and Other Addictive Substances as amended, which, inter alia, defines responsibilities regarding the 
guaranteeing of drug policy by state administration and self-administration bodies. For the first time in the history 
of the Czech Republic, it defines basic types of services for drug users. 
• Launch of the system of Certification of the Professional Competency of Services for Drug Users, which was 
approved by Government Resolution No. 300 in March 2005. 
• Adoption of Rules for Drawing Financial Resources for Drug Policy from the State Budget, which were approved 
by Government Resolution No. 700 in June 2005. 
Drug policy expenditures increased by approximately CZK 44 million (€ 1.48 million) in 2005 compared to 2004. 
There is an annual increase in the amount of financial resources provided by regions.  
The situation in the field of drug use in the general population has remained stable; no significant change was 
recorded in 2005. No general population survey or national school survey was carried out in 2005. Approximately 
20% of the adult population has tried an illicit drug, according to surveys from 2002 and 2004, and the prevalence of 
drug use among secondary school students is even higher (44% among 16-year-old and 56% among 18-year-old 
secondary school students). Cannabis and ecstasy are the most commonly used illicit drugs, and there is a very 
limited extent of experience with drugs with more serious health and social risks (opiates, pervitin, cocaine) in the 
general population.  
The estimated number of problem users of pervitin and opiates increased slightly in 2005. As far as pervitin is 
concerned, the increase was most probably caused by the further dissemination of pervitin in night-life and dance 
settings, including small towns. The increase in the number of opiates users involves those who use Subutex 
obtained from the black market as their primary drug by injection. There are still significant regional differences in the 
prevalence of problem drug users and the types of the substances used (Prague and the Ústí region report a 
significant proportion of users of opiates, including Subutex, while pervitin users prevail in other regions and the use 
of Subutex is reported less frequently or seldom). The average age of problem drug users who are in contact 
with helping facilities increased again; the proportion of problem users aged under 19 has a decreasing 
tendency. Therefore, it is very likely that no new generation of young problem drug users is growing up.  
Approximately a third of the users who are in contact with helping facilities are infected with hepatitis C, and 
approximately 10% are infected with hepatitis B. There was a decline in the number of new reported cases of drug 
users infected with hepatitis A and B. HIV/AIDS prevalence in the population of Czech injecting drug users 
continues to remain under 1%. The occurrence of infections among drug users has been stable in recent years; 
infections are not spreading in an epidemic manner. However, it is alarming that the number of tested drug users 
is continually decreasing, which is largely caused by a shortage of quick screening tests on the Czech 
market which can be used in low-threshold facilities, and that the number of problem drug users from Eastern 
Europe, where the occurrence of hepatitis and HIV/AIDS is markedly higher, is increasing. The number of syringes 
distributed in exchange programmes continues to increase – 3.3 million of them were exchanged in 2005. 
The number of drug-related deaths (overdoses) has remained stable. Drug-related deaths most commonly 
involve opiates, pervitin, and inhalants – each of these accounts for approximately 20 deaths per year. Sporadic 
overdoses on ecstasy and cocaine have been reported in the last 2–3 years.  
A wide spectrum of services with good accesibility provides for harm (risk) reduction and the treatment and 
resocialisation of drug users in the Czech Republic. The network of low-threshold programmes has remained 
stable (approximately 60% of problem drug users are in contact with them). Outreach work with drug users has 
been developing in recent years. The network of outpatient and inpatient health facilities has remained stable. Two 
therapeutic communities ceased to operate in 2005; on the other hand, aftercare programmes including sheltered 
housing and sheltered work programmes have been developing. The number of specialised substitution centres 
is increasing, and new methadone programmes were opened in the Southern Bohemia and in 2006 in Karlovy 
Vary regions. A pilot methadone treatment programme started in two prisons in 2006. The quantity of Subutex 
being consumed is increasing. The number of people who use Subutex (either prescribed by a physician or from the 
black market) is unknown. One of the reasons is that the Substitution Treatment Register does not yet allow for 
reporting from outpatient facilities which prescribe Subutex only. It is estimated that 20–30% of opiates users are in 
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substitution treatment programmes (it is difficult to make a more exact estimate because of unknown number of 
Subutex users). 
The number of drug offences, as well as the number of those prosecuted for or accused of these crimes in 
2005, was approximately the same as in 2004. Even the number and proportion (8%) of cases of the possession 
of drugs in a quantity greater than small as a percentage of overall drug offences has remained approximately the 
same. The number of those sentenced for drug offences has decreased for the first time since the 
beginning of the 1990s. Pervitin is the drug which is most commonly associated with drug-related crime and its 
proportion is increasing, while the proportion of cannabis drugs is decreasing. The proportion of custodial sentences 
is increasing among those sentenced. The proportion of suspended sentences, first offenders, and juveniles among 
those sentenced for cannabis-related offences is markedly higher than among those sentenced for offences which 
involved other drugs.  
The number of drug seizures by law enforcement bodies in 2005 was approximately the same as in 2004. 
The only exception involved a decline in the volume of hashish and ecstasy seized and an increase in the volume of 
cocaine seizures. The Czech Republic is a country where pervitin (methamphetamine) is produced and from which it 
is also illegally exported abroad; an increase in pervitin production from freely available medicaments which contain 
pseudoephedrine occurred in 2005. A significant proportion of the cannabis consumed is also covered by domestic 
production. The Czech Republic continues to be a target and transit country for other drugs. 
Drug prices remain at a stable level; street drug purity has been relatively stable, despite year-on-year differences 
in the purity of drugs which were analysed by the law enforcement authorities – the differences can also be caused 
by seizures of large quantities of pure drugs (namely heroin) before they were adulterated for sale to the end user.  
DATA CONSISTENCY 
Despite partial insufficiencies, the quality of the data available in the Czech drug information system is satisfactory. It 
makes it possible to track multiple yearly trends and new phenomena on the drug scene. 
Low and stable rates of mortality resulting from overdoses on opiates correspond to a decreasing estimated number 
of heroin users and to an increasing number of Subutex users. The number of pervitin users who are in contact with 
low-threshold and treatment programmes is not decreasing, which suggests that pervitin is readily available on the 
black market – an increase in pervitin production from freely available medicaments which contain pseudoephedrine 
was recorded in 2005. Sporadic deaths resulting from cocaine overdoses were recorded in the last two years – this 
corresponds to an increasing prevalence of cocaine among recreational drug users on the dance scene and an 
increasing number of cocaine-related crimes; nevertheless, the prevalence of cocaine and its use in the general 
population or among problem drug users is still low in the Czech Republic. The stable occurrence of hepatitis and 
HIV/AIDS and the decreasing number of reported clinical cases of hepatitis reflect the growing efficiency of needle 
exchange programmes and expansion of substitution treatment. 
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PART A: DEVELOPMENTS AND NEW TRENDS IN 2005 
1 National Drug Policy and Its Context 
The Government of the Czech Republic is responsible for the preparation and enforcement of the national drug 
policy. The Council of the Government for Drug Policy Coordination (CGDPC) is the main initiating, counselling, and 
coordinating body of the Government for drug-related issues. Ministers of the appropriate ministries are members of 
this Council. The Council meets approximately four times a year. The Secretariat of the CGDPC is an organisational 
part of the Office of the Government of the Czech Republic and provides for the activities of the Council.  
Act 379/2005 Coll., on Measures for Protection from Harm Caused by Tobacco Products, Alcohol, and Other 
Addictive Substances, was adopted in 2005. Inter alia, it defines responsibilities regarding the guaranteeing of drug 
policy by state administration and self-administration bodies. It defines basic types of services for drug users for the 
first time in the history of the Czech Republic.  
The National Drug Policy Strategy for the period 2005 to 2009 (the 2005–2009 National Drug Strategy) has come 
into force. The Action Plan for the Implementation of the National Drug Policy Strategy for the period 2005–2006 
(the 2005–2006 Action Plan) was also adopted in 2005, and it defines activities, deadlines, and responsibilities 
regarding the goals which were mentioned in the strategy. 
The system of Certification of the Professional Competency of Services for Drug Users was launched.  
Regional drug coordinators were appointed in 13 out of the 14 regions, and they make use of a network of contact 
workers in individual municipalities with extended competencies in their region. Most regions (with the exception of 
the Pilsen and Vysočina regions) have drawn up a regional drug policy document.  
In comparison with 2004, drug policy expenditures increased by approximately CZK 44 million (€ 1.48 million) in 
2005. The amount of financial resources provided by regions has also increased. 
1.1 Legal Framework 
1.1.1 Legislation 
1.1.1.1 Act 379/2005 Coll. on Measures for Protection from Harm Caused by Tobacco Products, 
Alcohol, and Other Addictive Substances 
After several years of discussing the draft bill, the Lower House of the Parliament of the Czech Republic adopted 
the Act on Measures for Protection from Harm Caused by Tobacco Products, Alcohol, and Other Addictive 
Substances (No. 379/2005 Coll.) in August 2005. It came into force on January 1, 2006 and replaced the previous 
Act on Protection against Alcoholism and Other Drug Addictions (No. 37/1989 Coll.), which no longer complied with 
contemporary state of knowledge and needs in the field of drug prevention and did not take into account the new 
regional administration of the Czech Republic.  
The new law defines legal measures which especially involve the prevention and harm reduction of substance use, 
as well as health care and the system of social services. According to the submitters of the bill, the main goals 
especially involved: 
• to transfer responsibilities to regional and municipal level, in accordance with the reform of public administration, 
and increase their powers to implement preventive measures and address drug-related issues, 
• to provide for the expedient and effective spending of financial resources for the reduction of the harms caused 
by tobacco products, alcohol, and addictive substances, 
• to reduce the availability of and demand for tobacco products and alcohol by establishing rules for alcohol and 
tobacco sales and distribution and by introducing measures for the protection of the public, including sanctions for 
failure(s) to observe them, 
• to reduce the harm caused by the use of addictive substances; unlike the previous one, this act briefly defines the 
types of professional care supplied to those who harmfully use tobacco products and alcohol and other addictive 
substances and those addicted to these substances.  
The new Act codifies several codes and principles which were embedded in all previous national drug strategies 
(since the 1990s). These principles used to be applied in practice, but lacked clear legislative support. For the 
purposes of the Act, the term “drug policy” relates to illicit drugs, as well as tobacco products and alcohol. According 
to the Act, drug policy involves measures in primary, secondary, and tertiary prevention. The government 
coordinates the implementation of drug policy at the national level via ministries and other state administration 
bodies. The Act also gives the government an opportunity to establish a special advisory body for drug policy 
coordination (the CGDPC currently fulfils this role).  
The Act also defines rules for examination for the presence of alcohol or another addictive substance. A 
professional examination which detects the content of alcohol and other addictive substances is mandatory for a 
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person about whom it is reasonable to assume that the use of the substances put him/her in a condition in which 
he/she could harm him/herself or other persons, or that he/she could cause bodily harm to someone else under the 
influence of the substance(s). It also specifies which bodies are entitled to carry out an orientation breath test or take 
a saliva sample (the police, prison service, or employer) and medical examination by means of a breath test and 
taking samples of biological material (only health care facilities with adequate professional and operational 
competency).  
The transfer of a significant proportion of the competencies to individual territorial self-governing units (regions and 
municipalities) represents a substantial change from the previous legislative arrangement.  
In particular, self-governing regions: 
• coordinate and participate in the implementation of drug policy in their territory (while cooperating with state 
bodies, municipal bodies, and service providers); 
• prepare a regional drug policy strategy; 
• establish a position of a regional drug coordinator (his/her job description must not include the fulfilment of other 
tasks); the Act also defines his/her competencies, and 
• collect and evaluate data on the drug situation in their territory. 
1.1.1.2 Act 411/2005 Coll. Amending Act 361/2000 Coll., on Traffic on Land Communications (Road 
Traffic Act) and Amending Certain Laws  
Inter alia, adoption of the Act 411/2005 Coll. amended the merits of misdemeanours (Act 200/1990 Coll., on 
misdemeanours) and criminal offences (Act 140/1961 Coll., Penal Code) which penalise the driving of motor 
vehicles under the influence of addictive substances. 
A misdemeanour against safety and the free flow of traffic on land communications (Section 22 of the Act on 
Misdemeanours) is committed by a person who does the following while driving or riding on land communications:  
• drives a vehicle or rides an animal immediately after drinking an alcoholic beverage or using another addictive 
substance or during a period after drinking alcohol or using an addictive substance while he/she is still under the 
influence of it/them,  
• drives a vehicle or rides an animal while in a state of incapability as a result of the use of alcohol or another 
addictive substance,  
• refuses to submit to a test to indicate whether he/she was under the influence of alcohol or another addictive 
substance while driving a vehicle or riding an animal, even though the examination does not pose a danger to 
his/her health. 
Section 201 of the Penal Code newly stipulates that it is a criminal offence of menace under the influence of 
addictive substances when a person “performs employment duties or another activity during which he/she could 
endanger the life or health of other persons or cause considerable damage to property while (even negligently) in 
an incapable state as a result of the use of an addictive substance”. According to the previous legal regulations, the 
commission of this offence also required other circumstances (previous sanction, causing a serious consequence, 
especially risky activities) which nowadays represent the qualified facts of the case (Section 201, paragraph 2 of the 
Penal Code). 
In comparison with the previous legislation, the new penalties for the above-mentioned misdemeanours and 
criminal offences are more stringent – see Table 1-1.  
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Table 1-1: Changes in penalties for misdemeanours and criminal offences of driving under the influence of addictive 
substances which came into force on July 1, 2006 
Driving immediately after using 
and under the influence 
Driving while in a state of incapability Type of 
unlawful 
conduct Before June 30, 
2006 
From July 1, 
2006 
Before June 30, 2006 From July 1, 2006 
Misdemeanour  Statutory 
penalty up to 




activities for up 




up to 20,000  
 
Prohibition of 
activities for 1 to 
2 years 




Prohibition of activities for up 
to 2 years 
Statutory penalty from CZK 
25,000 
up to CZK 50,000  
 
Prohibition of activities for 1 to 
2 years 
It was not regarded as a 
criminal offence 
Unsuspended sentence for up 
to 1 year, statutory penalty, 
prohibition of activities 
Criminal offence It was not 
regarded as a 
criminal offence  
It is not 
regarded as a 
criminal offence




Unsuspended sentence for up 
to 1 year, statutory penalty, 
prohibition of activities 




Unsuspended sentence from 
6 months to 3 years, 
prohibition of activities 
Note: A refusal to submit to a test for the presence of addictive substances was and still is classified as a misdemeanour; the sanctions 
are the same as for a misdemeanour committed in a ”state of incapability”. Accordingly, they have also become stricter since July 1, 
2006.  
1.1.1.3 Draft Bill of the New Penal Code 
The Lower House of the Parliament of the Czech Republic definitively rejected the draft bill of the new Penal Code, 
which also contained changes regarding “drug-related” criminal offences, on February 21, 2006.  
The changes proposed in the draft bill of the Penal Code involved drawing a distinction between cannabis drugs 
and other illicit drugs in cases of the possession of a quantity greater than small for personal use (currently, Section 
187a of the Penal Code). The draft bill assumed that the penalty for cannabis drugs, i.e. marijuana or hashish, 
would be reduced (to a maximum of one year’s imprisonment), while the penalties for other drugs would be 
increased (to up to two years’ imprisonment). The draft bill also assumed that a new offence of “growing 
psychotropic plants” would be introduced. It was expected that this provision would introduce different sanctions for 
the unauthorised growing of cannabis for personal use (growing of a small quantity for personal use only would be 
regarded as a misdemeanour) and illegal production of drugs – including cannabis – for the purpose of distributing 
them.  
The proposed draft bill represented an extensive and complex re-codification of the criminal law. For instance, it was 
supposed to increase the maximum length of the sentence for murder from 15 to 20 years and the maximum length 
of an exceptional sentence from 25 to 30 years, and to lower the age of criminal responsibility from 15 to 14 years of 
age. It also expected that so-called detention institutions for especially dangerous and insane offenders would be 
established, and that the possibility of a sentence of home confinement for up to two years would be introduced for 
criminal offences resulting from negligence. At the same time, the bill wanted to extend the list of racially motivated 
criminal offences and introduce other substantial changes.  
The Lower House of the Parliament of the Czech Republic discussed the recodification of the Penal Code for nearly 
two years. After the government draft bill was approved in November 2005, the Senate rejected it and the draft bill 
was returned for renegotiation to the Lower House of the Parliament. At this stage of negotiations, the Constitution 
of the Czech Republic no longer makes it possible to raise new amendments. In the end, the draft bill did not 
receive the necessary majority of votes (March 2006) because of the deletion of the provisions which penalised the 
misuse of information in business relations and which were supposed to prevent the so-called tunnelling of firms.1  
                                                          
1 Advocates of approving the bill of the Penal Code argued that the misuse of information can be punished by means of other 
provisions, for instance as fraud. They also pointed out that the provisions of this Section were only used in a few dozen cases, while 
most of the cases took place in combination with other criminal offences. 
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1.1.2 Implementation of the Law 
Knowledge on the implementation of the law in the prosecution of drug offences or misdemeanours is not 
extensive. One of the reasons is the almost total absence of published studies in this field. The exceptions involve, 
for instance, the ‘Impact Analysis Project of New Drugs Legislation in the Czech Republic’ (Zábranský et al.  2001) 
or the study ‘Drugs and the Czech Prison Population in the Context of the Drug Scene and Criminal Law 
Legislation’ (Marešová, 2003). 
According to the Report on the Activities of the Office of the Supreme Prosecutor, the provisions ensuring the 
protection of the identity and appearance of witnesses according to Section 55, paragraph 2 of the Code of Criminal 
Procedure, the surveillance of persons according to Section 158d of the Code of Criminal Procedure, and 
eavesdropping and recording of telecommunication operations according to Section 88 and Section 88a of the 
Code of Criminal Procedure are often used during preliminary proceedings pertaining to the prosecution of drug 
offences (Nejvyšší státní zastupitelství, 2006).  
In 2005 and 2006, the Institute for Criminology and Social Prevention has implemented an extensive research 
project, ‘Possibilities for Criminal Justice in Drug Policy’. The project aims to assess the mutual influence between 
legislation and the application of criminal law measures and the development of drug crime and the drug scene in 
the Czech Republic after 1989. An analysis of criminal law regulations, available literature, documents from relevant 
institutions, available statistical data, and selected criminal files was carried out within the framework of the research 
project. A questionnaire survey among experts in a given field (police officers, public prosecutors, judges, court-
appointed experts etc.) and controlled interviews with experts were carried out. The final report of the project will be 
drawn up in December 2006 (Institut pro kriminologii a sociální prevenci, 2005).  
As far as drug-related crime is concerned, statistical data on persons prosecuted, accused, and sentenced in 
connection with drug offences and other information, presented in the Annual Reports of the National Drug Squad 
(Národní protidrogová centrála , 2006a) and the General Customs Headquarters (Generální ředitelství cel , 2006b) 
and in the above-mentioned report of the Office of the Supreme Prosecutor (Nejvyšší státní zastupitelství, 2006) 
provide information on the practice of the bodies responsible for criminal proceedings – see the chapters Drug-
Related Crime, page 56 and Drug Markets, page 66.  
1.2 Institutional Framework, Strategies and Policies 
1.2.1 National Strategy 
The year 2005 was the first year of the implementation of the 2005–2009 National Drug Strategy, which was 
adopted by Government Resolution 1305 in December 2004, and the 2005–2006 Action Plan – see the 2004 
Annual Report of the National Monitoring Centre for Drugs and Drug Addiction (NMC). 
The Secretariat of the CGDPC drew up an evaluation report regarding the implementation of the 2005-2006 Action 
Plan in 2005. The government acknowledged it in Government Resolution No. 514 in May 2006.  
The 2005–2006 Action Plan contains a total of 144 tasks which are divided into 43 goals which relate to seven drug 
policy fields: (1) primary prevention; (2) treatment and after-care; (3) risk reduction; (4) drug supply and demand 
reduction and law enforcement; (5) coordination and funding; (6) the field of information, research, and evaluation 
and (7) international collaboration. 
72 (i.e. 50%) of the 144 tasks were to be fulfilled by December 31, 2005 or they were being fulfilled on a continual 
basis. 54 of these 72 tasks were fulfilled, 6 partially, 8 were not fulfilled and insufficient information was available 
about 4 tasks. Therefore, 85% of the tasks for the year 2005 were fulfilled completely or partially.  
The most significant framework changes to the drug policy in 2005 involve: 
• Adoption of Act 379/2005 Coll., on Measures for Protection from Harm Caused by Tobacco Products, Alcohol, 
and Other Addictive Substances as amended. Inter alia, the act defines responsibilities regarding the 
guaranteeing of drug policy by state administration and self-administration bodies. For the first time in the history 
of the Czech Republic, it defines basic types of services for drug users – see the chapter on Legislation, page 3 
for more information. 
• Launch of the system of Certification of the Professional Competency of Services for Drug Users, which was 
approved by Government Resolution No. 300 in March 2005 – see the chapter on Treatment, page 32. 
• Approval of Rules for Drawing Financial Resources for Drug Policy from the State Budget, which was approved 
by Government Resolution No. 700 in June 2005. 
1.2.2 Drug Policy Coordination 
The Council of the Government for Drug Policy Coordination (CGDPC), an interministerial advisory body of the 
government which is in charge of the Czech Republic's drug policy coordination, met five times in 2005. The 
Secretariat of the CGDPC controls the activities of working committees and groups which are entrusted with 
horizontal (interministerial) and vertical coordination – see the overview in Figure 1-1. 
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Figure 1-1: System of vertical and horizontal drug policy coordination in the Czech Republic 
  
Regional drug coordinators have been appointed in all regions except the Moravian-Silesian region, and they take 
advantage of a network of outreach workers in individual municipalities with extended competencies in their region. 
Most regions have prepared their regional drug policy strategies (with the exception of the Pilsen, Vysočina, and 
Olomouc regions) – see Table 1-2. The Secretariat of the CGDPC continued to collaborate with regions within the 
framework of the operation of the Vertical Coordination working group (regional drug coordinators from all regions 
are members of the working group). 
Secretariat of the CGDCP
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(CGDCP) 
Government of the Czech 
Republic  
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document of the drug 
policy in the region  
Institutional assurance, advisory bodies,  
commissions, working groups  
Prague 2002–2006 Strategic Drug 
Policy Plan  
– Regional drug coordinator and Regional Drug Prevention Department 
at the Office of the Mayor  
– Drug Commission of the Prague City Council 
– Working groups for (1) primary prevention, (2) harm reduction, (3) 
treatment and after-care, and (4) data collection 
Central 
Bohemia 
2005–2009 Regional Drug 
Strategy  
– Regional drug coordinator and Departments of Prevention and 
Humanitarian Activities at the Departments of Social Affairs  
– Drug Commission as an advisory body of the President of the Region 
– Working groups for (1) primary prevention, (2) harm reduction, and (3) 
treatment and resocialisation 
Southern 
Bohemia  
2005–2009 Drug Policy 
Strategy, including 2005–
2009 Action Plan 
– Regional drug coordinator at the Department of Social Affairs and 
Health  
Drug Coordination Group as an advisory body of the Deputy President 
of the region 
Pilsen – – Regional drug coordinator at the Department of Health 
– Drug Commission has not been appointed 
Karlovy 
Vary 
2005–2009 Regional Drug 
Strategy and Action Plan  
– Regional drug coordinator at the Department of Social Affairs 
– Drug Commission of the Council of the Region 
Ústí nad 
Labem 
2005–2009 Drug Policy 
Action Plan  
– Regional drug coordinator at the Department of Social Affairs and 
Heallth  
– Health Commission of the Council of the Region  
– Working groups for (1) primary prevention, (2) harm reduction, (3) 
treatment and resocialisation, and (4) coordination  
Liberec 2005–2006 Drug Policy 
Action Plan 
– Regional drug coordinator at the Department of Social Affairs 
– Drug Commission of the Council of the Region 
– Working groups for (1) primary prevention, (2) harm reduction, (3) 
treatment and resocialisation, and (4) coordination  
Hradec 
Králové 
2002–2006 Drug Policy 
Strategy  
– Regional drug coordinator at the Department of Health and Social 
Affairs 
– Commission for Specific Commission at the Council of the Region 
– Anti-drug working group 
Pardubice 2005–2009 Drug Policy 
Strategy, including Action 
Plan 
– Regional drug coordinator at the Department of Health 
– Drug Commission of the Council of the Region  
 
Vysočina – – Regional drug coordinator at the Secretariat of the President of the 
Region  
– Drug Commission has not been appointed  




2005–2009 Drug Policy 
Strategy, including Action 
Plan 
– Regional drug coordinator at the Department of Social Affairs 
– Drug Commission has not been appointed 
– Working group for prevention 
Olomouc Strategic Anti-drug plan 
for the period 2005–2010, 
2006–2007 Drug Policy 
Action Plan 
– Regional drug coordinator at the Office of the President of the Region 
– Commission for prevention of social-pathological phenomena at the 
Council of the Region 
Zlín 2005–2009 Drug Policy 
Strategy, and 2005–2006 
Action Plan  
– Regional drug coordinator at the Office of the Rpesident of the Region
– Commission for prevention of social-pathological phenomena at the 
Council of the Region  
Moravian-
Silesian 
Strategic Antidrug Plan for 
the Period 2005–2010, 
Drug Policy Action Plan 
for the Period 2006–2007 
– The position of a regional drug coordinator has not been established – 
an officer of the Department of Social Affairs is in charge of the agenda  
– Drug Commission has not been appointed 
– Working group for drug prevention at the Department of Social Affairs 
of the Regional Board of Representatives 
 
page 9 
1.3 Budget and Public Expenditure 
The data in this chapter involve public budget expenditures which are identified as drug policy expenditures. Other 
expenditures in the field of supply and demand reduction cannot be calculated without further research. 
As in previous years, drug policy funding was implemented on two levels, i.e. at the central and the local levels. The 
government gave the The Council of the Government for Drug Policy Coordination (CGDPC) the task of distributing 
financial resources from the budget chapter General Cash Administration – Drug Policy Expenditures. Since 2004, 
the Office of the Government of the Czech Republic has administered the provision of subsidies approved by the 
CGDPC. The following ministries had Drug Policy Programme expenditures in their budget in 2005: the Ministry of 
Health; Ministry of Education; Ministry of Labour and Social Affairs; Ministry of Finance – General Customs 
Headquarters, Ministry of Justice, and the Ministry of Defence. The Ministry of the Interior does not have Drug 
Policy Programme expenditures in its budget; however, it supports drug prevention activities within its Social and 
Crime Prevention Programme. 
Table 1-3 shows the expenditures for drug policy from the state budget and regional budgets in 2005. 




















































































































































Prague 953 468 21 93 0 846 83 2,463 1,029 407 3,899
Central Bohemia 192 92 25 117 0 134 14 573 495 176 1,244
Southern 
Bohemia  170 119 14 142 0 3 5 454 175 55 683
Pilsen 246 10 12 7 0 9 5 288 113 133 534
Karlovy Vary 96 0 7 62 0 11 0 176 35 26 237
Ústí nad Labem 380 107 19 175 0 75 2 758 232 155 1,145
Liberec 162 58 10 3 0 51 0 284 271 36 591
Hradec Králové 67 45 13 44 0 16 2 186 69 28 284
Pardubice 50 2 12 23 0 5 4 96 185 39 320
Vysočina 141 142 12 161 0 3 0 459 233 33 726
Southern Moravia 370 37 30 227 0 21 13 698 249 159 1,106
Olomouc 224 32 14 131 0 21 6 427 67 47 541
Zlín 58 3 14 53 0 0 0 126 71 66 263
Moravian-Silesian 306 10 30 207 0 39 1 593 147 338 1,078
Total with 
regional 
destination 3,414 1,124 232 1,445 0 1,233 133 7,582 3,369 1,699 12,650
Projects without 
regional 
destination 133 0 83 101 487 0 0 804 0 0 804
Total 3,547 1,124 315 1,546 487 1,233 133 8,385 3,369 1,699 13,453
 
The CGDPC decided to support 173 local drug policy programmes with a total amount of € 3,414,000. The 2005 
subsidy proceedings took place in two rounds: the original first round was completed with a second one in the 
course of the year so that the implementation of several programmes would not be endangered. The support 
especially involved projects of NGOs in the field of low-threshold services, outpatient treatment, intensive outpatient 
treatment, therapeutic communities, resocialisation, and aftercare. The amount of € 133,000 for the expenditure on 
the activities of the Secretariat of the CGDPC (including the National Monitoring Centre for Drugs and Drug 
Addiction) was withdrawn according to the classification presented in Table 1-4. 
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Table 1-4: Expenditure of the Secretariat of the CGDPC from the General Cash Administration in 2005 (€) 
Purpose of drawing Withdrawn resources 
Assessment of applications for subsidies of the 
CGDPC 6,310
Translations and other services 11,950
Pilot verification of Primary Prevention Standards 
and preparation of evaluation criteria 1,310
Training of regional drug coordinators and 
members of certification teams 13,770
Publication and information activities  33,270
Analyses of quality and availability of services  24,810
Studies and research outsourced 41,570
Total 132.990
 
In 2005, the Ministry of Health gave priority to funding projects which met the priorities of the Ministry of Health. 
They involved substitution and detoxification treatment for drug users, outpatient treatment, including AT treatment, 
smoking cessation programmes, educational programmes for physicians and health care staff, inpatient treatment 
of drug users, and other secondary prevention programmes.  
The Ministry of Education provided resources within the framework of two programmes which aimed to promote 
healthy lifestyles and the rejection of all forms of self-destruction, manifestations of aggressiveness, and 
lawbreaking among children. Regional authorities provided for preventive programmes implemented by schools, 
school facilities, and NGOs; the total budget was € 232,000. The Ministry of Education carried out separate subsidy 
proceedings and supported supragional and national projects with an amount of € 83,000.  
The Ministry of Labour and Social Affairs earmarked a total of € 1.54 million for its drug policy programme. A total of 
104 projects involving 50 organisations were subsidised; it is 18 projects less than in 2004 as a consequence of the 
merging of several projects and organisations. A critical part of the resources was expended on the operations of 
low-threshold centres (€ 561,000) and therapeutic communities (€ 272,000). 
The expenditures of the Ministry of Finance for drug policy involved the budget of the General Customs 
Headquarters; an amount of € 487,000 was used for operational investigative activities and technical quipment. 
The drug policy budget of the Ministry of Defence was especially used to fund the implementation of monitoring and 
preventive projects and for purchases of professional literature and training for future lecturers among Army 
personnel and prevention methodologists. 
The budget of the Police of the Czech Republic provided for the operations of the National Drug Squad; the amount 
of resources for the activities of the National Drug Squad was not published, as they are a classified matter. 
Antidrug activities were also supported within the framework of the Crime Prevention Programme; it is impossible to 
express numerically the level of costs of these activities without further analysis.  
The regions earmarked € 3.37 million for drug policy programmes in 2005; 11 of the 14 regions earmarked more 
resources in 2005 than in 2004 and 3 regions earmarked fewer resources – see Table 1-5.  
Table 1-5: Drawing of financial resources from regional budgets in 2002–2005 (€ thousand) 
Region 2002 2003 2004 2005 
Prague 426.4 418.5 878.7 1,028.6
Central Bohemia 117.8 268.6 462.3 495.2
Southern Bohemia  97.8 94.2 194.1 174.6
Pilsen 0.0 33.6 50.4 113.0
Karlovy Vary 3.2 16.8 16.8 34.7
Ústí nad Labem 48.2 253.2 265.2 231.8
Liberec 0.0 91.7 193.4 271.1
Hradec Králové 24.8 31.7 67.8 68.8
Pardubice 50.4 50.4 60.4 184.7
Vysočina 0.0 60.4 138.7 232.7
Southern Moravia 100.7 67.2 167.9 248.9
Olomouc 2.7 10.3 43.6 67.2
Zlín 36.8 117.2 80.6 70.5
Moravian-Silesian 76.2 100.7 119.9 147.0
Total 985.0 1,614.4 2,739.7 3,368.7
Note: Figures for 2002–2004 were re-calculated by the 2005 exchange rate (1 € = CZK 29,784) 
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Table 1-6 provides an overview of the development of drug policy expenditures from state, regional, and municipal 
budgets. Map 1-1 gives an overview of financial resources drawn from public budgets for the implementation of 
drug policy programmes in 2005.  
Table 1-6: Drawing of financial resources from the state budget and from municipal budgets in 2002–2005 (€ thousand) 





2002* 6,829 985 n.a. 7,814
2003* 7,415 1,614 n.a. 9,029
2004* 6,909 2,740 2,113 11,762
2005 8,385 3,369 1,699 13,453
Notes: * Figures for 2002–2004 were re-calculated by the 2005 exchange rate (1 € = CZK 29,784), ** state budget without the budget 
of the National Drug Squad and other police branches, *** expenditures for drug policy from municipal budgets were not monitored in 
2002 and 2003.  
Map 1-1: Drawing of financial resources for drug policy from state and municipal budgets in regions of the Czech 
Republic in 2005 (€ per 100,000 inhabitants) 
 
 
1.4 Social and Cultural Context of the Drug Policy 
Public attitudes towards drug use and drug users are described in the chapter on Drug Use in the Population, 
page 14.  
1.4.1 Approaches Towards Drugs and Drug Users 
A legal categorisation of drugs based on their degree of health and social risks according to an intent from 2001 
which was approved by the government in 2001 (Vláda ČR, 2001) was originally included in the recodification of the 
Penal Code (House Print 265/2003). It was approved by the Lower House of the Parliament of the Czech Republic 
but then the Senate rejected the draft; the Lower House then failed to manage to outvote the so-called veto of the 
Senate2 and so the draft was not adopted – see also the chapter on Legal Framework, page 3. The interest of the 
MPs and the professional public focused especially on the provisions which would change the approach to 
cannabis drugs. 
Public debate about this topic practically faded away in 2005 and even the former (until June 2006) parliamentary 
party the Union of Freedom, which put the topic of the decriminalisation of drugs in its controversial programme for 
elections to the Lower House of the Parliament of the Czech Republic in June 2006, did not manage to reopen it. 
Seven articles in the daily press paid detailed attention to the wording of the new drug sections in the new Penal 
Code. It is especially worth mentioning the article in the daily newspaper Právo (Cihlářová, 2005), in which the 
Director of the National Drug Squad, Jiří Komorous, expressed his disapproval of the wording of the law, which was 
approved by the Lower House of the Parliament of the Czech Republic. According to the new wording, the 
possession of marijuana and hashish and growing cannabis for personal use would be punished less strictly than 
the possession or production of so-called hard drugs. On the other hand, drug professionals from the field of 
demand reduction who have publicly expressed their opinion on this topic welcomed the proposed arrangement. 
                                                          
2 The controversial nature of other provisions, especially those concerning economic offences, is more likely to have been the cause of 
the rejection of this draft bill.  
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1.4.2 Initiatives in the Parliament and Civic Society 
No initiatives regarding drugs issues were submitted by MPs in the Parliament of the Czech Republic in 2005; 
however, significant draft bills were discussed. See the chapter on Legal Framework, page 3. 
Act 379/2005 Coll., on Measures for Protection from Harm Caused by Tobacco Products, Alcohol, and Other 
Addictive Substances was adopted in August 2005 with no major interest on the part of the public (it was a 
governmental draft bill). It came into force on January 1, 2006. The public was interested especially in the provision 
which banned smoking at public transport stops (even under the open sky). There was a media debate about the 
advantages and disadvantages of a ban on smoking in restaurants (which was not included in the Act, but the topic 
was medialised in connection with the legal regulations in several European countries). 
The trend from 2004 continued – the issues of alcohol and illicit drugs gradually penetrated the agendas of political 
parties. Five parties which are still in the Parliament now (Czech Social Democratic Party, Civic Democratic Party, 
Communist Party of Bohemia and Moravia, Christian and Democratic Union – Czechoslovak People’s Party, and 
Union of Freedom – Democratic Union3) and two non-parliamentary parties which were the most likely to get into 
the Parliament after the elections in June 2006 (the Green Party and the European Democrats) dedicated at least a 
short passage in their election programmes to drugs issues. The European Democrats4 (Evropští demokraté, 2006) 
and the Christian and Democratic Union – Czechoslovak People’s Party (Křesťanská a demokratická unie - Čs. 
strana lidová, 2006) gave the most extensive consideration to drugs issues in their election programmes. The 
Christian and Democratic Union changed its attitude in favour of a balanced drug policy and therefore it did not 
resume the War on Drugs campaign from 2004 (Křesťanská a demokratická unie - Čs. strana lidová, 2004); the 
topic of drugs is mentioned in the “Internal Security” section of the election programme. The Civic Democratic Party 
(the strongest parliamentary party after the elections) included a balanced programme, which involved drug policy, 
into the section “Safety of Citizens” (Občanská demokratická strana, 2006). An opposition party, the Communist 
Party of Bohemia and Moravia, also included its programme in the section entitled “Safety of the Citizen” (Haló 
noviny, 2006) and it focused on crime prevention and the protection of young people. The Green Party got into the 
Parliament for the first time in 2006, and it dealt in greater detail with issues concerning tobacco smoking (its further 
curtailment) and it mentioned in one sentence that it intends to support drug addiction prevention programmes; it 
mentioned drug crime in connection with the regulation of prostitution (Strana zelených, 2006). The 81-page 
election programme of the ruling Czech Social Democratic Party, whose minister has been responsible for drug 
policy coordination since 2004, only dealt with drugs marginally in connection with the leisure time activities of young 
people and prevention of socially pathological phenomena (Česká strana sociálně demokratická, 2005). 
The cultural association Kontext5 has been actively opposing the public promotion of alcohol; in particular, they file 
complaints to Trade Licensing Offices on the basis of the provisions of Act 40/1995 Coll., on the regulation of 
advertising and changes and amendments to Act 461/1991 Coll. on the Operation of Radio and Television 
Broadcasting, which bans advertisements for alcoholic beverages targeted at persons aged under 18. For instance, 
it highlighted the fact that alcoholic beverages were promoted during the Olympic Games for Children in 2005, 
which were held by the Southern Moravian regional authority. In the long term, the association has especially 
targeted trade fairs, celebrations, and festivals whose name and content is linked to alcoholic beverages and which 
take place with the participation of municipal and regional councils (Národní monitorovací středisko pro drogy a 
drogové závislosti, 2005). 
1.4.3 Media 
A media analysis was carried out on the basis of an assignment by the Secretariat of the CGDPC (NEWTON 
INFORMATION TECHNOLOGY, s.r.o., 2006a; NEWTON INFORMATION TECHNOLOGY, s.r.o., 2006b); some 
results were published in the Focused on Drugs periodical (Národní monitorovací středisko pro drogy a drogové 
závislosti, 2006b). 
The medialisation of drugs issues in the Czech media was approximately the same in 2004 and 2005, from a 
quantitative perspective. However, significant differences appeared in a comparison of the medialisation of the 
activities of the Secretariat of the CGDPC and the NMC in 2004 and 2005. 383 contributions about these activities 
(press releases and press conferences) were published in 2004, while only 143 contributions were published in the 
media in 2005, i.e. the number of contributions declined by 58%. 
The structure of the topics6 in the medialisation of drugs issues (drugs in general) was approximately the same in 
both of the monitored years – see Figure 1-2. 
                                                          
3 The Union of Freedom – Democratic Union was not successful in the 2006 elections. 
4 It did not succeed in the elections to the Lower House of the Parliament of the Czech Republic. 
5 An informal association which is based in Brno; it has been operating since 2001 (www.sweb.cz/sdruzenikontext). 
6 For the purposes of the analysis, the topics assigned were identical to those in the plan of implementation of the 2005–2006 Action 
Plan. 
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Figure 1-2: Structure of topics in drug policy medialisation in 2004 and 2005; number of contributions (NEWTON 









































The proportion between the medialisation of drugs by type was very similar in both years. Other legal drugs 
(alcohol, tobacco, and medicaments) drew the most attention in the context of drugs issues. Alcohol became the 
most medialised drug mentioned in the context of drugs issues. Stimulants, and especially pervitin, got the biggest 
media attention after licit drugs. Cannabis was the third most commonly mentioned group of drugs in the media in 
both years. The media also focused on opiates in a significant manner.  
The key findings of the media analysis of the drug policy are as follows: 
• 29,539 contributions dealt with general drugs issues in 2005; 4,087 (14%) of them were about drug policy.  
• 3% of the contributions were related to the activities of the CGDPC and the NMC. The Annual Report: The Czech 
Republic – 2004 Drug Situation and the certification of the professional competency of services for drug users 
attracted the greatest attention; at the same time, the EMCDDA´s Annual Report on the State of the Drugs 
Problem in Europe and the results of the international school survey ESPAD received high publicity.  
• The most frequently mentioned topics involved supply reduction and law enforcement, for instance in connection 
with reports of drug trafficking and police raids, the operations of the National Drug Squad, or the process of 
approving the new Penal Code.  
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2 Drug Use in the Population 
The situation in the field of drug use among the general population has remained stable, and no significant change 
was recorded in 2005. No general population survey or national school survey was carried out in 2005; only the 
results of several small-scale regional or local surveys are available.  
Approximately 20% of the adult population have tried an illicit drug, and the prevalence of experiences with drugs 
among young people is even higher (44% of high school students aged 16 and 56% of students aged 18) – see 
(Mravčík et al.  2005a). Cannabis and ecstasy are the most commonly used illicit drugs, and the scope of 
experiences with drugs which pose more serious health and social risks (opiates, pervitin, cocaine) is very low in the 
Czech Republic. 
The society shows low tolerance towards drug users, as well as towards heavy alcoholics. A large part of society 
still perceives drug use as unacceptable behaviour, similarly to, for instance, driving under the influence of alcohol. 
2.1 Drug Use Among the General Population 
The most recent general population survey which focused on the use of illicit drugs was carried out in 2004 
(General Population Survey of the Health Status and Lifestyle of the Population in the Czech Republic); its results 
were summed up in the 2004 Annual Report. A further analysis of the results was carried out in 2005, and detailed 
results of the survey in the field of the health status of the population, smoking, alcohol drinking and illicit drugs use 
are being prepared for press. It is anticipated that the next wave of the General Population Survey will take place in 
2008. 
Data on the subjectively perceived drug use in one’s own environment and data on the perceived availability of illicit 
drugs were analysed afresh. Nearly 37% of adults (aged 18–64) reported that they know someone who uses 
marijuana; more than 18% know an ecstasy user and nearly 13% know a user of magic mushrooms or other 
natural hallucinogens. 12.5% of the respondents know someone who uses inhalants and, surprisingly, as many as 
11% know someone who uses pervitin. Approximately 4% of the respondents know someone who uses heroin or 
cocaine (Ústav zdravotnických informací a statistiky, 2005e). 
The question of how easy or difficult it is to get an illicit drug within 24 hours, if desired, was also tracked. It has been 
shown that the subjectively perceived availability of illicit drugs is relatively high – 36% of the respondents reported 
that they could get marijuana or hashish rather easily or very easily, 22% would be able to get ecstasy, 15% magic 
mushrooms or other natural hallucinogens, and 11% would be able to get pervitin or other amphetamines. 5–6% of 
the respondents would easily be able to get heroin or cocaine (Table 2-1). 60% of adults would know how to get 
sedatives (without medical prescription) and 53% would easily get inhalants. More than 40% of the respondents 
reported that they cannot assess whether they would be able to get all of the substances tracked, with the exception 
of sedatives, inhalants, and cannabis.  
Table 2-1: Subjectively perceived availability of drugs – answers to the question: “How difficult do you think it would be to 
get the following drugs within 24 hours if you intended to?” (%) (Ústav zdravotnických informací a statistiky, 2005e) 









Sedatives, hypnotics 3.9 6.9 9.9 27.7 31.9 19.6 
Marijuana, hashish  11.6 8.7 10.0 18.0 17.9 33.8 
Ecstasy  16.2 10.9 9.4 12.9 9.1 41.4 
Pervitin, amphetamines 19.8 14.4 9.0 7.0 4.4 45.4 
Cocaine, crack 22.4 16.6 7.4 3.7 2.1 47.7 
Heroin, opiates 23.3 17.2 6.7 3.4 1.9 47.6 
LSD 22.2 16.4 6.9 4.1 2.2 48.0 
Magic mushrooms, natural hallucinogens 17.2 14.5 8.8 8.8 6.0 44.8 
Inhalants 7.1 4.9 5.8 19.0 33.9 29.3 
 
45.5% of the adult population had been offered an illicit drug for free or for money; 22.5% of the respondents 
reported that it was a one-off event. 14% of the adults mentioned that they had been offered illicit drugs more than 
five times in their lifetime. The persons who had been offered a drug most commonly reported that it had occurred 
at a club or disco (24%), in a bar or restaurant (21.5%), or at a private party (16%) – see Figure 2-1. The data from 
the survey do not make it possible to determine which illicit drug was involved. 
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The prevalence of experiences with illicit drug use was tracked in 2005 within the framework of a three-year project, 
‘Epidemiology of Psychiatric Diseases in the Population’ (implemented by the Prague Psychiatric Centre); the 
results have not been made available so far. 
The Institute of Health Information and Statistics of the Czech Republic did not carry out the expected fresh wave of 
the Sample Survey on the Health Status of the Population of the Czech Republic in 2005. The survey has been 
implemented on a periodical three-year basis since 1993, and it has also tracked the use of drugs, alcohol, and 
smoking in the population aged above 15.  
2.2 Drug Use among the School Population 
The most recent national school survey was carried out in 2003 (European School Survey on Alcohol and Other 
Drugs, ESPAD). The results of the study, which involved 16- and 18-year-old secondary school students, were 
summed up in the 2003 and the 2004 Annual Reports of the NMC. In 2006, a report summarising the results of 
ESPAD study was published. The results of the HBSC (Health Behaviour in School-aged Children) survey, which 
involved elementary school pupils aged 15, are also available; the most recent results are from 2002 and another 
wave of the study is due to be conducted in 2006.  
Several regional school surveys were implemented in 2005. They usually focused on children aged under 15 – see 
the detailed results in the special chapter on Drug Use and Related Problems among Very Young People (Under 
15 Years) , page 71.  
2.3 Drug Use among University Students 
A repeated survey of the Faculty of Pharmacy at Charles University in Hradec Králové which studies experiences 
with addictive substances among university students continued in 2005. A total of 1,239 students were surveyed in 
the 2004/2005 academic year, and 226 have been surveyed so far in the 2005/2006 academic year. The results 
indicate that more than 52% of the students have tried marijuana and nearly 16% have tried hashish. 9% of the 
respondents have tried magic mushrooms, nearly 8% have tried ecstasy, and 5.5% of the students have tried LSD. 
A relatively low number of respondents (4.1% and 2.8%) reported experiences with pervitin and cocaine 
respectively (Trojáčková and Višňovský, 2006). 
At the same time, the Philosophical Faculty at Charles University in Prague carried out a survey in the 2004/2005 
academic year. It targeted the field of the health, behaviour and attitudes of students at Czech universities and 
colleges towards the use of addictive substances. 1,232 respondents were surveyed; the results are comparable to 
those from the above-mentioned survey. The survey did not monitor magic mushrooms separately; it only tracked 
LSD and other hallucinogens (7.7%). The respondents mentioned ecstasy more frequently (9%), while heroin and 
other opiates were reported less often (1%) (Csémy and Hrachovinová, 2006). During the last 12 months, 32.5% of 
the respondents had used cannabis and 3% had used ecstasy. The prevalence of all the substances which were 
monitored was higher among males – see Table 2-2. 
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Table 2-2: Prevalence of illicit drug use among university students (%) (Csémy and Hrachovinová, 2006) 
Lifetime prevalence  Prevalence in the last 12 months Drug Total Males Females  Total Males Females 
Any illicit drug 51.9 58.4 47.0  – – –  
Cannabis  51.7 57.6 47.2 32.5 41.3 25.8 
Ecstasy  8.9 9.6 8.4 3.2 4.2 2.5 
LSD, hallucinogens  7.7 8.5 7.1 2.7 3.5 2.0 
Pervitin, amphetamines  4.1 4.8 3.5 1.4 1.7 1.2 
Heroin, opiates  1.1 1.1 1.0 0.2 0.4 0.1 
  
2.4 Drug Use Among Specific Population Groups 
The situation in the field of drug use among specific population groups is summed up in the chapter on Social 
Correlates and Consequences of Drug Use, page 54. The Social Workers Support Programme for workers who 
work in Roma communities continued in 2005; at the same time, a survey which tracked substance use among 
Prague's homeless people was carried out. However, the results of the survey among homeless people are not 
available because the Institute of Health Policy and the Economy, which implemented the survey within the 
framework of a project which focused on the health status of the homeless, has discontinued its activities. 
2.5 Attitudes towards Drug Use and Drug Users 
The Public Opinion Research Centre carried out two surveys which focused on tolerance towards certain groups of 
citizens and the acceptability of selected types of behaviour. The survey showed that 87% of the respondents (out 
of a total of 1,067 respondents aged above 15) would not like to have drug users or heavy alcoholics as their 
neighbours. This comparison also showed low tolerance towards persons with a criminal history and against the 
Roma people; Czech society is tolerant towards persons of different religious or political beliefs or disabled persons 
(2% would not like to have disabled persons as their neighbours) (Centrum pro výzkum veřejného mínění, 2005a). 
Table 2-3 shows a comparison with a similar survey from 2003. 
Table 2-3: Tolerance towards selected societal groups – proportion of the respondents who would not like to have a 
member of these groups as their neighbour (Centrum pro výzkum veřejného mínění, 2005a) 
They would not like to have neighbours 
who are 
March 2003 March 2005 
Heavy alcoholics 86 87 
People who use drugs 85 87 
People with a criminal history 78 77 
Roma people 79 75 
Homosexuals 42 34 
Foreigners who live in the Czech Republic  24 22 
People of a different religious belief 8 7 
 
The respondents were also asked to assess the tolerance of the whole society towards these population groups – 
according to them, society is the least tolerant towards Roma people (61%), heavy alcoholics (60%), and drug 
users (57%). In comparison with 2003, there was a higher proportion of respondents who believe that society is 
tolerant towards drug users (an increase from 21% to 34%) and heavy alcoholics (from 18% to 34%) (Centrum pro 
výzkum veřejného mínění, 2005a). 
In the September survey, respondents (1,072 persons aged above 15) expressed their opinion regarding the 
acceptability or unacceptability of selected types of behaviour – a ten-point scale was used, with 1 meaning total 
unacceptability and 10 meaning perfectly acceptable behaviour. Driving under the influence of alcohol (69%), not 
looking for a job (65%), smoking marijuana or hashish (62%), and engaging in a fight with a police officer (61%) 
were regarded as the least acceptable forms of behaviour (answers 1 or 2). Other unacceptable forms of behaviour 
involved under-the-counter employment, accepting bribes, and using public transport without paying, but also 
infidelity. Drinking alcohol and drunkenness (out of joy or to drown sorrow) and a divorce were the most acceptable 
of the types of behaviour that were monitored (Centrum pro výzkum veřejného mínění, 2005b) – see Figure 2-2.  
A survey carried out by TNS Factum which focused on public informedness regarding drugs issues (it was carried 
out as early as in 2003; a total of 1,012 persons aged above 15) provided results showing a comparison of 
tolerance towards the use of individual drugs; more than 90% of the respondents condemn heroin and cocaine use 
and sniffing toluene and 86% condemn pervitin use. The opinion of the respondents regarding marijuana is not so 
strong – more than 20% of the respondents would allow its use and 3% would even allow children and juveniles to 
use it (TNS Factum, 2004). The respondents are the most tolerant towards alcohol and tobacco, and 5–6% of the 
respondents would also allow children to smoke tobacco and drink alcohol without any limitation. Nearly 22% of the 
respondents mentioned that they would ban smoking and 11% would ban alcohol drinking – see Figure 2-3. 
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Figure 2-2: Moral acceptability of behaviours – on a scale of 1–10 (1=totally unacceptable, 10=perfectly acceptable) 
(Centrum pro výzkum veřejného mínění, 2005b)  
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Driving under the influence of alcohol 
Not looking for a job, living from gifts
Smoking marijuana or hashish 
Physical fight with the police
Employing people under the counter
Being unfaithful
Accepting a bribe
Using public transportation (train, metro etc.) without paying
Playing cards for money
Not including all income for tax purposes 
Lying to one´s own benefit
Killing in self-defence
Terminating the life of an ill person (euthanasia)
Getting divorced
Drinking to drown one´s sorrow







Figure 2-3: Tolerance towards the use of individual drugs (TNS Factum, 2004)  









I don’t know 5.36.55.98.79.54.43.0
Ban for children and adults 92.190.390.985.769.021.611.9
Allow adults only 1.82.22.44.518.167.479.9
Allow with no restrictions 01.00.81.13.46.55.2
HeroinTolueneCocainePervitinMarijuanaTobaccoAlcohol
 
Other results showed that the Czech public is quite interested in drugs issues;  2/3 of the respondents are interested 
in drugs and their effects, 3/4 believe they have enough information about drugs. People most commonly get their 
information from the media, mostly from television, young people from friends, school, and the internet. Expert 
sources (physicians, psychologists, preventive workers, and also publications about drugs and theri effects) are 
perceived as most reliable. 
According to the survey, most parents believe that they would be able to recognise if their child was using drugs 
(approximately 3/4) and know what to do in a situation like that (2/3). Nevertheless, every tenth parent would not 
recognise drug use and every fifth one would not know how to handle it. As far as drug prevention is concerned, the 
public requires both the direct and the indirect route to be taken, i.e. it recommends combining raising awareness, 
explaining consequences, proper upbringing, the use of leisure time, and sports (TNS Factum, 2004). 
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Parents of children aged 10–18 were also surveyed about their attitudes towards possible drug use by their child 
(225 respondents who live with their child in a household were surveyed). 40% of the parents agreed with the 
statement “I have nothing against my child trying a bit of alcohol during family celebrations”. On the contrary, 44.6% 




All elementary and secondary schools in the Czech Republic have established the position of a school prevention 
methodologist and implement various forms of a minimum preventive programme; the system of primary drug 
prevention in schools is provided for by school and district prevention methodologists and regional school 
coordinators who work under the methodological guidance of the Ministry of Education. 
NGOs participate significantly in school prevention, as well as in selective and indicated prevention, in the Czech 
Republic. Standards for the Professional Competency of Primary Drug Prevention Programmes were approved in 
2005. 
Approximately 130 organisations provide telephone or internet counselling on drugs and associated issues in the 
Czech Republic. About 20% of them work 24 hours a day, 7 days a week. 
3.1 Primary Prevention Coordination 
The 2005–2006 Action Plan defines many activities which relate to the following goals of primary prevention: 
• Efficient coordination of primary prevention with clearly defined competencies of the organisations which 
participate in the field of primary prevention, 
• Available, quality, and effective primary prevention programmes, 
• Availability of targeted primary prevention and early intervention programmes which focus on the most at-risk 
target groups, 
• Uniform data collection in the field of primary prevention. 
The government gave the Ministry of Education the task of primary drug prevention coordination. In 2004, the 
Ministry of Education completed a 2005–2008 Strategy for the Prevention of Social-Pathological Phenomena 
among Children and Juveniles within the Sphere of Competence of the Ministry of Education. It defined the 
following goals:  
• Education towards healthy lifestyles, 
• Development and support of social competencies, 
• To achieve better quality and efficiency of programmes through improved coordination and control of specific 
primary prevention. 
Specific long-term, medium-term, and short-term goals involve, in particular, system changes, coordination of the 
prevention and distribution of competencies, the funding of programmes, legislation, and, exceptionally, also the 
training of school prevention methodologists and service providers. 
The strategy emphasises “specific primary prevention”, i.e. activities and services which aim to prevent drug use or 
its further development. It also mentions that it is necessary to focus explicitly on target groups of more at-risk 
individuals (Ministerstvo školství, mládeže a tělovýchovy, 2004b). However, the strategy does not define the at-risk 
groups, and thus not even the specific target groups. The terminology used in the strategy is based on a 
classification of prevention into specific and non-specific primary prevention; terms such as universal, selective, and 
indicated prevention were not included in the strategy.  
The strategy identified the following weaknesses in the field of prevention (Ministerstvo školství, mládeže a 
tělovýchovy, 2004b): 
• Absence of preventive activities in family and out-of-school settings, 
• Poor collaboration with parents, 
• Lack of measurability of the efficiency of programmes, unclear definition of indicators, 
• Insufficient training for teachers and preventive programme implementators, 
• Counterproductive media policy with regard to primary prevention. 
Threats in the field of prevention involve an absence of a feeling of responsibility for one’s own health, high public 
tolerance towards licit drugs, the disparagement of prevention, and also the reluctance of teachers to develop 
activities which do not bring an immediate result (Ministerstvo školství, mládeže a tělovýchovy, 2004b). 
3.2 Universal Prevention – School Programmes 
As in the previous period, drug prevention programmes in schools represent the highest proportion of the total 
number of preventive activities. The Minimum Preventive Programme (the Ministry of Education now uses the term 
School Prevention Strategy) continues to be the basis of activities in schools and school facilities. Professional and 
methodological guidance for the system of school prevention programmes is provided by a school and district 
prevention methodologist and a regional school coordinator – see the 2003 and 2004 Annual Reports of the NMC 
for more information. 
No detail information on the number, scope, or types of programmes that have been implemented is available.  
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3.3 Selective and Indicated Prevention 
No comprehensive overview of the situation in the field of selective and indicated prevention is currently available; 
there are only some programmes at the regional/local level which are being implemented by a number of NGOs. 
None of the basic documents – the 2005–2009 National Strategy, the 2005–2006 Action Plan, or the 2005–2008 
Strategy for the Prevention of Social-Pathological Phenomena among Children and Juveniles within the Sphere of 
Competence of the Ministry of Education – uses this classification of prevention or specifies activities in these fields. 
3.4 Activities of NGOs in the Field of Prevention 
Altogether 67 of 142 programmes which were subsidised via the subsidy proceedings of the The Council of the 
Government for Drug Policy Coordination (CGDPC) in 2005 reported activities in the field of primary prevention 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). They involve specialised prevention 
centres, as well as organisations which provide other types of services; 44 cases involved programmes supplied by 
facilities which target harm reduction and prevention services – they especially involve low-threshold centres in 
small towns whose position makes them play the role of a so-called drug agency, i.e. they provide drug users with 
various types of services at the same time.  
The above-mentioned 67 programmes operated in 1,150 schools in the Czech Republic (46 kindergartens, 701 
basic schools (pupils aged 6–15), 387 secondary schools, 10 higher professional schools, and 6 universities), and 
they approached more than 131,000 persons (approximately 98,000 pupils of basic schools and approximately 
31,000 secondary school students (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). Cycles 
of lectures and seminars which are implemented in the course of a three-year period prevail at basic schools (nearly 
46% of schools), followed by one-off lectures (nearly 21%). As concerns secondary schools, one-off lectures (30% 
of schools) and one-off composed programmes (25%) supplemented by 2-year cycles of lectures are the most 
common.  
More than 7,000 pupils at basic schools and nearly 3,000 secondary school students were addressed within 
extracurricular activities which involve prevention for children and juveniles; the activities involved one-off lectures, 
as well as early intervention programmes and peer programmes. At the same time, there were specific 
programmes which focused on young Roma people endangered by social-pathological phenomena, children from 
a refuge for mothers with children, and students living in boarding houses (Národní monitorovací středisko pro 
drogy a drogové závislosti, 2006g). Nearly 7,000 adults were contacted; they were mostly parents (4,000) and 
teachers (more than 1,500 persons). Nearly 20,000 more perople, mostly young people and young adults, were 
involved in the activities carried out by low-threshold clubs or adventure programmes and they were in contact via 
internet counselling.  
3.5 Telephone and Internet Counselling, Help Lines 
A survey on counselling activities which were available over the phone or on the internet in the Czech Republic was 
carried out in 2005 (April until September). On the one hand, counselling on drug addiction is provided by facilities 
which focus on crisis intervention over the phone or the internet; the facilities only deal marginally with drug 
addiction (for instance help lines, crisis lines, or internet counselling); when necessary, they refer the client to a 
specialised facility. The second group then involves facilities which specialise in prevention and drug addiction 
treatment and phone and internet counselling represents only one of their activities. 
127 facilities provide counselling on addiction in the Czech Republic; 121 of them provided detailed information on 
their activities (Sadílek and Mravčík, 2006). There are three free-of-charge help lines (“800” numbers) in the Czech 
Republic; they deal only marginally with addiction-related issues. 20% of all the organisations provide counselling 
24 hours a day, 7 days a week; approximately 40% of them provide counselling over the internet. The queries most 
commonly involve questions from parents and family members about what to do when their child or another relative 
uses drugs, and then requests for help with one's own drug addiction, questions about treatment options, and 
demands for the mediation of treatment.  
Research has shown that phone counselling involves many practical issues (e.g. financial problems, insufficient 
collaboration between organisations in the region, or a distorted public image of the facilities which provide drug 
prevention and treatment). Recommendations for improving the situation involve establishing a free-of-charge help 
line which will target exclusively the issues of addiction prevention and treatment, training for the employees of 
preventive and treatment services in phone crisis intervention, and the introduction of uniform standardised 
recording of phone calls; it is a priority to draw up a methodology and standards for internet counselling (Sadílek 
and Mravčík, 2006). One of the outputs concerns a list of help lines and internet pages which provide counselling on 
drugs in the Czech Republic; the list is also available in the Map of Help on the web page of the NMC (www.drogy-
info.cz).  
The Czech Association of Helplines approved an Ethical Code for Internet Counselling in 2005. It had been lacking 
before then in the Czech environment. 
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Internet information provision and counselling has been developing quickly in the Czech Republic. The internet is an 
attractive medium for the target population of recreational drug users who do not make use of any other services for 
drug users; at the same time, internet services are a good way to establish the first contact with this hidden 
population. Family members and friends of drug users represent another group which often uses the internet 
services. 
Altogether 98,904 internet users visited the internet drug counselling site www.drogovaporadna.cz, operated by the  
NGO SANANIM, in 2005; it is twice as many as in 2004 (48,195 visits). The popularity of the website has continued 
to increase – 61,628 visits have already been recorded during the first six months of 2006. Altogether, 2,989 queries 
(2,112 in 2004) were sent in 2005; the questions were most commonly asked by drug users (990 queries), parents 
and other relatives (431 queries), and partners (252). The queries were most commonly about pervitin (789) and 
cannabis (643), then about alcohol (336) and heroin (211); the type of drug was not specified in 707 queries. 861 
queries were about the need for help (to the caller), 815 queries were about information on drugs, 469 were directly 
aimed at treatment, and another 464 involved getting help for another person. The expressions most commonly 
searched for involved pervitin, heroin, marijuana, and ecstasy (Marečková, 2006). 
3.6 Other Activities in the Field of Prevention 
Meal vouchers for elementary school pupils and secondary school students with pictures which relate to drug-
related topics and focus on prevention were issued in January 2005. Seven versions which targeted different drugs 
were prepared for basic school pupils (see, for instance, Figure 3-1); three versions were designed for secondary 
school students and they contain links to web pages for young people, teachers, and parents (www.drogy-info.cz, 
www.odrogach.cz, www.drogovaporadna.cz). 254,619 meal vouchers were distributed in 2005 – 227,194 were for 
basic school pupils, 23,224 for secondary school students, and 4,201 were for adults. The distribution of the 
vouchers (cards) has also continued in 2006. 
Figure 3-1: Examples of the front side of meal vouchers for basic school pupils and secondary school students  
 
 
The distribution of DVDs with six authorial documentaries on drugs continued in 2005. The DVDs were distributed 
within the framework of a project entitled ‘Jeden svět na školách’ (One World in Schools), organised by the People 
in Need organisation (the films were broadcast on Czech TV in 2003 and VHS copies were distributed in 2003–
2004 under the common title ‘When you have to, you have to?’). 916 DVDs, together with a thematic brochure, 
were distributed to schools in 2005. The entire project was covered from the state budget resources for drug policy. 
In collaboration with the SANANIM civic association and the Ministry of Education, the Secretariat of the CGDPC 
published a Czech version of ‘Making Schools a Healthier Place’ – a manual on effective school-based prevention – 
in 2005.7 The publication summarises the principles underpinning the preparation, planning, and implementation of 
school-based drug prevention programmes; it gives an overview of effective interventions and also provides 
information on the significance and methods of evaluation of drug prevention programmes. It also contains many 
practical guides and tools for an assessment of the current situation and implementation and evaluation of school-
based programmes (Lejčková, 2006). 
The Prev-Centrum civic association published a Czech translation of the handbook ‘Prevention: Drug, Alcohol, and 
Tobacco’8 (Příručka prevence: drog, alkoholu a tabáku) in November 2004. The Embassy of the Kingdom of the 
Netherlands in Prague and the Prague Magistrate participated in its publishing. The publication was distributed to all 
basic and secondary schools in Prague and to pedagogical-psychological counselling offices, libraries, and other 
professional institutions which deal with the primary prevention of substance use. The publication is a source of 
detailed information necessary for the planning and implementation and subsequent evaluation of primary 
prevention programmes. 
3.7 Evaluation of Preventive Programmes 
The government adopted the Rules for Granting Financial Resources on Drug Policy in the Government Resolution 
700/2005 in June 2005. It stipulated the certification of the professional competency of services for drug users as a 
prerequisite for the allocation of a subsidy for the year 2007. Certification is a formal acknowledgment that a 
                                                          
7 4,000 copies were printed; the publication was originally published in the Netherlands. 
8 A publication written by Dutch authors; it was originally published in 1998 with the help of the Pompidou Group of the Council of 
Europe. 
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programme is of good quality and complies with the criteria specified in the Standards of Professional Competency. 
The Standards for the Quality of Primary Prevention Programmes, which the CGDPC approved on September 30, 
2005, were defined for specific primary prevention programmes which are provided in schools or as part of 
extracurricular activities, for early intervention programmes, educational programmes, and publication activities in 
the field of primary prevention. The following aspects of individual programmes are assessed (Ministerstvo školství, 
mládeže a tělovýchovy, 2004a): 
• Accessibility (i.e. financial availability and equal approach to all clients),  
• Observance of the rights of clients,  
• Manner of implementation of programme,  
• Professional competency and professional development of employees,  
• Programme availability (territorial and time availability),  
• Budget and management of financial resources, 
• Level of quality of programme and efficiency evaluation.  
The actual process of the certification of primary prevention services has not been launched yet. The Government 
Resolution No. 693/2006 stipulated that the process of the certification of primary prevention programmes is to be 
launched on October 2, 2006. At the same time, it stated that facilities will only be obliged to submit a certification of 
professional competency with an application for financial resources (subsidies) for their drug policy programme for 
the year 2008.  
The Czech School Inspectorate is in charge of the evaluation of the efficiency of the prevention of 
social-pathological phenomena in schools and school facilities. It evaluates the implementation of preventive 
problems in selected schools every year. 90 schools were inspected in the spring of 2005 – 45 basic schools, 25 
secondary schools, 16 schools for pupils with specific educational needs, and 4 children’s homes. The evaluation 
especially concerned the activities of school prevention methodologists and the involvement of other workers in 
prevention, and it also targeted collaboration between schools and parents and providers of preventive 
programmes, the School Prevention Strategy (also called the Minimum Preventive Programme), and other activities 
of the school (Česká školní inspekce, 2005). 
Altogether, 89 out of the total of 90 schools drew up their Minimum Preventive Programme; however, in 11% of 
basic schools and 12% of secondary schools it did not comply with the methodological guidelines of the Ministry of 
Education. At the same time, 11% of basic schools and 4% of secondary schools did not carry out a periodical 
evaluation of their preventive programme, and the content of the Minimum Preventive Programme was often not 
adjusted to the current situation in the school (18% of basic and 44% of secondary schools). Approximately 10% of 
the Minimum Preventive Programmes that were evaluated only contained a list of events. The individual schools 
reported the occurrence of the phenomena monitored in a given school year – vulgar behaviour and thefts were the 
most common in basic schools, and smoking and truancy in secondary schools (see Table 3-1). 22% of basic 
schools and 32% of secondary schools dealt with drug use and distribution during the year (Česká školní inspekce, 
2005).  
Table 3-1: Occurrence of negative social phenomena in schools (% of assessed schools) (Česká školní inspekce, 2005) 
Phenomenon  Occurrence in elementary schools 
Occurrence in 
secondary schools  




Bullying  48.9 56.0
Thefts 80.0 68.0
Alcohol consumption 51.1 28.0
Drug use and distribution  22.2 32.0
Racism and xenophobia  15.6 0.0
Virtual drugs 8.9 0.0
 
The occurrence of the problems in the school was also investigated by means of a questionnaire survey in the 
schools monitored. A total of 2,906 elementary school pupils and 1,220 secondary school students were surveyed. 
Nearly 50% of secondary school students and almost 25% of basic school pupils admit drug use in school; 20% of 
secondary school students and 10% of elementary school pupils confirm that drugs were passed among pupils 
(Česká školní inspekce, 2005).  
The Institute of Pedagogical and Psychological Counselling dealt with the assessment of the Minimum Preventive 
Programme in schools in the previous years; however, the most recent report available is for the school year 1998–
1999 (Slavíková et al.  2000).  
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4 Problem Drug Use 
In the Czech Republic, problem drug use is defined as the use of drugs by injection and/or the regular or long-term 
use of opiates and amphetamine-type drugs. Cocaine is not included in the national definition, and its occurrence in 
the Czech Republic is still sporadic – see the special chapter on Cocaine and Crack, page 80. 
As far as the use of opiates is concerned, heroin is the most common. At the same time, buprenorphine (Subutex), 
either prescribed by a physician or obtained from the black market, is also being used increasingly often in some 
regions. Home-made opiates made from medicinal products or poppy heads are rather a (seasonal) exception. The 
problem use of amphetamine-type drugs in the Czech Republic is limited exclusively to the use of pervitin 
(methamphetamine). 
The estimated number of problem drug users increased slightly to 32,000 in 2005; approximately 11,500 of them 
use opiates and 20,500 use pervitin; approximately 30,000 problem drug users inject drugs. The increase especially 
involves the number of (mostly injecting) users of Subutex and their proportion in the number of opiates users – 
even other data sources confirm this trend. The increase in the number of pervitin users is obvious from data on the 
clients of low-threshold facilities from which prevalence estimates are made (see also the chapter on Services 
Provided by Low-Threshold Facilities, page 49) as well as from data in the Register of Treatment Demands. 
The number of treated drug users decreased in 2005. With the exception of all treatment demands relating to 
pervitin use, a decline in the number of both all treatment demands and first treatment demands occurred with 
regard to all the main groups of drugs. There has been a year-on-year decline in the number of injecting users, 
females, and users aged under 19 who have been treated. The average age of patients asking for treatment 
continues to increase. 
At the same time, the proportion of injecting users among all problem drug users of pervitin and opiates (both heroin 
and Subutex) continues to be high (80–90%). 
4.1 Estimates of Prevalence and Incidence of Problem Drug Use 
A national prevalence estimate was carried out in 2005, using a multiplication method with the use of data from low-
threshold facilities. The number of problem drug users in contact with reporting low-threshold facilities, extrapolated 
to the total number of these facilities in the Czech Republic, was used as the basis for the calculations. The 
multiplier (in-treatment rate), i.e. the estimated number of problem drug users in contact with such facilities, was 
obtained by means of a nomination technique9 within the framework of the HCV Seroprevalence Among Injecting 
Drug Users survey; see the chapter on Drug-related Infections, page 42.  
An overview of the prevalence estimates which were made using a multiplication method with the use of data from 
low-threshold facilities during the last four years is given in Table 4-1. There was a slight increase in the estimated 
number of pervitin users, as well as those of opiates. As far as pervitin is concerned, the increase is probably 
caused by a further dissemination of pervitin in the nightlife and dance environments, including small towns. The 
rise in the estimated number of opiates users is partly caused by an increase in the number of users who use 
Subutex obtained from the black market as their primary drug. 
Table 4-1: Development of prevalence estimates of problem drug use carried out using a multiplication method with the 
use of data from low-threshold facilities in 2002–2005 (Národní monitorovací středisko pro drogy a drogové závislosti, 
2006c) 
Total number of  
problem drug users  
Number of opiates  
users  
Number of pervitin  
users  
Number of injecting drug 
users 
Year 
Abs. Per 1,000 
inhabitants 
aged 15–64 
Abs. Per 1,000 
inhabitants
aged 15–64
Abs. Per 1,000 
inhabitants
aged 15–64
Abs. Per 1,000 
inhabitants
aged 15–64
2002 35,100 4.89 13,300 1.85 21,800 3.04 31,700 4.41
2003 29,000 4.02 10,200 1.41 18,800 2.61 27,800 3.86
2004 30,000 4.14 9,700 1.34 20,300 2.80 27,000 3.73
2005 31,800 4.37 11,300 1.55 20,500 2.82 29,800 4.10
 
In addition, the agency INRES-SONES and the Medical Information Centre carried out a periodical national 
representative omnibus10 survey among practitioners in the Czech Republic. As well as the 2003 survey, the survey 
included questions for general practitioners which aimed to find out the prevalence of problem opiates and pervitin 
users (Mravčík et al.  2005b). General practitioners for adults and children were asked three questions: (1) “How 
many registered patients do you have?”, (2) “According to your information or estimate, how many of your patients 
inject heroin or other illicit opiates or use them on a regular or long-term basis?”, (3) “According to your information 
                                                          
9 As no new data were obtained in 2005, the multiplier used for the 2004 estimate was used.  
10 Omnibus surveys focus on multiple topics – they contain more thematic modules. 
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or estimate, how many patients inject pervitin (methamphetamine) or use it on a regular or long-term basis?”.11 180 
general practitioners for adults and 118 general practitioners for children participated in the survey in 2005. The 
results of the questionnaire surveys among general practitioners are given in Table 4-2. 
Table 4-2: Prevalence estimates of problem drug users obtained from questionnaire surveys among general practitioners 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2006d) 
Total number of problem 
drug users  
Number of opiates users Number of pervitin users 
Rok Abs. Per 1,000 
inhabitants 
aged 15–64 
Abs. Per 1,000 
inhabitants 
aged 15–64 
Abs. Per 1,000 
inhabitants 
aged 15–64 
2003 n.a. n.a.  21,200 2.6* – – 
2005 32,000 4.4 17,000 2.3 15,000 2.0 
Note: * Per 1,000 inhabitants aged 18 and above. 
The prevalence estimates obtained with the help of general practitioners most probably overestimate the number of 
users of opiates, and, on the contrary, they most probably underestimate the number of pervitin users. Opiates 
users can receive Subutex substitution treatment from general practitioners (and so they can be in better contact 
with them); however, no similar therapeutic method is available from general practitioners for pervitin users.  
Prevalence estimates carried out using the multiplication method were also carried out on a regional level in 2005 – 
see Table 4-3 and Map 4-1. However, it is necessary to take the estimates according to individual regions as 
indicative numbers only because of the specifics of the source data from individual regions and the difference 
between the real proportion of problem drug users who are in contact with treatment services and the “average” 
value for the Czech Republic.  
Table 4-3: Prevalence estimates of the number of problem drug users in the Czech Republic in 2005 by regions (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2006c) 
Region  
Total number  
of problem  
drug users  
Number of 
opiates users  
Number of 
pervitin users  
Number of 
injecting users  
Prague 9,800 6,100 3,700 9,650 
Central Bohemia 2,500 1,050 1,450 2,300 
Southern Bohemia  1,700 600 1,100 1,600 
Pilsen 1,450 700 750 1,350 
Karlovy Vary 1,450 300 1,150 1,400 
Ústí nad Labem 4,450 1,350 3,100 3,950 
Liberec 750 <50 750 750 
Hradec Králové 1,150 150 1,000 1,050 
Pardubice 600 <50 600 500 
Vysočina 600 <50 600 550 
Southern Moravia 2,800 800 2,000 2,550 
Olomouc 1,900 100 1,800 1,650 
Zlín 1,150 <50 1,100 1,100 
Moravian-Silesian 1,500 150 1,350 1,350 
Total 31,800 11,300 20,500 29,800 
                                                          
11 Fraction Σ(2) / Σ(1) and Σ(3) / Σ(1) respectively then gives the prevalence of problem opiates or pervitin users (recalculated to 1,000 
adult inhabitants of the appropriate age). 
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Map 4-1: Number of problem drug users per 1,000 inhabitants aged 15-64 and the proportion of problem users of opiates 
and pervitin in the Czech Republic in 2005 (Národní monitorovací středisko pro drogy a drogové závislosti, 2006c) 
 
4.1.1 Injecting Drug Use 
The proportion of injecting drug users among first treatment demands has varied between 85–90% on a long-term 
basis (with the exception of 1998, when it was just under 80%). Injecting drug use is less common among pervitin-
related first treatment demands; it has been around 80% on a long-term basis. The proportion of injecting heroin 
and pervitin users among all treatment demands is higher by 3–5% than among first treatment demands – slightly 
above 90% for heroin, and under 85% for pervitin. The development in 1998–2005 is given in Figure 4-1; more 
information on treatment demands is included in the chapter on Profile of Drug Users in Treatment, page 27. 
Figure 4-1: Proportion of injecting use among heroin- and pervitin-related first treatment demands in 1998–2005 and 























1998 1999 2000 2001 2002 2003 2004 2005
I.v. use among heroin users - FTDs
I.v. use among pervitin users - FTDs
I.v. use among heroin users - all TDs
I.v. use among pervitin use - all TDs
 
Altogether 760 respondents with a valid anti-HCV test result participated in the HCV Seroprevalence Among 
Injecting Users survey from September 2002 to December 2003; 495 (65.1%) of them were males and 265 (34.9%) 
females (Mravčík et al.  2006). The respondents were aged 15 to 59; the average age was 24.6 (modus 19, median 
23) and the group aged 20–24 was the most represented (38.2%). All respondents were current injecting drug 
users (i.e. they had injected during the last 12 months). 740 (97.4%) respondents had injected a drug within the last 
six months, 661 (87%) within the last month, and only 1.8% (19 persons) mentioned that they had last injected 
a drug even before then. 
232 (30.5%) respondents had injected a drug for the first time less than two years before the testing, 527 (69.3%) 
more than two years before the testing.  
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The length of the respondents’ regular injecting use (a sum of all periods of regular use) is given in Figure 4-2. 
Figure 4-2: Length of regular injecting use among respondents of the HCV Seroprevalence Among Injecting Users 



























The sample had the following structure with regard to the substances used: 127 (16.7%) respondents mentioned 
heroin as their current primary drug, 14 (1.8%) mentioned Subutex, 16 (2.1%) another opiate (opium, codeine, 
braun12, or methadone), 490 (64.7%) pervitin, and 58 (7.6%) respondents mentioned the combination of an opiate 
and pervitin. 55 (7%) respondents mentioned a primary drug other than those offered in the answers. Most 
commonly, this other primary drug involved cannabis – 43 persons. 3 persons mentioned inhalants as their primary 
drug, 2 persons mentioned ecstasy13; cocaine was mentioned in one case – see Figure 4-3. 












The frequency of current injecting drug use by the use of opiates is given in Table 4-4. It is apparent that the 
frequency is higher among opiates users. 
                                                          
12 A home-made mixture of opiates made from medicines; it mostly contains codeine. 
13 These 48 cases probably involved a misunderstanding of the question, which was about a primary injection drug.  
page 27 
Table 4-4: Frequency of injecting use by opiates use (Mravčík et al.  2006) 
Opiates use  
Yes No Total Frequency 
Abs. % Abs. % Abs. % 
Less than once a month 27 12.6 104 19.3 131 17.4 
1–4 times per month 35 16.4 143 26.6 178 23.7 
2–3 times per week 29 13.6 141 26.2 170 22.6 
4–6 times per week 13 6.1 63 11.7 76 10.1 
Daily 50 23.4 43 8.0 93 12.4 
More times per day 60 28.0 44 8.2 104 13.8 
Total  214 100.0 538 100.0 752 100.0 
 
4.1.1.1 Risky Behaviour among Injecting Drug Users 
The occurrence of risk factors of injecting drug use, according to the HCV Seroprevalence among Injecting Drug 
Users survey: 
• 585 (77%) respondents have used a syringe after someone else, 104 (13.7%) of them have only used a syringe 
after their partner. On the other hand, 158 (20.8%) denied that they have ever shared injecting equipment. The 
results regarding sharing other injecting equipment are similar. 228 (39.0% of those who mentioned that they 
have shared a needle) mentioned that they had shared a needle for the first time during the last year. 
• 302 (39.7%) respondents have been in prison (90 were in custody and 212 were sentenced to prison). 120 
(39.7%) of these 302 respondents mentioned that they had injected a drug while in prison; 10 of them mentioned 
that they injected in prison for the first time in their life. 
• 163 (21.4%) respondents have injected a drug abroad, mostly in Germany (58), then in the Netherlands (22), 
France (15), Slovakia (15), and Spain (12).  
• 96 (12.6%) respondents have shared a needle with a foreigner, mostly with Germans (14), Slovaks (12), 
Ukrainians (8), and Russians (8). 
• 190 (25.0%) respondents were aware of having used a needle after someone who was HCV positive; other 273 
(35.9%) did not know whether the person after whom they used a needle was or was not HCV positive. 
Occurrence of risky sexual behaviour among respondents of the same survey: 
• 425 (55.9%) respondents mentioned that they had had more than 10 sexual partners in their lifetime; 164 
(21.7%) respondents mentioned five or fewer sexual partners. 580 (76.3%) mentioned that at least one of their 
sexual partners was a drug user.  
• 75.2% respondents mentioned that they always or mostly do not use a condom during sexual intercourse. 
• 100 (13.1%) respondents, mostly females, reported having performed sex for money, services, or drugs – see 
Table 4-5.  
Table 4-5: Experiences with having sex for money, services, or drugs according to the HCV Seroprevalence among 
Injecting Drug Users survey, by gender (Mravčík et al.  2006) 
Commercial sex Gender Never Exceptionally Often Total 
Abs. 450 36 8 494Males* % 91.1 7.3 1.6 100.0
Abs. 209 38 18 265Females  % 78.9 14.3 6.8 100.0
Abs. 659 74 26 759Total  % 86.8 9.7 3.4 100.0
Note: * 1 male did not answer the question. 
4.2 Profile of Drug Users in Treatment 
Data about drug users who use the services of low-threshold and treatment facilities are mainly available 
through the nationwide system of reporting to the Treatment Demand Register, which has been 
administered by the Hygiene Service of the Czech Republic since 1995. The Treatment Demand Register 
involves drug users who have asked for treatment, counselling, or social services at a facility which provides 
services to drug users during the year; those who have done so for the first time in their life (so-called first treatment 
demands) are recorded separately (Polanecký et al.  2006).  
Other sources of data on treated drug users involve data from the Institute of Health Information and Statistics of 
the Czech Republic (IHIS) on inpatient and outpatient psychiatric facilities and substitution treatment centres. The 
number of health care facilities which report to the register of the IHIS is higher than the number of facilities which 
report to the register kept by the Hygiene Service. The latter, for instance, does not include facilities which provide 
page 28 
substitution treatment, nor approximately a third of all outpatient health care facilities. The register kept by the 
Hygiene Service also gathers data from non-health care facilities for drug users, e.g. therapeutic communities, low-
threshold centres, and non-health care outpatient facilities. 
Data on clients of low-threshold facilities have been available since 2003 thanks to the uniform system of data 
collection in low-threshold facilities (FreeBase14) and final reports from subsidy proceedings of the The Council of 
the Government for Drug Policy Coordination (CGDPC). 
More detailed data of the IHIS are included in the chapter on Treatment, page 32; data on the clients of low-
threshold facilities are included in the chapter on Services Provided by Low-Threshold Facilities, page 49. 
4.2.1 Treatment Demand Register of the Hygiene Service of the Czech Republic  
A total of 253 treatment and low-threshold centres (76 low-threshold, 122 outpatient, and 55 inpatient facilities) 
contributed to the Register in 2005. Low-threshold centres are the facilities that are visited most commonly; as in the 
previous years, clients of these facilities represented more than a half of all treatment demands. 
8,534 (83.7 per 100,000 inhabitants) drug users, i.e. 3.5% less than in 2004, sought treatment at the above-
mentioned centres in 2005. 4,372 (42.9 per 100,000 inhabitants) persons, i.e. 5% less than in 2004, sought 
treatment for the first time. Most of them, i.e. more than 57%, sought treatment in relation to the use of stimulants, 
especially pervitin. The proportion of stimulants users is even higher among first treatment demands (60%). Opiates 
users are the second most numerous group among all treatment demands (24%) and cannabis users are the 
second most represented group among first treatment demands (20%); 13% of first treatment demands involve 
opiates users. The sequence according to the drugs used has remained the same since 2002 (Figure 4-4, Figure 
4-5). 225 (i.e. 2.6% of all treatment demands) Subutex users were reported in 2005 – see the chapter on 
Substitution and Maintenance Programmes, page 36, for more information. 







Pervitin 4 589 4 490 4 790 4 855
Cannabinoids 2 353 2 133 2 169 2 058
Opiates 1 489 1 403 1 462 1 238
Inhalants 322 226 221 183
Ecstasy 218 50 37 23
Cocaine+crack 13 22 18 15
2002 2003 2004 2005
 
 
The prevalence and incidence of treatment demand rates and the proportion of drugs used vary between individual 
regions. The Ústí nad Labem and Prague regions report the highest prevalence, and the Karlovy Vary and Ústí nad 
Labem regions report the highest incidence. As in previous years, Prague is the only region where the proportion of 
opiates users is higher than the proportion of users of other drugs; in other regions, the proportion of pervitin users is 
the highest. Opiates users are also significantly represented in the Ústí nad Labem, Southern Bohemia, and Pilsen 
regions; the proportion of cannabis users was significant in the Vysočina and Central Bohemia regions – see Map 
4-2.  
                                                          
14 See http://freebase.drogy-info.cz. 
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Pervitin 1 005 1 390 1 510 2 177 2 042 1 880 1 969 2 389 2 281 2 685 2 605
Cannabinoids 300 391 512 631 648 912 747 1 070 981 994 893
Opiates 457 882 692 657 869 1 044 1 213 788 656 710 702
Inhalants 326 274 167 209 166 161 147 171 116 107 88
Ecstasy 3 6 12 7 10 23 50 193 24 27 16
Cocaine+crack 14 12 7 7 10 5 3 15 13 5
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
 
 
Map 4-2: Number of all treatment demands in 2005 by type of drug and regions (per 100,000 inhabitants) (Polanecký et 
al.  2006) 
 
 
There are also differences between the basic characteristics of the users who seek treatment in relation to different 
drugs. Opiates users were the oldest15 on average (26.4 years of age); 70% of the group were males. The 
proportion of males (67.5%) and the average age (24.5) were lower among the group of pervitin users. The highest 
proportion of males was among the users of inhalants (83.1%) and cannabis (74.6%). Cannabis users were the 
youngest, on average (20 years of age). 
The average age of people demanding treatment is increasing; the group aged 25–39 was the most numerous in 
2005 (39.4% of all users demanding treatment). The group aged 20–24 was the most represented among first 
treatment demands for the first time in 2005 (33.7%); the group of those aged 15–19 used to be the most 
represented in the past). The average age of those who seek treatment is increasing, most quickly among the users 
of opiates and inhalants – see Figure 4-6 and Figure 4-7. 
                                                          
15 Apart from cocaine users, whose number was very low. 
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Heroin 21.9 21.2 21.0 21.9 21.5 21.5 22.1 23.4 24.6 25.1 25.5
Pervitin 21.3 20.9 20.2 20.4 21.0 21.4 21.6 22.2 22.2 23.1 23.4
Marijuana 19.3 18.7 18.6 18.4 18.6 18.5 18.3 18.7 18.9 19.5 19.3
Inhalants 19.3 18.1 19.0 18.1 17.5 18.6 18.3 18.4 19.6 20.0 20.4
Cocaine+crack 21.7 23.4 27.2 32.0
All drugs 22.8 21.5 20.8 20.6 20.8 20.9 21.3 21.8 21.9 22.7 22.9
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
 





Heroin 23.2 25.1 26.1 26.4
Pervitin 23.7 23.6 24.2 24.5
Marijuana 19.4 19.6 20.1 20.1
Inhalants 21.1 21.2 22.0 22.7
Cocaine+crack 25.2 25.7 26.9 29.1
All drugs 23.4 23.6 24.1 24.8
2002 2003 2004 2005
 
 
In the long term, the proportion between males and females among treatment demands has not changed much; 
females represent approximately a third of the treatment demands. The proportion of males has been increasing 
slightly since 2002. The proportion of males is the lowest among the group aged 15–19; females prevail slightly 
among pervitin users in this age group. 
Altogether 7,372 (86.4%) of all treatment demands and 3,600 (82.3%) of first treatment demands complied with the 
EMCDDA definition of problem drug use16 in 2005. The trend in the development of the proportion of problem users 
among those demanding treatment is given in Figure 4-8 and Figure 4-9; the curves copy the total number of drug 
users demanding treatment – no significant differences occurred during the nine years. In comparison with previous 
years, there was a slight decline in the proportion of injecting drug users among all treatment demands (by 3.5%) 
and first treatment demands (by 4.3%). Injecting drug use (including secondary drugs) was reported by 5,837 
(68.4%) out of all drug users demanding treatment and 2,649 (60.6%) out of drug users demanding first treatment. 
(Polanecký et al.  2006). 
                                                          
16 The EMCDDA defines problem use as injecting drug use and/or the long-term and regular use of opiates and/or amphetamines and/or 
cocaine. The definition in the Czech Republic does not involve cocaine users. 
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Total 3 252 3 132 3 858 3 891 4 148 4 233 4 719 4 158 4 600 4 372
Number of problem users 2 319 2 253 2 871 2 943 2 966 3 187 3 472 3 196 3 701 3 600
Number of injecting users 1 838 1 723 2 385 2 490 2 586 2 745 2 761 2 516 2 986 2 796
Number of persons aged under 19 1 867 1 694 2 023 1 914 1 970 1 860 2 000 1 808 1 656 1 506
Number of females 1 132 1 152 1 307 1 337 1 431 1 637 1 541 1 359 1 503 1 381
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
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4.3 Problem Drug Use in Other Data Sources 
A questionnaire survey among clients of the low-threshold centre and the outreach programmes operated by the 
SANANIM civic association in Prague was carried out in 2006 (Mravčík, 2006). 198 questionnaires were collected, 
99 in the low-threshold centre and 99 in the outreach programmes. Table 4-6 provides an overview by drugs used. 
96.5% of the respondents reported injecting drugs, and there is also a high proportion of injecting drug users among 
those who use Subutex only (95.1%). 
Other information on problem drug users is included in the chapters on Treatment, page 32, Services Provided by 
Low-Threshold Facilities, page 49, or Substitution and Maintenance Programmes, page 36. 
Table 4-6: Drugs used by the clients of the low-threshold programmes of the SANANIM NGO, Prague (Mravčík, 2006) 
Type of drug Number of clients % 
Subutex 82 41.4
Pervitin 66 33.3
Pervitin + Subutex 23 11.6
Heroin 14 7.1
Other combinations  13 6.6




The treatment of addiction to psychoactive substances is understood as professional, focused, and structured work 
with a client with the objective of achieving abstinence or reduction of drug use, reduction of the frequency and 
severity of relapses, and the involvement of clients in productive life in the family, work, and society, thus improving 
the quality of their life to a maximum. A wide spectrum of interdisciplinary services provides treatment and social 
reintegration in the Czech Republic. By type, the following types of treatment are recognised: outpatient (AT clinics, 
day-care programmes, and structured aftercare programmes) and inpatient (therapeutic communities, specialised 
hospital departments, and psychiatric hospitals). Treatment is also divided into short-term (4–8 weeks), medium-
term (3–6 months), and long-term (7 months and more).  
Table 5-1: Treatment programmes which supplied services to drug users in 2005 (Ústav zdravotnických informací 
a statistiky, 2006a, 2006b, 2006c, 2006d; Národní monitorovací středisko pro drogy a drogové závislosti, 2006g; 
Řeháček, 2006) 
Programme type Number Capacity (places, beds) 
Capacity utilisation  
(number of persons)
Sobering-up stations 16 n.a. n.a.
Detoxification units  19 n.a. n.a.
Outpatient health care facilities (clinics)a) 401 n.a. 17,531
Day-care centres 2 10b) 36b)
Substitution (methadone) centres 10 n.a.  758
Buprenorphine substitution in outpatient clinics  n.a. n.a. 1,000–2,500
Psychiatric hospitals  17 9,538c) 3,104
Psychiatric departments of hospitals  32 1,439c) 1,613
Psychiatric hospitals for children 3 320c) 27
Therapeutic communities  15 193d) 486d)
Aftercare programmes 20 385e) 865
– out of which sheltered housing  12 118 244
Inpatient departments which specialise in treatment of children 
endangered by drug addiction (special education facilities 5 66 104
Detoxification units in prisons 1 n.a. 172
Departments for differentiated serving of sentence 6 286 523
Departments for compulsory treatment in prisons  3 105 184
Drug-free zones in prisonsf) 34 1,606 2,859
Note: a) they involve outpatient health care facilities with various specialisations, not only the AT clinics, b) data from one day-care 
centre only, c) number of all psychiatric beds, d) data from 12 communities only, e) the data only involve intensive aftercare, f) drug-
free zones do not provide therapy. 
A system for the certification of the professional competency of services for drug users started to operate in 2005 
(see the chapter on Evaluation of Preventive Programmes, page 21, for more information on the certification of 
primary prevention programmes). It should especially provide for the availability of quality services in the field of 
harm reduction, treatment, and resocialisation in the following standard types: outreach programmes, low-threshold 
and counselling services, detoxification, substitution treatment, outpatient treatment, day-care programmes, short-
term and medium-term institutional treatment, inpatient treatment in therapeutic communities, and outpatient 
aftercare programmes. Only certified programmes run by NGOs should be subsidised from the state budget after 
2007. 
Certification of professional competency had been granted to 16 treatment facilities by the end of 2005, and another 
25 facilities had been certified by May 31, 2006. Table 5-2 shows the number of certifications granted to individual 
types of services in the field of treatment and resocialisation. So far, certification has been denied only to one 
treatment facility (which was asking for certification for an outpatient treatment service).  
In the field of harm reduction, certification of professional competency had been granted to 16 facilities by the end of 
2005 and 21 facilities by May 31, 2006 – see Table 5-2 for more information. Certification was not granted to 
6 facilities; 3 of them were asking for certification for an “outreach programme” and three were asking for 
certification for “low-threshold and counselling services” (Národní monitorovací středisko pro drogy a drogové 
závislosti, 2006a). The chapter on Responses to Health Correlates and Consequences of Drug Use, page 49, deals 
with services which were provided in the field of harm reduction. 
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Table 5-2: Number of certifications of professional competency of services for drug users granted by May 31, 2006 by 
type of service in the field of treatment and resocialisation (Národní monitorovací středisko pro drogy a drogové 
závislosti, 2006a) 




number of points 
Detoxification 4 933 960
Outpatient treatment  8 918 940
Day-care programmes  1 975 975
Short-term and medium-term inpatient 
treatment  3 960 995
Inpatient care in therapeutic communities  9 1 005 1 025
Outpatient aftercare programmes  12 1 034 1 055
Substitution treatment 4 1 001 1 015
Outreach programmes 17 924 955
Low-threshold and counselling services 20 937 975
 
5.1 Outpatient Treatment 
401 outpatient health care facilities reported providing outpatient treatment to users of licit and illicit drugs (Ústav 
zdravotnických informací a statistiky, 2006b). The number of outpatient facilities which also report that they provide 
services to illicit drugs users has continued to increase since 2000. In 2005, 78% of outpatient clinics treated 50 or 
fewer and 44% only 10 or fewer patients who were drug users – see Table 5-3 and Table 5-4. 
Table 5-3: Number of outpatient health care facilities providing care to drug users in 2000–2005 (Ústav zdravotnických 
informací a statistiky, 2006b) 






2005  401 
Note: * This involves the facilities which filled in an A013 appendix of the AT psychiatric report. 
Table 5-4: Number of outpatient health care facilities by number of patients in 2003–2005 (Ústav zdravotnických 
informací a statistiky, 2006b) 
Number of facilities  Number of 
patients 2003 2004 2005 
1–10 139 144 156 
11–50 106 109 107 
51–100 27 32 37 
101–200 18 19 18 
201–300 10 8 10 
301–400 5 3 4 
401 or more 8 7 8 
 
17,531 drug users (with the diagnosis F11–F19, i.e. including tobacco), i.e. 14% more than in 2004, were treated in 
outpatient clinics of health care facilities – see Table 5-5. The number of treated drug users has been increasing in 
a stable manner since 2000 (with a fluctuation in 2003) – see Figure 5-1. 
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Table 5-5: Number of drug users (with diagnosis F11–F19) treated in outpatient health care facilities in 2003–2005 
(Ústav zdravotnických informací a statistiky, 2006b) 
2003 2004 2005 












Inpatient facilities with 
outpatient services  53 4,105 49 3,896 49 4,131
Outpatient facilities 24 2,107 23 1,458 26 1,877
General practitioners 2 14 1 5 1 7
Independent outpatient clinics 
of specialist physicians 229 8,643 243 8,611 257 8,890
Drug addiction treatment 
facilities* n.a. n.a. n.a. n.a. 6 2,584
Other outpatient facilities  5 2,995 6 1,420 1 42
Total 313** 17,864 322** 15,390 340** 17,531
Note: * Drug addiction treatment facilities were excluded from the group “other outpatient facilities” in 2005. ** The facilities are 
identified by their company identification number; at the same time, it holds true that each of them can have more surgeries. 
Figure 5-1: Development in the number of drug users (with diagnosis F11–F19) treated in outpatient health care 
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In 2005, 18 NGOs funded by the Council of the Government for Drug Policy Coordination (CGDPC) from the 
General Cash Administration budget chapter also provided outpatient treatment. They supplied their services to 
1,743 illicit drug users. The average age of the clients was 26.8. 1,034 (59%) clients injected drugs, 540 (31%) 
clients used pervitin, 391 (22%) used heroin, 169 (10%) used cannabis, and 126 (7%) used opiates other than 
heroin, i.e. especially illicitly procured Subutex (Národní monitorovací středisko pro drogy a drogové závislosti, 
2006g). 
Only one facility in Prague provided intensive outpatient treatment in the form of a three-month day-care 
programme in 2005. The capacity of the programme was 10 persons, and the services were provided to a total of 
36 clients (18 males, 18 females). The average age of the clients was 26.2. Altogether, 22 (61%) clients injected 
drugs, 15 (42%) clients used heroin, and 7 clients (19%) used pervitin. 61% of the clients successfully completed 
their treatment. The average length of treatment per client was 1.5 months. The Elysium day-care 
psychotherapeutic sanatorium in Brno provided a structured programme which targeted unemployed methadone 
programme clients – in the course of the year, the clients attended three one-week day-care sessions which lasted 
three hours per day (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). 
5.2 Inpatient Treatment (Residential Treatment Facilities) 
There were no changes in the network of sobering-up stations and detoxification units in 2005 (Ústav 
zdravotnických informací a statistiky, 2006d). 
There was a slight decline in the number of psychiatric beds in 2005 (by 110 beds) as a result of the closure of the 
Psychiatric Hospital for Children in Branky na Moravě and one psychiatric department; the network and bed 
capacity of psychiatric hospitals for adults has not changed (Ústav zdravotnických informací a statistiky, 2006b). 
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Inpatient psychiatric facilities reported 16,492 hospitalisations resulting from disorders caused by drug use; 11,748 
of them were due to alcohol-related disorders and 4,744 due to disorders caused by the use of other psychoactive 
substances. The development in the number of hospitalisations is given in Figure 5-2. Multiple drug use and the use 
of other substances (diagnosis F19) were the most common reasons for hospitalisations in 2005 (51.9% of children 
and 51.1% of adults). Other reasons for hospitalisations in psychiatric hospitals for children involve the use of 
cannabis and inhalants, and the use of stimulants (28.7%) and opioids (12.4%) in psychiatric hospitals for adults – 
see Table 5-6. The group of patients aged 20–29 was the most represented among the group of drug users 
hospitalised in psychiatric hospitals for adults (56%) and the group of patients aged 15–19 was the most 
represented in psychiatric hospitals for children (55.6%) (Ústav zdravotnických informací a statistiky, 2006b). 
Table 5-6: Number of hospitalisations caused by the use of alcohol and other psychoactive substances in inpatient 
psychiatric hospitals in 2005 by type of health care facilities, gender, and diagnosis (Ústav zdravotnických informací a 
statistiky, 2006b) 
Psychiatric hospitals for 
children  
Psychiatric clinics for 
adults  
Psychiatric departments of
hospitals  Diagnosis 
Males Females Total Males Females Total Males Females Total 
F11–19 (all illicit drugs) 21 6 27 2,249 855 3,104 1,087 526 1,613
– F11 (opioids) 1 0 1 289 97 386 n.a. n.a. n.a.
– F12 (cannabis) 5 2 7 54 12 66 n.a. n.a. n.a.
– F15 (stimulants) 0 0 0 590 302 892 n.a. n.a. n.a.
– F18 (inhalants) 5 0 5 49 9 58 n.a. n.a. n.a.
– F19 (multiple drug use 
and other substances) 10 4 14 1,214 371 1,585 n.a. n.a. n.a.
F10 (alcohol) 0 1 1 6,549 2,295 8,844 1,796 1,108 2,903
Total 21 7 28 8,798 3,150 11,948 2,883 1,634 4,516
Figure 5-2: Development of the number of hospitalisations in inpatient psychiatric facilities resulting from disorders 
caused by the use of alcohol and other psychoactive substances in 1995–2005 (Ústav zdravotnických informací a 
statistiky, 2006b)  
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Fifteen therapeutic communities supplied inpatient treatment in 2005. The usual length of the programme was 6–15 
months. The Helianna Therapeutic Community and the Domov Agapé Therapeutic Community ceased to operate 
in 2005. Data from twelve therapeutic communities are available. Their capacity was 183 beds (12 for juveniles and 
9 for mothers with children), and 491 drug users (15 of them were mothers with children) were treated there in 2005. 
The average age of the patients was 24.9 (the average age of the mothers was 24). Altogether, 400 (81%) patients 
injected drugs, 287 (58%) patients used pervitin, and 132 (27%) used heroin. 16 (3%) patients were treated in 
connection with the use of cannabis. 102 patients (4 of them were mothers) successfully completed treatment and 
the average period of successful treatment was 314 days. 219 (45%) patients stopped their treatment prematurely, 
62% after two weeks of treatment and 31% after two thirds of the treatment. The average period of treatment of all 
patients was 177 days (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). 
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The NMC carried out a survey among school facilities which provide residential care and protective education and 
in school facilities for preventive educational care. The survey focused on treatment in relation to drug use among 
the children (aged under 18) who were placed in the facilities. 53 school facilities (out of 64 which were invited to 
participate) were involved in the survey; 60 questionnaires were sent back (some of the organisations operate in 
several school facilities). Tobacco, drug use, and aggression represent the three issues which the facilities had to 
address the most commonly. Nearly 97% of facilities deal with tobacco use, 78% deal with drug use, and 77% deal 
with alcohol use. While resolving drug-related issues, the school facilities collaborate the most with inpatient 
treatment facilities (psychiatric hospitals, therapeutic communities, and detoxification units), outpatient treatment 
facilities (psychological and psychiatric clinics and pedagogical-psychological counselling offices), and other school 
facilities which serve for the execution of residential care and protective education. Collaboration with NGOs and the 
family of the child is less common (Národní monitorovací středisko pro drogy a drogové závislosti, 2006f). 
Specialised departments for the treatment of children at risk of drug addiction were part of five facilities in 2005. The 
total capacity of the departments was 66 beds and the average length of the stay was five months (within the range 
of 2–7 months). 104 children who had either experimented with drugs or use them were treated there (86 boys and 
18 girls); their average age was 16.3 (within the 12–18 range). Altogether, 32 children (31%) were injecting drug 
users. Pervitin, cannabis, and inhalants were the most commonly used illicit drugs (Národní monitorovací středisko 
pro drogy a drogové závislosti, 2006f). 
See the chapter on Prevention of Drug-Related Crime, page 65, for more information on treatment in prisons. 
5.3 Substitution and Maintenance Programmes 
5.3.1 Substitution Treatment with Opiate Agonists 
Methadone prepared from an imported generic substance has been used for opiate substitution in the Czech 
Republic since 2000, and it has only been administered in specialised substitution centres. The medicinal product 
Subutex (buprenorphine) has been registered since 2000, and it can be prescribed by every physician, regardless 
of his/her specialisation. However, there is a certain limitation because of the fact that it is necessary to use a so-
called “opiate prescription with a blue stripe” – i.e. a prescription with a higher degree of registration and control. 
Substitution preparations in the Czech Republic are administered exclusively orally. 
The Substitution Treatment Standards (Ministerstvo zdravotnictví ČR, 2001a) define the methodology for 
substitution treatment in the Czech Republic, including the criteria for admission to treatment. The Substitution 
Treatment Register has been functioning in the Czech Republic since mid-2000 (Ministerstvo zdravotnictví ČR, 
2001b). Treatment in all health centres, not only in specialised substitution centres, now has to be registered (since 
January 1, 2006), i.e. it also applies to treatment with Subutex in the clinics of outpatient general practitioners or 
specialists. Nationwide reporting from clinics other than the specialised centres has not been introduced yet. 
5.3.1.1 Specialised Substitution Centres 
A substitution centre was opened in České Budějovice in 2005 and another in Karlovy Vary in February 2006. The 
Centre for Outpatient Detoxification and Substitution operated by the SANANIM civic association in Prague joined 
the Substitution Treatment Register in July 2006. Accordingly, there are currently twelve substitution centres in the 
Czech Republic and four of them are in Prague (Drop In operates two centres). In addition, substitution centres in 
the prisons in Prague-Pankrác and Příbram were opened within the framework of a pilot project of substitution 
treatment during the execution of sentence – see the chapter on Assistance to Drug Users in Prisons, page 65. Still, 
no coverage is available in the Pilsen, Karlovy Vary, Pardubice, Vysočina, and Zlín regions – see Map 5-1. 
All of the programmes give patients methadone prepared from an imported generic substance and the mass-
produced medicament Subutex (buprenorphine). 
Altogether, 758 patients were treated in ten substitution programmes in 2005; methadone was administered to 525 
of them and Subutex to 233. 
Table 5-7 shows the development in the number of patients of the specialised centres (by December 31 of each 
year). It is apparent that the programmes in Prague and Ústí nad Labem have the highest volume and turnover of 
patients, which corresponds to the regional distribution of prevalence of problem opiates users, which is the highest 
in these regions. 
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Map 5-1: Specialised substitution centres in the Czech Republic by July 31, 2006 
 
 
Table 5-7: Patients of specialised substitution treatment programmes as of December 31 of each year (Ústav 
zdravotnických informací a statistiky, 2006c) 
Centre/year 2000 2001 2002 2003 2004 2005 
Prague (General 
Teaching Hospital) 50 60 54 117 96 115 
Ostrava 0 1 4 10 11 10 
Olomouc 2 2 5 4 6 12 
Brno 4 50 53 46 46 63 
Ústí nad Labem 54 124 123 190 182 184 
Prague (Drop In) 71 110 100 142 135 135 
Hradec Králové 5 9 13 13 18 32 
Mělník 4 7 9 22 16 12 
České Budějovice 0 0 0 0 0 8 
Total 190 363 361 544 510 571 
 
5.3.1.2 Buprenorphine Substitution Treatment 
Each practitioner, regardless of his/her specialisation, can prescribe Subutex; it is also administered to suitable 
patients in specialised substitution centres. The number of patients who receive Subutex in specialised centres is 
accurately known (see above), while the number of patients using Subutex prescribed by outpatient physicians, as 
well as the number of these physicians, is not known accurately. 
Data from the State Institute for Drug Control about the distribution of Subutex on the Czech market are available 
(Státní ústav pro kontrolu léčiv, 2006). According to the data, the quantity of Subutex consumed is increasing. Given 
an average daily consumption of 6 mg and an average length of treatment of six months (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2004), it is possible to estimate that there were approximately 2,700 
Subutex users in the Czech Republic in 2005 – see Figure 5-3. 
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Figure 5-3: Distributed quantities of Subutex and estimated number of Subutex users in 2000–2005 (Státní ústav pro 





































Distributed Subutex in g 23.49 86.25 509.82 1 309.36 2 221.86 2 957.32
Estimated number of
Subutex users
21 79 465 1 195 2 028 2 699
2000 2001 2002 2003 2004 2005
 
 
Even the data from the Treatment Demand Register kept by the Hygiene Service confirm the increasing trend of the 
number of Subutex users; however, it is true that the absolute numbers are underestimated. It is unclear why there 
was a decline in the number of first treatment demands among clients who use Subutex – see Table 5-8. 
Table 5-8: First treatment demands and all treatment demands in relation to the use of Subutex as a primary or 
secondary drug (Polanecký et al.  2004; Polanecký et al.  2005; Polanecký et al.  2006) 









2003 4 13 17 16 41 57 
2004 58 51 109 145 114 259 
2005 6 72 78 223 187 410 
5.3.2 Occurrence of Substitution Preparations on the Black Market 
Methadone hardly ever appears on the black market. If it does, only anecdotal and unverified data are available. 
Subutex appears on the black market and on the open drug scene, especially in Prague and Northern and 
Southern Bohemia. Injecting it is not exceptional – see also the 2003 and 2004 Annual Reports of the NMC. 
The black market in Subutex in Prague most commonly involves the sales and purchases of small quantities of 
Subutex tablets among individual users. No large supplier or dealer who would offer a large quantity of illicitly 
procured Subutex is known. It is most likely that all the Subutex which appears on the black market comes from 
pharmacies where it was picked up with a prescription and then (a part of it) was sold under the counter.17 
In collaboration between NMC and the SANANIM civic association, a questionnaire survey was carried out among 
the clients of an low-threshold centre and outreach programme in February – June 2006 – see the chapter on 
Problem Drug Use in Other Data Sources, page 31, for more information. Altogether, 56.1% of the respondents use 
Subutex which they get from their physician or on the black market (24.2% of the respondents use Subutex which 
they get from their physician, 37.9% of the respondents use Subutex from the black market).18 41.4% of the clients 
use Subutex only; 95.1% of them reported injecting it. 
Three fatal overdoses with the presence of methadone were recorded in 2005; no overdose on Subutex was 
reported – see the chapter on Drug-Related Deaths and Mortality of Drug Users, page 40. 
                                                          
17 Source: personal communication with workers of the low-threshold centre and outreach programme operated by the SANANIM civic 
association, July 2006. 
18 The proportion between Subutex prescribed by a physician and from the black market could then be 48/75. In other words, 
approximately 60% of Subutex which is consumed in Prague by clients of low-threshold facilities comes from the black market. 
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5.3.3 Evaluation of Substitution Treatment Results 
The availability of substitution treatment increased in 2005. A new specialised centre in České Budějovice was 
opened in 2005, and others in Karlovy Vary and in two prisons in 2006 – see above. 
Patients can only receive methadone in specialised centres; no methadone-based mass-produced medicament has 
yet been registered in the Czech Republic – it could further improve its availability. Subutex consumption increased 
in 2005 – see above.  
On the basis of the above-mentioned data, it is possible to estimate that approximately 20–30% of problem drug 
users were in substitution treatment in 2005.  
Table 5-9 shows the reasons for terminating treatment in specialised centres. 
Table 5-9: Reason for termination of substitution treatment in specialised centres from 2000 until May 31, 2006 (Ústav 
zdravotnických informací a statistiky, 2006c) 
Number of treatment episodes Reason for treatment termination Centre Admission Termination 1 2 3 4 5 6 Total 
Prague (General 
Teaching Hospital) 469 358 50 40 152 6 1 109 358
Ostrava 46 34 5 1 15 1 0 12 34
Olomouc 34 20 3 1 11 0 0 5 20
Brno 104 41 1 0 27 6 0 7 41
Ústí nad Labem 857 681 11 30 552 39 2 47 681
Prague (Drop In) 1,439 1,327 55 59 1,088 11 3 111 1,327
Hradec Králové 53 27 4 7 10 1 1 4 27
Mělník 102 87 12 4 19 1 1 50 87
České Budějovice 36 24 1 4 16 0 0 3 24
Karlovy Vary 4 2 0 0 0 0 0 2 2
Prison Praha-Pankrác 1 0 0 0 0 0 0 0 0
Total 3,145 2,601 142 146 1,890 65 8 350 2,601
Note: Reason for treatment termination: 1 – transfer of a patient to another facility, 2 – transfer of a patient to another type of 
treatment, 3 – failure to observe rules, 4 – imprisonment, 5 – death of a patient, 6 – another reason. 
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6 Health Correlates and Consequences of Drug Use 
The number of drug overdoses has remained stable. Opiates, pervitin, and inhalants represent the most common 
(street) drugs involved in drug-related deaths – there was a slight increase in opiates overdoses and a slight decline 
in overdoses on pervitin and inhalants. Sporadic overdoses on ecstasy and cocaine have been reported in the last 
2–3 years. 
There is a favourable trend in the occurrence of infectious diseases among drug users. HIV seroprevalence among 
injecting drug users continues to be under 1%. Despite low absolute numbers, the number of injecting drug users 
newly infected with HIV is increasing. Approximately 30–35% of injecting drug users are infected with hepatitis C; 
this proportion is higher among specific subpopulations (substitution treatment patients, drug users in prison). As in 
2004, the availability of testing for infectious diseases directly among the at-risk population of injecting drug users 
can be regarded as insufficient; at the same time, the declining number of tests which are carried out among this 
population is alarming. 
A study which examined morbidity among those hospitalised as a result of disorders caused by drug use showed 
that “psychiatric disorders” and “injuries, poisonings, and some other consequences of external reasons” were the 
most common reasons for hospitalisation. 
6.1 Drug-Related Deaths and Mortality of Drug Users 
Drug-related deaths (overdoses) have been monitored by means of a special register kept by all thirteen 
departments of forensic medicine and forensic toxicology departments since 1998. Czech laws (Ordinance 18/1988 
Coll. of the Ministry of Health) specify mandatory autopsy in all cases of sudden death when the examining 
practitioner could not determine the cause of death and in all cases of violent deaths. Data on deaths “with the 
presence of narcotic and psychotropic substances” have been reported since 2003.19 The entire automated system 
and coordination of the collection of this type of data in general has been developed in close collaboration between 
the NMC and the Professional Association of Forensic Medicine and Toxicology of the Czech Medical Association 
of J. E. Purkyně. The representatives of the association are also members of the appropriate working group of the 
NMC. 
6.1.1 Drug Overdoses 
218 deaths resulting from drug overdoses were detected in 2005; 156 involved psychoactive medicines – see 
below. Leaving aside medicaments, presently and traditionally opiates (24), inhalants (18), and pervitin (14) have 
been the most common causes of these overdoses. Three overdose-related deaths with the presence of 
methadone were identified (one case in combination with ethanol, two in combination with other drugs). No fatal 
buprenorphine overdose was recorded. Furthermore, two fatal ecstasy (MDMA) overdoses and one cocaine 
overdose were reported (Národní monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 
2006) – see Table 6-1. 
Overdoses on psychotropic medicaments represent a very heterogeneous category and it is difficult to provide an 
accurate assessment. The reason is that these include suicide overdoses, accidental overdoses with lege artis 
prescribed medicaments, and also accidental overdoses on abused medicaments and overdoses without an 
established cause. Altogether, 156 overdoses on psychotropic medicaments were recorded in 2005; 56 of these 
cases involved overdoses on benzodiazepines.  
The number of overdoses on illicit opiates20 increased in 2005 (from 19 in 2004 to 24 in 2005), while the number of 
overdoses on pervitin and inhalants declined slightly (from 16 in 2004 to 14 in 2005 and from 20 in 2004 to 18 in 
2005 respectively). Sporadic cases of overdoses on MDMA and cocaine were reported during the last three years; 
no such cases had been reported prior to 2002 – see Figure 6-1. 
                                                          
19 A detailed methodological overview on how to determine drug-related deaths is included in a methodological publication which was 
published in 2004 (Zábranský et al., 2004). 
20 The number of opiates overdoses in 2004 was corrected. The number of 32 cases which was published last year was reduced to 19 – 
thirteen cases involved overdoses on medicaments which contained opiates; after the correction, these thirteen deaths were included in 
the category ”overdoses on medicaments”. 
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Table 6-1: Fatal drug overdoses in the Czech Republic in 2005 by groups of drugs, age groups, and gender (Národní 
monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006) 
Total 








































Only opiates or opioids 
(excluding methadone) 0 0 4 4 3 1 0 0 0 0 0 0 0 11 1 12
Only methadone  0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1
More substances 
including opiates/opioids 0 0 2 3 3 2 1 0 0 0 0 0 0 10 1 11
– of which methadone  0 0 0 1 0 0 1 0 0 0 0 0 0 2 0 2
Opiates total 0 0 6 7 7 3 1 0 0 0 0 0 0 21 3 24
More substances or one 
substance – not 
opiates/opioids 
1 6 7 4 4 4 4 1 3 0 0 1 0 32 3 35
– of which inhalants  1 4 2 1 0 2 4 1 2 0 0 1 0 18 0 18
– of which pervitin  0 2 4 3 2 2 0 0 1 0 0 0 0 12 2 14
– of which cocaine  0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 1
– of which dance drugs 
(e.g. MDMA)   0 0 1 0 1 0 0 0 0 0 0 0 0 1 1 2
– of which hallucinogens  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Psychoactive medicines  0 4 9 8 9 17 15 18 31 14 6 23 2 77 79 156
– of which 
benzodiazepines  0 0 4 1 3 9 5 5 9 8 2 9 1 32 24 56
Unspecified/uknown  0 1 0 0 2 0 0 0 0 0 0 0 0 3 0 3
Total excluding 
medicines 1 7 13 11 13 7 5 2 3 0 0 1 0 56 7 63
Total 1 11 22 19 22 24 20 19 34 14 6 24 2 133 85 218
Figure 6-1: Fatal overdoses on selected drugs in 1998–2005 (Národní monitorovací středisko pro drogy a drogové 












Benzodiazepines 41 56 65 66 50 91 94 56
Opioids 40 45 47 56 21 21 19 24
Inhalants 0 0 0 15 14 22 20 18
Amphetamines (pervitin) 21 34 31 5 8 9 16 14
MDMA 0 0 0 0 0 1 0 2
Cocaine 0 0 0 0 0 0 1 1
Hallucinogens 0 0 2 0 0 0 0 0
Canabinoids 0 0 0 0 0 0 0 0
1998 1999 2000 2001 2002 2003 2004 2005
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6.1.2 Deaths with the Presence of Drugs 
Altogether, 151 deaths with the presence of drugs were identified in 2005; 2 were due to illness, 66 due to 
accidents, 76 were suicides, 4 were cases of manslaughter or murder, and 3 deaths were due to other causes. 
Table 6-2 gives a summary of the proportion of selected groups of drugs in the individual groups of deaths with the 
presence of drugs, and Table 6-3 gives the trend in the last three years. It is especially worth mentioning an 
increase in the number and proportion of deaths with the presence of pervitin. 
Table 6-2: Deaths with the presence of drugs detected by forensic medicine departments in the Czech Republic in 2005 
by selected groups of drugs and causes of death (Národní monitorovací středisko pro drogy a drogové závislosti and 
SSLST ČLS JEP, 2006) 













Benzodiazepines 1 17 32 0 1 51 33.8 
Pervitin 1 20 9 2 0 32 21.2 
THC 0 11 4 1 2 18 11.9 
Inhalants 0 8 5 0 1 14 9.3 
MDMA 0 2 1 0 0 3 2.0 
Opiates/opioids 0 1 0 0 0 1 0.7 
Cocaine 0 0 0 0 0 0 0.0 
Table 6-3: Proportion of selected groups of drugs among all deaths with the presence of drugs detected by forensic 
medicine departments in the Czech Republic in 2003–2005 (Národní monitorovací středisko pro drogy a drogové 
závislosti and SSLST ČLS JEP, 2006) 





Benzodiazepines  38.2 50.0 33.8 
Pervitin 11.6 11.6 21.2 
THC 16.7 6.1 11.9 
Inhalants 4.8 3.7 9.3 
MDMA 0.4 1.8 2.0 
Opiates/opioids 4.8 8.5 0.7 
Cocaine 0.0 0.6 0.0 
 
Information about the detection of drugs in the bodies of persons who died in traffic accidents is included in the 
special chapter on Drugs and Driving, page 85.  
6.1.3 Mortality of Drug Users 
The most recent data are presented in the 2004 Annual Report.  
6.2 Drug-related Infections 
6.2.1 HIV/AIDS 
The occurrence of new cases of HIV infection among injecting drug users and among the general population is 
relatively low in the Czech Republic; however, it seems to have been increasing during the last three years. 90 new 
cases of HIV were diagnosed in 2005 (i.e. 25% more than in the previous year); 6 of them may have become 
infected as a result of illicit drug use. 827 HIV-positive persons with a permanent place of residence in the Czech 
Republic were registered on December 31, 2005; 37 of them are injecting drug users and another 11 are injecting 
drug users and homo/bisexuals at the same time, (altogether, 5.8%, 4–10% in individual years) – see Table 6-4 
(Brůčková et al.  2006). 
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Table 6-4: HIV incidence in the Czech Republic by December 31, 2004 by route of transmission (Brůčková et al.  2006) 
Route of transmission 
(risk group) 
Before 
2000 2000 2001 2002 2003 2004 2005 Total 
Homo/bisexual intercourse 236 27 27 28 37 30 49 434 
Heterosexual intercourse 130 22 13 20 19 30 31 235 
Injecting drug use 14 4 3 1 4 6 5 37 
Haemophiliac 17 0 0 0 0 0 0 17 
Blood recipient  14 0 0 0 0 0 0 14 
Homo/bisexual intercourse 
and injecting drugs 5 0 2 1 1 1 1 11 
Mother-child 2 1 0 0 1 0 0 4 
Nosocomial transfer 2 0 0 0 0 0 0 2 
Not ascertained  23 4 6 0 1 5 4 43 
Total 443 57 51 50 63 72 90 827 
 
Altogether, 855,010 laboratory tests for HIV antibodies were carried out in the Czech Republic in 2004, and 0.11% 
were positive. 1,374 persons (15% less than in 2004) reported injecting drugs as the reason for testing; one of them 
was positive.21 So far, positive injecting drug users have been diagnosed sporadically among this at-risk group (in 5 
out of 48 cases). Furthermore, the number of tests for HIV antibodies among injecting drug users decreased by one 
half in 1999–2003 and efforts to increase the numbers proved unsuccessful – see Table  6-5 (Brůčková et al.  2006; 
Jedlička et al.  2006). Information on the availability of testing among injecting drug users is also included in the 
chapter on Responses to Health Correlates and Consequences of Drug Use, page 49. 
Table 6-5: Tests of injecting drug users for HIV antibodies in 1994–2005 (Brůčková et al.  2006; Jedlička et al.  2006) 
Blood tests Saliva tests Total 















Before 1998 2 101 1 895 0 2 996 1 
1998 2 158 0 1 124 0 3 282 0 
1999 2 320 0 1 219 0 3 593 0 
2000 2 091 0 1 001 0 3 092 0 
2001 2 169 1 961 0 3 130 1 
2002 1 536 0 734 1 2 270 1 
2003 985 1 652 0 1 637 1 
2004 1 609 0 222 0 1 831 0 
2005 1 374 1 449 1 1 823 1* 
Total 14 741 4 6 814 2 20 228 5 
Note: * It involves one newly identified case which was detected by a saliva test and then confirmed by a blood test. 
6.2.2 Viral Hepatitis 
There was a decline in the number of reported new cases of acute HBV and all cases of HCV in the Czech 
Republic in 2005 – see Figure 6-2 and Figure 6-3 (Beneš and Částková, 2006). 
                                                          
21 Other positive IDUs were diagnosed within examinations of a different group (e.g. psychiatric patients, other clinical diagnoses, 
prisoners, contacts of HIV-positive persons, pregnant women etc.). 
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Figure 6-2: Reported HBV incidence and proportion of injecting drug users in the Czech Republic in 1996–2005 (Beneš 
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Figure 6-3: Reported HCV incidence – acute and chronic cases and proportion of injecting drug users in the Czech 
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Most cases of hepatitis among injecting drug users do not get into the reporting system, and so data from 
seroprevalence studies or routine testing among injecting drug users provide a better picture of the situation.  
Besides the prospective part of the “HCV Seroprevalence among Injecting Drug Users” survey carried out by the 
NMC, which ended in December 2005 (see below), no new data on the occurrence of hepatitis among injecting 
drug users in the Czech Republic are available. Available studies show that HCV seroprevalence among clients of 
low-threshold facilities is at 30–35% and HBV seroprevalence is at around 10%. Approximately 60% of the groups 
of users with a long history of drug use (clients in substitution treatment or in prison) are HCV positive, and 
approximately 15% are HBV positive.  
6.2.2.1 HCV Seroprevalence among Injecting Drug Users Survey 
The most extensive survey on the seroprevalence and seroincidence of HCV among injecting drug users in the 
Czech Republic was carried out in 2002–2005. 760 persons were examined in the basic part of the study, and 226 
tests22 were reactive. After adjustments to the sensitivity and specificity of the tests, an HCV seroprevalence of 
35.0%, with a 95% interval of reliability 31.6–38.4, was calculated (more detailed information is also included in the 
2004 Annual Report). Besides a strong association between a history of HCV and factors associated with injecting 
use (especially the length and the intensity of injecting use and needle sharing), the place of residence (the highest 
prevalence was in Ústí nad Labem and Prague) and previous incarceration have shown to be significant predictive 
factors. In accordance with the results of similar studies from around the world, factors such as risky sexual 
behaviour and transfusion were insignificant (Zábranský et al.  2006; Mravčík et al.  2006). 176 persons, i.e. 33.0% 
of patients whose test was not reactive in the basic part, were examined at least once within the framework of the 
prospective part of the study. The total length of monitoring of all users was 52,213 person-days; the average length 
                                                          
22 The test Hepatitis C Virus Whole Blood Test (Cassette) of Alfa Scientific Designs, Inc., USA was used. It is a quick orientative 
(screening) test from a drop of capillary blood taken from a fingertip. The test was evaluated prior to the start of the study, and it has 
been shown that it has a sensitivity of 86% and 100% specificity. 
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of monitoring was 297 days per person, with a minimum or 41 and a maximum of 1,017 days. The HCV incidence 
rate in the entire sample was 11.2 cases per 100 persons and year (Mravčík et al.  2006).  
6.2.3 Monitoring of Infections among Specific Populations of Drug Users 
Most Czech low-threshold centres for drug users offer testing for infectious diseases (see the chapter on Services 
Provided by Low-Threshold Facilities, page 49, for more information). The facilities carried out 6,513 tests for 
infections in 2005; results are available for 3,368 tests from 31 facilities. Orientative tests from capillary blood (66%) 
were the most common, followed by tests from venous blood (31%) and saliva tests (3%). The results of the 
monitoring indicate a lower occurrence of hepatitis than do the results of national and local seroprevalence surveys 
– see Table 6-6. A possible explanation involves the fact that, unlike in studies, monitoring also takes place in small 
towns where the occurrence of hepatitis is lower and the fact that new clients who are not infected very often take 
up the offer of being tested.23 
Table 6-6: Results of testing for infections among injecting drug users in low-threshold facilities in 2005 (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2006e) 






HIV – capillary blood 916 0 0.0
HIV – venous blood 317 0 0.0
HIV – saliva 87 0 0.0
HCV – capillary blood 1,321 49 3.7
HCV – venous blood 254 54 21.3
HBV – venous blood 242 15 6.2
HAV – venous blood 231 6 2.6
 
6.3 Other Drug-Related Disorders 
6.3.1 Co-Morbidity among Hospitalised Drug Users 
The NMC carried out an analysis of the 2001–2005 data from obligatory hospitalisation reports to the Institute of 
Health Information and Statistics of the Czech Republic. The survey involved all hospitalisations of persons who had 
been diagnosed with a primary or secondary diagnosis of a mental or behavioural disorder caused by drug use 
(F11–F16 and F18–F19) at least once during 2001 to 2005. The sample analysed consisted of 19,795 persons 
aged 30.7 on average in the range of 0–100 years; 64% of the sample were males. Altogether, there were 93,182 
hospitalisations in the sample; the average was 4.7 hospitalisations per person; 4,370 persons were hospitalised 
only once. 1 person was hospitalised 243 times during the five-year period (Ústav zdravotnických informací a 
statistiky, 2006a). 
Regardless of whether it was a primary or secondary analysis, multiple drug use and the use of other psychoactive 
substances, and the use of opioids and stimulants were the most common – see Table 6-7. 
Table 6-7: Number of hospitalised patients diagnosed with disorders caused by the use of individual groups of drugs in 
2001–2005 (Ústav zdravotnických informací a statistiky, 2006a) 
Diagnosis Number of patients  
Proportion 
in % 
F11 – opioids 5,723 28.9
F12 – cannabinoids  1,800 9.1
F13 – sedatives or hypnotics 2,545 12.9
F14 – cocaine 227 1.1
F15 – stimulants  4,688 23.7
F16 – hallucinogens  438 2.2
F18 – inhalants  756 3.8
F19 – multiple drug use and other substances 8,075 40.8
Total 19,795 100.0
Note: The sum of cases according to diagnoses is higher than the total number of clients; the reason is that some patients have 
multiple diagnoses.  
5,044 (25.5%) persons were diagnosed with a disorder caused by multiple drug use and use of other substances 
(F19), 3,971 (20.1%) by the use of opioids, 2,831 (14.3%) by the use of stimulants, and 2,013 (10.2%) by the use of 
hypnotics. 3,749 were diagnosed with the use of two and more different psychoactive substances, most commonly 
multiple drug use and use of other substances use with the use of opioids and/or stimulants – see Table 6-8. 
                                                          
23 Information from representatives of service providers from a meeting of the Infectious Diseases working group of the National 
Monitoring Centre for Drugs and Drug Addiction, June 2006. 
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Table 6-8: Combination of diagnoses F11–F16 and F18–F19 among selected patients who were hospitalised in 2001–
2005 (Ústav zdravotnických informací a statistiky, 2006a) 
Diagnosis and combinations of diagnoses 
Number of 






F19 – multiple drug use and other substances 1 5,044 25.5 
F11 – opioids 1 3,971 20.1 
F15 – stimulants  1 2,831 14.3 
F13 – sedatives or hypnotics 1 2,013 10.2 
F12 – cannabis  1 1,200 6.1 
F11 and F19 2 957 4.8 
F15 and F19 2 934 4.7 
F18 – inhalants  1 532 2.7 
F16 – hallucinogens  1 284 1.4 
F13 and F19 2 232 1.2 
F11 and F15 2 226 1.1 
F11, F15 and F19 3 202 1.0 
Other 1–4 1,369 6.9 
Total  1–4 19,795 100.0 
 
Hospitalisations with a primary diagnosis of a mental and behavioural disorder24 (86%) prevail among the sample; 
then, hospitalisations with a primary diagnosis of an injury, poisoning, and some other consequences or external 
causes (28%) and hospitalisations resulting from digestive disorders (13%) were the most common – see Table 
6-9.  
Table 6-9: Primary diagnoses of hospitalisations of selected patients in 2001–2005 (Ústav zdravotnických informací a 
statistiky, 2006a) 
Groups of primary diagnoses Number of patients 
% 
of patients 
Mental and behavioural disorders 16,984 85.8 
Injuries, poisonings, and other consequences of external causes 5,506 27.8 
Digestive disorders  2,494 12.6 
Infectious and parasitic diseases 2,306 11.6 
Abnormalities unclassified elsewhere 2,070 10.5 
Diseases of the circulatory system  1,872 9.5 
Respiratory diseases 1,517 7.7 
Diseases of the genito-urinary system  1,403 7.1 
Pregnancy, delivery, and puerperium 1,362 6.9 
Diseases of the musculo-skeletal system and connective tissue 1,320 6.7 
Diseases of the nervous system  1,181 6.0 
Factors which influence health and contact with health care services  1,118 5.6 
Diseases of the skin and subcutaneous tissue 758 3.8 
Neoplasms 724 3.7 
Endocrine, nutritional, and metabolic diseases  467 2.4 
Diseases of the eye and adnexa 269 1.4 
Diseases of the blood and blood-forming organs and some 
disorders concerning the immune mechanism 124 0.6 
Diseases of the ear and mastoid process 118 0.6 
Congenital malformations, deformations, and chromosomal abnormalities  49 0.2 
Certain conditions originating in the perinatal period  9 0.0 
Total 19,795 100.0 
Note: The sum of cases according to diagnoses is higher than the total number of patients; it is because the primary diagnosis of 
several patients contained several diagnostic groups in the period monitored. 
6.3.1.1 Occurrence of Other Diagnoses Excluding Substance Addictions 
The diagnoses F11–F16 and F18–F19 and other psychiatric diagnoses were the most common (they occurred 
among 7,387 patients, i.e. 37%, at least once during the period monitored), followed by injuries, poisonings, and 
other consequences of external causes (6,273 patients; 32%). The proportion of individual diagnostic groups which 
                                                          
24 It is understandable because of the selection criteria for sample selection. 
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occurred at least once among the persons suffering from disorders caused by the use of individual drugs is given in 
Table 6-10.  
Table 6-10: Diagnoses which occur in combination with illicit drugs use among selected patients who were hospitalised in 
2001–2005 (%) (Ústav zdravotnických informací a statistiky, 2006a) 

















A00–B99 24.2 11.1 8.5 14.1 19.8 14.6 9.8 18.6 15.6
C00–D48 5.9 2.9 8.6 11.9 1.9 4.6 3.2 3.3 4.7
D50–D89 3.9 2.3 5.2 4.0 1.9 4.6 3.2 2.8 3.3




20.2 51.1 66.1 29.1 30.2 31.7 42.7 44.9 37.3
G00–G99 8.9 7.8 16.6 15.0 4.5 11.0 7.9 8.8 8.9
H00–H59 2.3 2.2 3.7 11.5 1.1 2.3 1.5 1.7 2.2
H60–H95 1.2 1.4 2.1 2.6 0.6 1.4 1.6 1.1 1.2
I00–I99 20.7 11.5 31.9 44.5 7.5 21.2 16.8 12.0 17.3
J00–J99 14.4 15.4 17.0 26.0 10.5 18.9 14.0 13.1 13.6
K00–K93 19.8 16.7 27.8 25.6 13.2 23.1 18.8 18.5 18.8
L00–L99 7.2 4.9 5.0 7.0 6.1 5.5 6.6 6.4 5.7
M00–M99 10.6 8.6 20.2 22.5 5.1 9.6 8.5 8.3 10.3
N00–N99 11.6 8.5 17.5 19.8 8.2 9.8 9.5 9.6 10.8
O00–O99 8.9 4.4 5.0 4.8 9.2 7.5 2.2 6.7 7.0
P00–P96 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.1
Q00–Q99 0.6 1.3 0.9 0.9 0.6 1.1 0.9 0.6 0.7
R00–R99 15.3 17.1 23.3 21.6 12.1 20.5 18.0 14.6 15.4
S00–T98 28.2 31.8 38.4 31.3 29.2 43.8 39.9 35.7 31.7
V01–Y98 0.4 6.1 9.1 5.3 4.1 8.7 5.8 6.1 5.3
Z00–Z99 17.1 18.8 20.0 19.4 14.2 18.9 16.4 16.2 15.9
Note: Three most common groups of diagnoses of users of individual drugs are in bold.  
A00–B99 – Certain infectious and parasitic diseases 
C00–D48 – Neoplasms 
D50-D89 – Diseases of the blood and blood-forming organs and certain 
disorders concerning the immune mechanism 
E00–E90 – Endocrine, nutritional, and metabolic diseases   
F00–F99 – Mental and behavioural disorders 
G00–G99 – Diseases of the nervous system 
H00–H59 – Diseases of the eye and adnexa 
H60–H95 – Diseases of the ear and mastoid process 
I00–I99 – Diseases of the circulatory system 
J00–J99 – Diseases of the respiratory system 
K00–K93 – Diseases of the digestive system  
L00–L99 – Diseases of the skin and subcutaneous tissue 
M00–M99 – Diseases of the musculo-skeletal system and connective tissue 
N00–N99 – Diseases of the genitourinary system 
 
 
O00–O99 – Pregnancy, childbirth, and the puerperium 
P00–P96 – Certain conditions originating in the perinatal period 
Q00–Q99 – Congenital malformations, deformations, and 
chromosomal abnormalities 
R00–R99 – Symptoms, signs, and abnormal clinical and 
laboratory findings, not elsewhere classified  
S00–T98 – Injuries, poisonings, and other consequences of 
external reasons 
V01–Y98 – External causes of morbidity and mortality 
Z00–Z99 – Factors influencing health status and contact with 
health services 
 
Mental and behavioural disorders caused by the use of opioids – 
F11, cannabis – F12, sedatives or hypnotics – F13, cocaine – F14, 
stimulants – F15, hallucinogens – F16, inhalants – F18, multiple 
drug use and use of other psychoactive substances – F19. 
Psychiatric disorders most commonly occur together with the use of hypnosedatives (66% of patients with the 
diagnosis F13) and cannabinoids (51% of patients with the diagnosis F12), and they occur the least in combination 
with the use of cocaine (29% of patients with the diagnosis F15) and opioids (20% of patients with the diagnosis 
F11). As far as opioid users are concerned, injuries, poisoning, and certain other consequences of external causes 
(28%) and infectious diseases (24%) prevail. Psychiatric disorders (30%) and injuries, poisoning, and certain other 
consequences of external causes (29%) were the most common among stimulants users.  
6.3.1.2 Psychiatric Co-morbidity 
Psychiatric disorders which occurred at least once together with drug use in the period monitored concern 
especially disorders of adult personality and behaviour (F60–F69; 16%) and neurotic, stress-related and 
somatoform disorders (F40–F49; 15%), and then schizophrenia, schizotypal and delusional disorders (8%), among 
the users of cannabis, stimulants, hallucinogens and polydrug users and users other substances, and affective 
disorders (8%) among the users of opioids, hypnosedatives, and cocaine. A group of diagnoses of behavioural and 
emotional disorders of children (F90–F99) is associated with the use of inhalants (12%). The proportion of individual 
groups of psychiatric diagnoses which occur in combination with the use of illicit substances is given in Table 6-12. 
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Table 6-11: Psychiatric diagnoses which occurred in combination with drug use among selected patients in 2001–2005 
(%) (Ústav zdravotnických informací a statistiky, 2006a)  

















F00–F09 2.9 1.8 11.1 3.1 1.2 1.8 3.6 3.6 3.8
F20–F29 3.4 13.7 7.9 4.4 7.1 9.4 7.0 11.5 7.9
F30–F39 4.6 6.0 25.5 6.2 3.9 5.7 3.4 8.1 7.9
F40–F49 7.6 18.4 38.3 14.5 9.8 11.2 11.1 16.8 15.2
F50–F59 0.9 1.2 3.4 3.1 1.4 1.1 0.8 1.6 1.4
F60–F69 7.7 22.4 24.4 15.0 16.2 14.4 16.1 22.5 15.8
F70–F79 1.0 2.0 1.1 0.9 0.8 2.3 7.1 2.1 1.6
F80–F89 0.0 0.6 0.2 0.4 0.1 0.2 1.3 0.2 0.2
F90–F98 1.4 10.9 2.8 3.5 3.4 3.4 12.4 4.2 3.6
F99 0.2 0.4 0.6 1.8 0.3 0.7 0.4 0.4 0.4
Note: The three most common groups of diagnoses of users of individual drugs are in bold. 
F00–F09 – Organic, including  symptomatic, mental disorders 
F20–F29 – Schizophrenia, schizotypal, and delusional disorders 
F30–F39 – Mood (affective) disorders 
F40–F49 – Neurotic, stress-related and somatoform disorders 
F50–F59 – Behavioural syndromes associated with physiological 
disturbances and physical factors  
F60–F69 – Disorders of adult personality and behaviour 
F70–F79 – Mental retardation  
F80–F89 – Disorders of psychological development 
F90–F98 – Behavioural and emotional disorders of children 
F99 – Unspecified mental disorder  
 
Mental and behavioural disorders due to use of opioids – F11, 
cannabinoids – F12, sedatives or hypnotics – F13, cocaine – F14, 
stimulants – F15, hallucinogens – F16, inhalants – F18, multiple drug 
use and use of other psychoactive substances  – F19.  
6.3.2 Non-Fatal Drug Intoxications 
The collection of data about non-fatal intoxications25 is based on the system administered by the Hygiene Service. 
Considerable regional differences in data collection systems have persisted. Various types of health care facilities 
represent a source of data. Intoxications caused by pervitin and heroin (20.5% and 18.6% of cases respectively) 
were those most commonly reported in 2005. A comparison of the rate of intoxications in 2001 to 2005 by drugs is 
included in Table 6-12.  
Table 6-12: Intoxications with drugs in the Czech Republic, a comparison of the years 2001–2005, by drugs (Polanecký 
et al, 2002–2006) 
2001 2002 2003 2004 2005 
Drug  Abs. % Abs. % Abs. % Abs. % Abs. % 
Heroin 285 24.1 176 17.6 152 17.3 179 18.8 244 20.5
Pervitin 163 13.8 191 19.1 149 16.9 180 18.9 222 18.6
Benzodiazepines  137 11.6 89 8.9 157 17.8 126 13.2 153 12.8
Other drugs and medicines 182 15.4 179 17.9 100 11.4 92 9.7 111 9.3
Sedatives, hypnotics 176 14.9 121 12.1 73 8.3 97 10.2 77 6.5
Cannabis  63 5.3 101 10.1 90 10.2 84 8.8 73 6.1
Inhalants  75 17.8 58 5.8 69 7.8 64 6.7 48 4.0
Other opiates 16 1.4 23 2.3 22 2.5 20 2.1 19 1.6
Subutex n.a. – n.a. – 2 0.2 12 1.3 14 1.2
Amphetamines  4 0.3 12 1.2 7 0.8 17 1.8 13 1.1
Barbiturates 19 1.6 16 1.6 9 1.0 6 0.6 11 0.9
Methadone 2 0.2 6 0.6 3 0.3 2 0.2 10 0.8
Ecstasy  15 1.3 4 0.4 8 0.9 3 0.3 8 0.7
Cocaine, crack 4 0.3 2 0.2 6 0.7 5 0.5 7 0.6
Psilocybin 15 1.3 7 0.7 4 0.5 10 1.1 6 0.5
LSD 3 0.3 2 0.2 3 0.3 7 0.7 3 0.3
Thorn apple  4 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Unknown  20 1.7 13 1.3 27 3.1 48 5.0 173 14.5
Total 896 100.0 818 100.0 881 100.0 952 100.0 1193 100.0
6.3.3 Drugs and Traffic Accidents 
See detailed information in the special chapter on Drugs and Driving, page 85. 
                                                          
25 The system also includes the reporting of overdoses and other health complications which require hospitalisation. 
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7 Responses to Health Correlates and Consequences of Drug Use 
Harm reduction is one of the four pillars of the Czech Republic's drug policy. In the national strategy, activities from 
the field of harm reduction are specified within one of the six basic goals of the drug policy – the reduction of the 
potential risks posed by all types of drugs and the reduction of the economic, social, and health impacts of drug use 
for individuals and society. The measures targeted at the reduction of drug-related health risks are carried out by 
treatment institutions (see the chapter on Treatment, page 32) and, especially, by low-threshold facilities for drug 
users. The availability, capacity, and use of the facilities have been increasing continually since the second half of 
the 1990s. The proportion of problem users who are in contact with the facilities is relatively high. On the contrary, a 
decrease in the availability of testing for infectious diseases in the population of injecting drug users can be 
mentioned as a weakness.  
7.1 Services Provided by Low-Threshold Facilities 
The network of low-threshold facilities has been developing in the Czech Republic since 1992. It consists of 
low-hreshold centres, outreach programmes (streetwork), and needle exchange programmes; there were 92 of 
them in 2005 – see Map 7-1. The target population of the low-threshold facilities consists of problem drug users, 
experimenters, and their friends and relatives; some facilities also provide services to recreational users of dance 
drugs. The basic goals of the services provided in the field of health harm reduction involve improving the level of 
informedness of users about the effects of individual drugs, prevention of overdoses, prevention of the spread of 
hepatitis and HIV/AIDS, mediation of contact between users and other helping and treatment facilities, increasing 
users' motivation to engage in less risky behaviour and changing lifestyles towards abstinence, and regular 
exchange and safe disposal of used injecting equipment.  
Map 7-1: Low-threshold facilities in the Czech Republic in 2005 
 
 
Data on the services provided by low-threshold facilities and on persons who have received them are available in 
annual reports which were drawn up by the facilities for the purposes of the subsidy proceedings of the The Council 
of the Government for Drug Policy Coordination (CGDPC). 78 low-threshold facilities, i.e. 84% of the total number, 
participated in the subsidy proceedings. An estimate of the volume of services and the number of persons who 
have used them was made on the basis of data from these facilities – see Table 7-1 and Table 7-2 (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2006g). Information on the activities of the low-threshold 
facilities follows on from aggregated data on individual projects, and so it is not possible to exclude contingent 
duplications regarding persons who used services in several facilities during the respective year. The analysis of the 
outputs of the FreeBase database (data from 34 facilities which provided a list of codes of their clients26) showed 
that 1,965 (22%) of the total number of 8,921 codes were present in several facilities. 
                                                          
26 Low-threshold facilities provide their services in an anonymous manner; they use codes to register their clients. The codes make it 
possible to distinguish between individual users while maintaining their confidentiality. 
page 50 
Table 7-1: Number of clients of low-threshold facilities in 2005 – extrapolated to 92 facilities (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2006g) 
Indicator Number 
Total number of persons  32,800 
Number of drug users  27,800 
Number of injecting drug users  17,900 
Number of primary opiates users  6,800 
Number of primary pervitin users  12,300 
Number of primary cannabis users  3,600 
Number of primary inhalant users  470 
Average age of drug users  25 years 
Table 7-2: Selected activities of low-threshold facilities in 2005 – extrapolated to 92 facilities (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2006g) 
Indicator Number 
Total number of visits  403,900 
Needle and syringe exchange programme 249,000 
Food service 99,500 
Hygiene service 40,900 
Medical treatment 12,500 
Individual counselling 25,800 
Group counselling 1,500 
Crisis intervention 2,500 
 
In comparison with the previous years, attendance at low-threshold facilities increased markedly, together with the 
volume of services supplied, especially the one most commonly utilised – needle and syringe exchange (154,000 
exchanges in 2002 and 249,000 in 2005) – see Table 7-3. The number of drug users who took advantage of the 
services supplied by these facilities and their structure by gender and drugs used has remained stable. In the long 
term, the average age of users increased from 22 in 2002 to 25 in 2005 (see also the 2002–2004 annual reports of 
the NMC). At the same time, the proportion of problem drug users in contact with the facilities has remained stable; 
60%, according to data which were obtained in 2002–2005 within the framework of the survey ‘HCV 
Seroprevalence among Injecting Drug Users’ – see the chapter on Estimates of Prevalence and Incidence of 
Problem Drug Use, page 23. Other studies mention a 56% proportion of injecting drug users in contact with the 
facilities in 2004 (Staníček, 2005). 
Table 7-3: Clients of Czech low-threshold facilities in 2002–2005 (Mravčík et al.  2005a; Národní monitorovací středisko 
pro drogy a drogové závislosti, 2006g) 
Indicator  2002 2003 2004 2005 
Number of low-threshold facilities  92 93 92 92
Number of drug users  n.a. 25,200 24,200 27,800
Number of injecting drug users  19,000 16,700 16,200 17,900
Number of opiates users  8,000 6,100 6,000 6,800
Number of pervitin users  12,900 11,300 12,200 12,300
Number of inhalant users n.a. 705 560 470
Number of cannabis users  3,400 5,500 4,100 3,600
Number of contacts/visits 290,000 315,000 318,000 403,900
7.1.1 Evaluation of Low-Threshold Services 
Three analyses of the current state of the network of low-threshold facilities in the Czech Republic were carried out 
in 2005 (Staníček, 2005; Libra, 2006; Mravčík, 2005). They indicate the following findings: 
• Differences between the network of facilities in individual regions involve accessibility for clients, the proportion of 
the estimated number of injecting drug users among the clients who use the services provided by the facilities 
(24–76%), average costs per injecting drug user and year (€ 87–363) and the amount of subsidies from the 
subsidy proceedings of the CGDPC (six regions were financially underestimated and five regions were financially 
overestimated against the proposed optimum). Prague and Central Bohemia (insufficient capacity) and Vysočina 
can be regarded as problematic regions (because of a low proportion of injecting drug users contacted, despite 
high costs) (Staníček, 2005).  
• There are differences in the target population and in the spectrum of the services provided. Facilities which cover 
a greater area (with a higher number and density of inhabitants) rather focus on problem drug users, and facilities 
which cover a smaller area also focus on other groups of drug users and on persons who are at risk of drug 
addiction (Staníček, 2005). 
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• There are also differences in the costs per individual low-threshold facility. The costs per contact were between 
€ 3 and € 305 (€ 35 on the average, compared with € 57 in 2001). Facilities with costs per contact above 
€ 22 can be regarded as too costly, and facilities with less than 40 clients and 200 contacts per employee and 
year can be regarded as insufficiently effective (Mravčík, 2005). 
• Although the costs of low-threshold facilities increase with inflation, the total amount of subsidies provided at the 
central level does not increase (Libra, 2006); selected data on the funding of low-threshold facilities within the 
subsidy proceedings of the CGDCP in 2002–2005 are given in Table 7-4. 
Table 7-4: Support to low-threshold facilities within subsidy proceedings of the CGDPC in 2002–2005 
Indicator  2002 2003 2004 2005 
Number of facilities supported  88 83 86 75 
Total costs (in € thousand) 4,469 4,644 5,036 5,035 
Subsidy from CGDPC (in € thousand) 1,593 1,646 1,692 1,510 
Proportion of the subsidy from the 
CGDPC in total costs (%) 35.6 35.4 33.6 30.0 
  
On the basis of the above-mentioned findings, a suggestion was made to increase the involvement of institutions in 
the region (e.g. the regional drug policy council and the regional drug coordinator) in the process evaluation and 
optimisation of the network of services. At the same time, a recommendation was made to reassess the existing 
subsidy system – to consider the proportion of the part of the population of problem drug users contacted when the 
efficiency of individual programmes is being assessed, so as to evenly distribute financial resources to individual 
regions in order to systematically support suitable types of low-threshold services27 with regard to the coverage area 
and character of the region (Staníček, 2005; Libra, 2006). 
7.2 Overdose Prevention 
In the Czech Republic, overdose prevention is only carried out through the education and training of drug users 
within the framework of services provided by low-threshold and treatment facilities. The main topics dealt with in 
education involve first aid in the case of an overdose, the risks of combining drugs, and principles of safer use.  
Besides the above-mentioned services and substitution treatment programmes, no other specific activities which 
lead to overdose prevention (e.g. the use of the preventive distribution of opioid antagonists to users or injecting 
rooms) have been introduced in the Czech Republic.  
7.3 Prevention of Infectious Diseases 
The activities of low-threshold facilities involve the provision of information on infectious diseases, education and 
motivation towards safer drug use, exchange programmes, including the safe disposal of used syringes and a 
secondary exchange programme,28 education and motivation towards safer sex, the distribution of condoms, 
motivational training to ascertain one’s own state of health, and the mediation of vaccination and contact with a 
specialist physician in the event of (the suspicion of) a disease. The types of services provided by individual facilities 
vary according to capacity, financial means, and demand on the part of users. 
7.3.1 Needle and Syringe Exchange Programmes 
A needle and syringe exchange programme was provided by 96% of Czech low-threshold facilities in 2005. The 
number of needles and syringes distributed has been increasing for a number of years – see Table 7-5 and Table 
7-6. According to information from final reports, each injecting user who visited a low-threshold facility in 2005 
exchanged fourteen times on the average and received a total of 197 sterile syringes.  
                                                          
27 Besides low-threshold centres, support should also be available to outreach programmes and so-called drug agencies. 
28 Involvement of active drug users who receive training and then, under professional supervision, exchange injecting materials and 
provide information to other drug users. 
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Table 7-5: Exchange programmes in the Czech Republic in 1998–2005 (Národní monitorovací středisko pro drogy a 
drogové závislosti, 2006g; Polanecký et al.  2006) 








1998 42 487,000 
1999 64 850,000 
2000 80 1,152,000 
2001 77 1,567,000 
2002 88 1,471,000 
2003 87 1,780,000 
2004 86 2,358,000 
2005 88 3,274,000 
Table 7-6: Exchange programmes in regions of the Czech Republic in 2002–2005 (Národní monitorovací středisko pro 
drogy a drogové závislosti, 2006g; Polanecký et al.  2006) 
Region/year 2002 2003 2004 2005 
Prague 858,507 979,560 1,210,704 1,697,554 
Central Bohemia 12,561 31,682 66,600 110,325 
Southern Bohemia  14,883 69,004 102,621 124,454 
Pilsen 23,221 44,670 88,450 116,611 
Karlovy Vary 16,608 29,299 35,756 58,680 
Ústí nad Labem 256,071 262,418 351,561 479,383 
Liberec 12,273 21,108 33,467 32,800 
Hradec Králové 22,250 45,089 41,021 86,221 
Pardubice 23,622 23,330 36,081 38,725 
Vysočina 11,254 29,363 39,348 61,425 
Southern Moravia 134,285 122,137 165,846 173,090 
Olomouc 21,809 33,832 85,872 96,416 
Zlín 19,973 11,362 41,977 143,771 
Moravian-Silesian 41,907 75,103 56,232 52,169 
Total 1,471,000 1,780,000 2,358,000 3,274,000 
Map 7-2: Number of exchanged needles and syringes in regions of the Czech Republic in 2005, per 1,000 inhabitants 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2006g; Polanecký et al.  2006) 
 
7.3.2 Sales of Needles and Syringes in Pharmacies 
Approximately 64% of 760 respondents to the ‘HCV Seroprevalence among Injecting Drug Users’ study mentioned 
that they had got clean needles and syringes from pharmacies during the previous six months; pharmacies 
represent the second biggest source of injecting equipment after low-threshold centres (68.8% of respondents). 
More than 40% of the respondents estimated that less than 20% of the pharmacies in the place of their residence 
page 53 
do not sell syringes to drug users; nearly 30% of the respondents believe that this proportion is 60% or more. 
52% of the respondents had personal experience of a pharmacy refusing to sell them syringes; 40% of respondents 
reported that the staff of the pharmacies were asking a price which was higher than usual for the syringes29 
(Mravčík et al.  2006). 
7.3.3 Testing for Infectious Diseases among Drug Users 
In 2005, 59% of low-threshold facilities offered testing for HCV antibodies, 58% for HIV, 30% for VHB, and 2% for 
syphilis. Only 15% of more than 16,000 injecting drug users who used the services provided by low-threshold 
facilities asked for an HIV test, and 16% asked for HCV testing30 (provided that the tests were not carried out 
repeatedly for the same persons)31 (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). The 
results of the tests are given in the chapter on Drug-related Infections, page 42. 
Table 7-7: Number of tests for infections carried out by low-threshold facilities in 2001–2005 (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2006g) 
2001 2002 2003 2004 2005 Test type 
Tests Facilities  Tests Facilities Tests  Facilities Tests  Facilities  Tests Facilities 
HIV  2,307 47 1,158  35 2,629 64 2,178 58 2,425  54
HBV 901  36 515  26 739 21 932 25 1,370  28
HCV 1,257 40 1,202  33 2,499 60 2,582 53 2,664  55
Syphilis n.a. n.a. 176  2 209 4 84 1 54  2
 
7.4 Interventions Relating to Psychiatric Co-morbidity 
The treatment of drug users who also suffer from other, dual diagnoses is carried out in an integrated manner, i.e. 
within the existing treatment system for drug users, and the specific needs of the patients are taken into 
consideration – see the chapter on Treatment, page 32. 
                                                          
29 The common price is approximately CZK 4 (€ 0.15); respondents often mentioned that they were asked to pay CZK 10, 20, 30, or 50; 
the highest price mentioned was CZK 80 (€ 2.70) for a syringe. 
30 Governmental order 453/2004 Coll. came into force at the beginning of 2006. According to it, all in vitro diagnostic devices must meet 
the requirements of the European directive 98/79/EEC before they can be put on the market (inter alia, they must have a declaration of 
conformity which is issued for the diagnostic health device and a CE marking of the device). Previously, quick orientative capillary blood 
tests were the most common tool for testing drug users for VHC antibodies (1.2 million tests per year). Currently, no such test which 
would meet the new requirements is available on the Czech or the European market; therefore, it is possible to expect a decline in the 
number of HCV tests carried out.  
31 No data on the number of persons tested are available. 
page 54 
8 Social Correlates and Consequences of Drug Use 
The most significant social problems of drug users involve family and work problems, unemployment, lower 
education, and poor housing, which sometimes even lead to homelessness; the accumulation of several social 
problems may lead to social exclusion. Social exclusion does not necessarily have to be a consequence of drug 
use (especially problem drug use); on the contrary, it can also be one of the causes of drug use.  
Besides drug users, unemployed and homeless persons and people with a low level of education, the groups which 
are directly endangered by social exclusion also involve immigrants, members of minorities, or children who grow 
up in problem families; in the Czech Republic, social exclusion involves especially certain groups of the Roma 
population. 
In 2005, the number of drug offences, as well as the number of prosecuted and accused drug offenders, was 
approximately the same as in 2004. Even the proportion of offences of the possession of drugs in a quantity greater 
than small (8%) among all detected drug offences has remained approximately the same. The number of those 
sentenced for drug offences declined for the first time since the beginning of the 1990s. Pervitin is the drug most 
associated with drug offences and this proportion is growing; the proportion of cannabis has been declining. The 
proportion of custodial sentences among those sentenced has been increasing. The proportion of suspended 
custodial sentences, first offenders, and juveniles among those sentenced for cannabis-related offences is markedly 
higher than among those sentenced for offences which involve other drugs. 
8.1 Social Exclusion 
It has been apparent in the long term that frequent drug-related social problems involve disturbed family relations, 
disturbed relationships in the workplace or at school, lower levels of education or even incomplete education, 
unemployment, lower socio-economic status, and/or poor housing, which sometimes even leads to homelessness. 
The accumulation of the above-mentioned social problems may lead to so-called social exclusion, i.e. the exclusion 
of an individual from society. However, social exclusion does not necessarily have to be a consequence of drug use 
(especially problem drug use); on the contrary, it can also be one of the causes of drug use. 
Social exclusion is often also supported by negative attitudes on the part of the majority society towards a particular 
group of citizens (so-called symbolic exclusion); on the other hand, it is also supported by the so-called subjective 
exclusion, when an individual or a group of citizens feels excluded from society (Mareš, 2002; Kancelář Rady vlády 
pro záležitosti romské komunity, 2005). 
The groups which are directly endangered by social exclusion involve, for instance, people who have been 
unemployed repeatedly or on a long-term basis, workers with uncertain and disadvantageous labour contracts, poor 
people and people with low incomes, unqualified people (especially those with incomplete elementary education), 
mentally or spiritually handicapped people, children who grow up in problem families (especially abused children), 
offenders (people with a record in the penal register), immigrants (illegal workers, asylum seekers, and refugees), 
minorities defined by race, religion, language, or culture, recipients of social benefits, homeless people, or people 
who live in ghetto-like localities (Mareš, 2006). 
Social exclusion in the Czech Republic involves especially several specific groups of the Roma population 
(Kancelář Rady vlády pro záležitosti romské komunity, 2005). Exclusion is regarded as an accumulation of social 
problems in the Roma communities; long-term unemployment, low incomes, inaccessible and poor housing are 
primary factors in the social exclusion of the Roma (Mareš, 2003; Sirovátka, 2003; Vašečka, 2002). The 2005–2015 
Action Plan for the Decade of Roma Inclusion was drawn up in 2005; the basic priorities of the action plan involve 
education, employment, housing, and health (Kancelář Rady vlády pro záležitosti romské komunity, 2006a). 
8.1.1 Roma Population and Drugs 
The Office of the Governmental Council for Roma Community Issues deals with the long-term monitoring and 
evaluation of the situation in Roma communities within the framework of the Social Workers Support Programme. 
The primary goal of the programme, and, similarly, also the goal of the outreach workers is to “improve the social 
competencies of socially excluded people in the target community in order to increase their ability to participate in 
activities which are common for other citizens and prevent their social exclusion” (Winkler and Šimíková, 2005).  
Altogether 57 municipalities with 87 outreach workers (and localities) were involved in the Social Workers Support 
Programme in 2005. Based on an analysis of the project carried out by the Research Institute for Labour and Social 
Affairs, the structure and content of monitored aspects of social issues in the Roma communities had changed 
considerably in comparison with the previous years (Winkler and Šimíková, 2005). A new form and a system for 
reporting activities within the framework of the programme were introduced. Therefore, unlike in previous years, it is 
no longer possible to assess, for instance, the degree of seriousness of individual monitored phenomena, including 
the seriousness of drugs issues, or which drugs are the most common. 
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Outreach social workers supplied services to 15,262 clients in 2005. The services most commonly involved housing 
(31%), debts (23%), and unemployment (20%). 464 interventions (3% of services) were carried out in relation to 
drug use – see Table 8-1. In comparison with the previous years, addressing the issues which relate to drugs, 
prostitution, usury, and gambling are on the decrease (Kancelář Rady vlády pro záležitosti romské komunity, 
2006b). However, it does not necessarily mean that there really were fewer of these problems; a possible 
interpretation is that outreach social workers targeted other areas. 
Table 8-1: Numbers of clients who received services from outreach social workers in individual areas (Kancelář Rady 
vlády pro záležitosti romské komunity, 2006b) 
Problem type Number of clients 
Proportion 
(%) 
Debts 3,513 23 
Quality of housing 3,065 20 
Unemployment  3,034 20 
Problematic tenant/landlord relations  1,746 11 
Insufficient hygiene 1,359 9 
Truancy  805 5 
Criminality 631 4 
Drug abuse 464 3 
Gambling 319 2 
Profiteering 269 2 
Prostitution 57 1 
Total 15,262 100 
 
In 2005, GAC Ltd. and the New School (Nová škola) started the project ‘Analysis of Socially Excluded Roma 
Localities and Communities in the Czech Republic and of Absorption Capacity of Entities which Operate in this 
Area’. The Ministry of Labour and Social Affairs commissioned the project. The aim of the project is to map living 
conditions in socially excluded Roma localities in the Czech Republic and determine the capacity of the 
organisations which operate near the localities; the first results will be available in September 2006. The output of 
the project will involve an electronic map of the excluded localities, a proposal for changes in the policy relating to 
social exclusion and Roma integration, and the targeting of resources from the European Social Fund to needy 
localities (Gabal Analysis and Consulting, 2006).  
8.1.2 Drugs and Homelessness 
The project on ‘Health of Homeless People and Its Determinants’ was launched in 2004. Its goal was to map the 
health of socially excluded people and related aspects which involve lifestyles, including mapping the extent of 
alcohol and illicit drug use in this population (Barták, M. et al., 2004; Barták, M. et al., 2005). At the end of 2005, the 
Institute of Health Policy and Economics, in collaboration with the Salvation Army and the Naděje civic association, 
carried out a survey among 1,000 homeless people in Prague. Its results were expected to be available in 2006; 
however, the Ministry of Health decided to abolish the Institute of Health Policy and Economics and neither the 
project nor a subanalysis of the implemented survey was completed.  
8.1.3 Social Characteristics of People Demanding Treatment 
The Prague Hygiene Station has been carrying out long-term monitoring of selected social characteristics of clients 
who demand treatment in relation to drug use in individual facilities. The sample consisted of 8,534 treatment 
demands; 7% of the persons were homeless, and nearly 8% lived in a facility (e.g. in prison, diagnostic and 
educational institutions, in dormitories or in refuges). The proportion of homeless people (8%) and people who live 
in facilities (10%) is higher among repeated treatment demands than among first treatment demands – see Table 
8-2. 
More than 50% of the treatment demands (and nearly 60% of repeated treatment demands) involve unemployed 
people and people who only work on an occasional basis (Polanecký et al.  2006). The low level of education of the 
people who demand treatment is a significant problem – nearly 50% completed basic education only, and 4% did 
not even complete basic school. The educational level is higher among those who sought treatment for the first 
time; however, it may be due to their lower age. 
The social characteristics of patients who seek treatment have not changed significantly since 2002; the proportion 
of homeless and unemployed people and people with a low level of education has remained stable from a long-
term perspective – see the previous annual reports of the NMC (Mravčík et al.  2003; Mravčík et al.  2004; Mravčík 
et al.  2005a). 
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Table 8-2: Selected social characteristics of people demanding treatment (%) (Polanecký et al.  2006) 





Homeless  7.2 6.4 8.0 
Living in an institution  7.9 6.2 9.7 
Unemployed, occasional work  53.4 48.5 58.6 
Incomplete elementary education  3.5 4.8 2.3 
Elementary education  49.4 51.7 46.9 
 
8.2 Drug-Related Crime 
8.2.1 Drug-Related Crime according to the Statistics of the National Drug Squad 
The National Drug Squad recorded 2,128 persons prosecuted for drug offences32 in 2005, i.e. approximately the 
same number as in 2004 (2,100 persons). The proportion of offences involving the possession of a drug in a 
quantity greater than small for personal use (Section 187a of the Penal Code) has remained relatively low – 8% in 
2005. The proportion varied slightly in terms of individual drugs; it was lower (5%) in all pervitin-related offences and 
higher in cannabis-related offences (10%) and heroin-related offences (15%).  
Pervitin-related offences continue to represent the highest proportion of detected drug-related crime – see Figure 
8-1. The trend of an increase in the proportion of pervitin-related offences continued in 2005 – 53%, against 39% in 
2002. The proportion of cannabis-related offences has been decreasing slightly since 2002 – 32% in 2005, 
compared to 37% in 2002 – see Figure 8-2. The number of cocaine-related offences has been rising during the last 
four years; the number and proportion of cocaine-related offences in 2005 was nearly at the same level as ecstasy-
related offences. There has been a slight increase in heroin-related drug offences during the last two years – see 
Figure 8-3 (Národní protidrogová centrála, 2006c). 











                                                          
32 Criminal offences of unauthorised production and possession of narcotic and psychotropic substances according to the provisions of 
Section 187, 187a, and 188 of the Penal Code (excluding criminal offences of the promotion of drug addiction according to Section 188a 
of the Penal Law). 
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Figure 8-2: Proportion of pervitin, cannabis, and other drugs in drug offences (persons prosecuted) in 2002–2005 
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Figure 8-3: Proportion of heroin, ecstasy, and cocaine in drug offences (persons prosecuted) in 2002–2005 (Národní 
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8.2.2 Drug-Related Crime according to Statistics of the Police of the Czech Republic 
In comparison with 2004, the number of those prosecuted for drug offences increased slightly according to the 
Statistical System of Criminality kept by the Police of the Czech Republic – see Figure 8-4. 2,209 prosecuted drug 
offenders were recorded in 2005 (2,149 in 2004) (Ministerstvo vnitra ČR, 2006); an overview by individual 
provisions of the Penal Code is shown Figure 8-4. 
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Figure 8-4: Prosecuted drug offenders in 1998–2005 according to the Police Statistical System of Criminality 








Section 188a 231 177 186 181 149 110 64 53
Section 188 49 42 78 80 120 125 144 120
Section 187a 0 98 139 166 178 232 173 184
Section 187 1075 1436 1412 1525 1757 1828 1768 1852
1998 1999 2000 2001 2002 2003 2004 2005
 
As in the last year, the relatively33 highest number of persons prosecuted for drug offences was recorded in the Usti 
nad Labem region (35 persons per 100,000 inhabitants), then in the Karlovy Vary, Vysocina, Liberec, and Prague 
regions (25 to 27 persons per 100,000 inhabitants). The lowest values were recorded in the Pardubice and Central 
Bohemia regions (13 and 15 persons per 100,000 inhabitants respectively). The highest year-on-year increase (by 
approximately 60%) occurred in the Hradec Kralove and Pardubice regions, which had recorded the lowest values 
in the previous year. A significant increase also occurred in the Zlin and Prague regions (by 34% and 26% 
respectively). Regional differences in the number of drug offences are shown in Map 8-1 and Figure 8-5 (it also 
includes a year-on-year comparison).  
The highest rate of prosecutions for drug offences, as well as the highest rate of overall detected criminal offences, 
was recorded in the Ústí nad Labem region (1,900 persons prosecuted per 100,000 inhabitants) – see Figure 8-6. 
High rates of drug offences and overall detected criminal offences were also recorded in the Karlovy Vary and 
Liberec regions. There is a different situation in the Vysočina region; it has a high drug-related crime rate but it 
reported the lowest overall crime rate. 
Map 8-1: Offenders prosecuted for drug offences in regions of the Czech Republic in 2005 per 100,000 inhabitants 
(Ministerstvo vnitra ČR, 2006) 
 
                                                          
33 Per the number of inhabitants. 
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Figure 8-5: Offenders prosecuted for drug offences in 2004 and 2005 by regions per 100,000 inhabitants (Ministerstvo 















































































Figure 8-6: Offenders prosecuted for drug offences and all criminal offences per 100,000 inhabitants (100% = values for 












































































8.2.3 Drug-Related Crime according to Statistics of the Ministry of Justice 
8.2.3.1 Primary Statistics 
According to the statistics of the Ministry of Justice, the number of persons accused of drug offences decreased by 
16.7% in 2005 compared to 2004 and, more notably, by 21% compared to 2003. However, a closer look into the 
statistics of the Ministry of Justice shows that the above-mentioned decline can be attributed especially to a decline 
in the number of accused drug offenders according to Section 188a (promotion of drug addiction) and partly also 
according to Section 188 (possession of equipment for the production of drugs). A slight year-on-year decline in the 
number of sentenced drug offenders (by 3.6%) occurred for the first time since the beginning of the 1990s – see 
Figure 8-7. 
The courts in the Czech Republic imposed 378 custodial sentences for drug offences in 2005; this number 
represents approximately 29% of the sentences imposed. Most commonly (in 74% of the cases), the custodial 
sentences imposed involved imprisonment for between 1 and 5 years. It corresponds to the basic sentence range 
for offences according to Section 187 and Section 188 of the Penal Code. Suspended sentences continue to be the 
most commonly imposed type of sentence for drug offences (51%). Community service was imposed in 9% of the 
cases – see Figure 8-8. The proportion of suspended sentences has been declining slightly and the proportion of 
custodial sentences has been increasing slightly since 2003 (Ministerstvo spravedlnosti ČR, 2006a). 
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Charged 1530 1765 2043 2160 2247 2737 2589 2157
Charged according to
Section 187
1029 1102 1276 1418 1444 1708 1710 1644
Sentenced 802 891 972 1094 1216 1304 1376 1326
Sentenced according to
Section 187
702 765 819 905 1007 1077 1146 1135
1998 1999 2000 2001 2002 2003 2004 2005
 
Note: Section 187 of the Penal Code – unauthorised production and/or distribution of drugs.  
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8.2.3.2 Statistics by Drug Types 
Changes have been made to the statistics of the Ministry of Justice which have been applicable since January 1, 
2005. They make it possible to track individual cases according to the type of drug which was directly connected 
with the offences in question (Ministerstvo spravedlnosti ČR, 2006b). Employees of the courts and Public 
Prosecutors’ Offices did not record the type of drug in all cases (only in 32% of charges and 68% of sentences for 
drug offences); however, the data still make it possible to gain a certain insight into differences in the prosecution of 
drug offences depending on the type of drug involved.  
Pervitin is the most commonly represented drug (65% of charges and 50% of sentences for drug offences for which 
these data are available), followed by cannabis (identically 22% of charges and sentences) and heroin (6% of 
charges and sentences) – see Table 8-3. 
The proportion of juvenile persons (aged 15–17) among those accused of or sentenced for cannabis-related 
offences is markedly higher than among those accused of or sentenced for other drug offences. As far as recorded 
cases for which the type of the drug involved was specified, juveniles represent 29% of those accused of and 32% 
of those sentenced for cannabis-related offences, whilst they only represent 4% of those accused of or sentenced 
for other drug offences. The proportion of persons aged 15–19 among those accused of cannabis-related offences 
is at 51%, and only at 15% among the offences which involved other drugs – see Figure 8-9 . 
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The proportion of first-time offenders is also higher among those sentenced for cannabis-related offences (69%) 
than among those sentenced for other drug offences (36%). A high proportion of first-time offenders also involved 
perpetrators of ecstasy-related offences (65% – 15 out of 23 persons). The proportion of females sentenced is 
lower in cannabis-related offences (6%) than in other drug offences (14% in pervitin-related offences and 19% in 
heroin-related offences) – see Figure 8-10. 
There are also significant differences between individual drugs in terms of the types of sentences imposed on the 
drug offenders. A custodial sentence was imposed in 40% of pervitin-related drug offences, in 49% of heroin-related 
offences, and only in 7% of cannabis-related offences. This is associated with the above-mentioned differences in 
the proportion of juveniles and first-time offenders; but, to a certain extent, it indicates that courts assess drug 
offences taking into account the degree of social and health risks of individual types of drugs. 
However, the proportions given may be distorted by the limited size of the sample – see also the information on the 
proportion of drugs among those prosecuted for drug offences according to the National Drug Squad in the chapter 
on Drug-Related Crime according to the Statistics of the National Drug Squad, page 56.  
Table 8-3: Prosecuted, accused and sentenced drug offenders by drug type (Ministerstvo spravedlnosti ČR, 2006b) 













Prosecuted 772 26.2 61.4 2.1 5.8 0.5 4.0
Accused 691 22.1 65.3 2.2 5.9 0.6 3.9
Sentenced (courts) 897 22.4 50.2 2.6 6.4 0.9 17.6
Note: * It involves those persons for whom data on the type of the drug are available. 






































Cannabis (n=201) 32.3% 68.7% 6.5% 6.0%
Pervitin (n=450) 2.7% 32.4% 39.8% 14.2%
Heroin (n=57) 0.0% 36.8% 49.1% 19.3%





8.2.4 Drug Misdemeanours 
According to the data of the Police of the Czech Republic, 886 misdemeanours involving the possession of a small 
quantity of drugs for personal use (Section 30, paragraph 1, letter j, Act No. 200/1990 Coll. on Misdemeanours) 
were detected in 2005. It involves a slight year-on-year decrease (958 misdemeanours were recorded in 2004). 503 
misdemeanours were dealt with in administrative proceedings. 45 cases were settled by a reprimand and 424 fines 
amounting to € 30,500 were imposed. 353 cases were ended with the suspension or discontinuance of the case or 
submission to another body and 9 cases were tentatively assessed as a criminal offence and placed in the hands of 
the bodies responsible for criminal proceedings (Národní protidrogová centrála , 2006a). 
8.3 Secondary Drug-Related Crime 
No estimate of the extent of secondary drug-related crime (i.e. criminal activities committed as a result of drug use, 
most commonly crimes against property) was made for the year 2005. According to the police estimate which was 
described in detail in the 2004 Annual Report, drug users committed approximately 46,000 financially motivated 
criminal offences, i.e. 16.6% of all detected criminal offences against property in 2004. 
8.4 Drug Use in Prisons 
The Prison Service of the Czech Republic has been monitoring the presence of drugs since 1996. It monitors the 
presence of drugs among persons entering the Pankrác and Ruzyně remand prisons in Prague and also among 
those who are already in prison. 
Testing methodology has evolved continually since 1996. In the initial stage (1996–1998), the most appropriate 
testing method was being sought and only a few facilities (three per year on average) participated in the system. 
The number of prisons which were involved in monitoring continued to increase between 1999 and 2002 (12 per 
year on average); however, sending samples for laboratory analysis was only voluntary. Organisational basis for the 
involvement of all of the 35 prisons in the testing system was established in 2003–2005. According to an instruction 
of the General Directorate of the Prison Service, 10% of randomly selected inmates were to be tested four times 
a year, and there were no limitations on testing in cases of suspicion of drug use..  
The proportion of positively tested persons entering remand prisons in Prague is several times higher than the 
proportion of inmates tested positive: 4.3% of inmates and 29.0% of those entering remand prisons in Prague were 
tested positive in 2005. In both groups, the most commonly detected drugs involved amphetamines and cannabis; a 
relatively high proportion of positive tests for the presence of opiates was found among those entering remand 
prisons (Vězeňská služba ČR, 2006) – see Table 8-4, Table 8-5, Figure 8-11, and Figure 8-12. 
Table 8-4: Results of testing among inmates in remand prisons and prisons (% of positive tests) (Vězeňská služba ČR, 
2006) 













1999 1,504 0.9 0.8 0.7 1.9 0.0 4.3
2000 1,236 2.9 1.2 2.3 0.5 0.2 7.1
2001 4,492 1.1 0.2 0.2 0.3 0.0 1.7
2002 1,808 2.4 0.7 1.4 1.4 0.0 5.9
2003 4,524 1.2 0.7 0.7 0.3 0.0 3.0
2004 9,380 1.4 0.8 0.7 0.4 0.0 3.3
2005 (1st half) 2,732 1.6 1.1 0.9 0.7 0.0 4.3
Note: The detection method changed in mid-2005, and so only the results from the first six months of 2005 were included in the 
comparison. 
Table 8-5: Results of testing among persons entering remand prisons in Prague (% of positive tests) (Vězeňská služba 
ČR, 2006) 













1999 4,180 8.3 4.6 4.6 2.1 0.1 19.8
2000 5,832 9.9 4.7 7.6 2.7 0.1 25.1
2001 5,840 9.3 4.9 5.9 1.3 0.2 21.5
2002 3,688 7.0 6.2 4.3 0.8 0.1 18.4
2003 4,568 10.8 6.6 3.6 0.9 0.2 22.1
2004 4,356 11.8 8.4 3.0 1.0 0.1 24.2
2005 (1st half) 2,220 12.8 11.0 4.3 0.6 0.1 29.0
Note: The detection method changed in mid-2005, and so only the results from the first six months of 2005 were included in the 
comparison. 
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8.5 Social Costs of Drug Use 
The most recent data on the social costs of drug use in the Czech Republic (Zábranský et al.  2001) were published 
in the 2002 Annual Report. 
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9 Responses to Social Correlates and Consequences of Drug Use 
The social reintegration and aftercare of drug users are provided particularly by means of structured outpatient 
aftercare programmes, which may also include sheltered housing and sheltered work programmes. The number 
and capacity of aftercare programmes has been increasing in recent years. 
The number and capacity of drug-free zones in Czech prisons increased in 2005, and the number of inmates 
undergoing voluntary or compulsory drug treatment also increased. A pilot methadone substitution treatment 
programme with the ability to provide for 40 males started in two prisons in 2006. 
NGOs provide services to drug users in 15 prisons; the number of persons who received services provided by 
NGOs in prisons increased in 2005.  
9.1 Social Reintegration (Aftercare) 
Outpatient aftercare programmes supply aftercare services. Certification standards define them as structured 
programmes of intensive outpatient treatment (for a period of at least six months) which partly follow on from the 
principle of afternoon day-care centres. The target group involves abstaining persons with a history of substance 
addiction, and it is recommended that they abstain for at least three months before they join the programme. 
persons who have gone through detoxification and received at least short-term treatment (outpatient or inpatient), 
persons with insight and motivation towards long-term abstinence, and persons with secured housing are preferred. 
Aftercare programmes may also include sheltered housing and sheltered work programmes. Sheltered housing 
provides temporary accommodation to clients and it serves as a means for social stabilisation. Sheltered work 
programmes aim to improve the work skills of clients, and they can help the clients receive requalification, reinforce 
their work habits, and possibly even find a job from an external employer. The number of aftercare centres has 
been increasing and they have been established in all regions with the exception of the Zlín region – see Map 9-1. 
Map 9-1: Aftercare facilities for drug users in the Czech Republic in July 2006 (Národní monitorovací středisko pro drogy 
a drogové závislosti, 2006g)  
 
 
Twenty facilities subsidised from the General Cash Administration budget chapter provided aftercare in 2005; nine 
of them provided outpatient and intensive aftercare, six provided intensive aftercare only, and five provided 
outpatient aftercare only. Twelve facilities offered their clients sheltered housing and four offered work in sheltered 
programmes. Altogether, 865 clients (562 males, 303 females) used the services. 617 (71%) of them had a history 
of injecting drug use; 458 (53%) used pervitin and 201 (23%) used opiates (heroin or buprenorphine). The total 
volume of sheltered housing provided was 118 beds and this capacity was used by 244 clients. 59 clients worked in 
sheltered shops (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). 
Fourteen facilities supplied outpatient aftercare to 339 clients (212 males, 127 females). The average age of the 
clients was 27.2. Altogether, 218 (64%) clients had a history of injecting drug use. 182 (54%) used to use pervitin 
and 50 (15%) used to use opiates (Národní monitorovací středisko pro drogy a drogové závislosti, 2006g). 
Fifteen facilities with a total capacity of 385 places supplied intensive aftercare to 526 clients (350 males, 176 
females). The average age of the clients was 26.4. Altogether, 399 (76%) clients used to inject drugs. 276 (53%) 
used to use pervitin and 143 (27%) used to use opiates. The average length of the programme was just under five 
months per client. Altogether, 117 (22%) clients successfully completed the programme, 113 (21%) ended the 
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treatment prematurely, and 60 (11%) were expelled from the programme (Národní monitorovací středisko pro drogy 
a drogové závislosti, 2006g). 
Besides the above-mentioned facilities, other inpatient or outpatient treatment facilities can also provide aftercare 
services; however, it is difficult to identify how many of them there are and which types of services they provide.  
The groups Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) work on the principle of self-help. There 
were 29 AA groups in 18 towns in the Czech Republic in 2005 (Anonymní alkoholici, 2005). 
9.2 Prevention of Drug-Related Crime 
9.2.1 Assistance to Drug Users in Prisons 
In comparison with 2004, the number of persons requiring detoxification increased by 70% in 2005; detoxification 
was carried out for 172 persons, 90 of whom were detoxified with Subutex. The detoxification is carried out in the 
medical department of the Prague-Pankrác prison hospital. 
Drug prevention counselling offices have been established in all 35 prisons and they provide individual and group 
therapy to addicted drug users. 
The number of drug-free zones in prisons increased from 30 to 34 in 2005, and their capacity increased from 1,440 
to 1,606 beds. 2,859 inmates served their sentences in drug-free zones in 2005 (331 more than in 2004). A specific 
regime for the serving of a sentence is used in the drug-free zones and it aims to prevent the inmates from having 
any contact with drugs. Therapy is not included in the programme of drug-free zones. 
Drug-using inmates who decide to undergo treatment may be placed in specialised prison departments which focus 
on drug users. Specialised departments for the differentiated serving of sentence operate in six prisons (Bělušice, 
Nové Sedlo, Ostrov, Pilsen, Příbram, and Všehrdy) and their total capacity in 2005 was 286 beds, i.e. 6 beds less 
than in 2004. 523 inmates, i.e. 34 more than in 2004, were serving their sentences in the departments in 2005. The 
second type of specialised prison departments for drug users involves inpatient compulsory treatment; this 
treatment is provided in three prisons (Opava, Rýnovice, and Znojmo), and the total capacity in 2005 was 105 beds, 
i.e. 32 beds more than in 2004. 184 inmates, i.e. 62 more than in 2004, were treated in these departments in 2005 
(Řeháček, 2006). 
The Prison Service of the Czech Republic launched a pilot substitution treatment project in two prisons 
(Prague-Pankrác and Příbram) in April 2005. The total capacity is 40 beds and it can be increased if necessary. The 
Czech Medical Association of J. E. Purkyně – Association for Addictive Diseases and other experts were involved in 
preparing the project. The pilot phase of the project is designed especially for those entering prison who are already 
patients receiving this type of treatment before they were sentenced or for those who can be expected to continue 
the treatment after they are released from prison. Methadone is used as the substitution preparation; in exceptional 
cases and when recommended by an attending physician, Subutex can also be administered (Zábranský, 2006).  
NGOs associated in the Section of Drug Services in Prison of the Association of Non-Governmental Organisations 
Dealing with Prevention and Treatment of Drug Addiction 34 continued to develop their services for drug-using 
inmates in 2005. The number of inmates to whom the organisations provided services in 15 prisons increased to 
610 in 2005 (from 450 in 2004). There were 2,783 contacts with inmates (counselling). The frequency of these 
contacts varied from one-off meetings to periodical weekly contact. The NGOs held 60 educational seminars of 
a preventive nature for 706 inmates and supplied training to 170 employees of the Prison Service. 
The Section of Drug Services in Prisons guaranteed the professional training programme ‘Client in Conflict with the 
Law’. The Institute for Education in the Field of Drug Addictions (I.E.S.) of the Podane Ruce NGO carried out the 
training in 2005 in collaboration with the Institute for Education of the Prison Service of the Czech Republic. It 
involved 125 lessons in the field of criminal law which were designed for staff members of the NGOs which provide 
services to drug-using inmates in prisons. The section also participated in the preparation and implementation of the 
course ‘Substitution Treatment in Prisons’, which the Institute for Post-Graduate Education in Medicine ran for 
employees of the Prison Service of the Czech Republic (Škvařilová, 2006). 
                                                          
34 By the end of 2005, the following non-governmental organisations were involved: Podane ruce civic association (Brno and Olomouc), 
Agentura Walhalla Olomouc, the SANANIM Prague civic association, the LAXUS Hradec Králové civic association, the CPPT Pilsen 
public service company, the Legal Advice Bureau of the Association of Non-Governmental Organisations in Prague, and the Semiramis 
Nymburk civic association. 
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10 Drug Markets 
The number of drug seizures by law enforcement bodies in 2005 was approximately the same as in 2004. The 
volume of seizures of hashish and ecstasy decreased and the number of cocaine seizures increased. 
The Czech Republic is a country where pervitin (methamphetamine) is produced; it is also illegally exported from 
the country. An increase in the production of pervitin from freely available medicaments which contain 
pseudoephedrine occurred in 2005. The bulk of cannabis consumption is also covered from domestic production. 
The Czech Republic continues to be a target and transit country for other drugs.  
Drug prices remain at a stable level; even street drug purity has remained relatively stable, although there are year-
on-year differences in the purity of drugs analysed by law enforcement authorities – the differences are caused by 
including the seizures of large quantities of drugs with a high level of purity before adulteration.  
10.1 Drug Availability and Supply 
No survey or study focusing on the monitoring of drug availability was carried out in the Czech Republic in 2005. In 
general, it is possible to claim that all the basic types of drugs are readily available in all the large towns of the 
Czech Republic; availability in small towns and rural areas has been increasing in recent years, according to 
available information – see, for instance, (Národní protidrogová centrála , 2006a). Marijuana is unambiguously the 
most commonly available drug and its use is relatively widespread in all regions and social groups. Ecstasy is 
especially freely available in environments which young people visit for entertainment (dance events or 
discotheques). The stable availability of the basic types of drugs is also indicated by the stable level of drug prices 
on the black market for several years now35. 
10.2 Drugs Production and Trafficking 
The Annual Reports of the National Drug Squad (Národní protidrogová centrála , 2006a) and the General Customs 
Headquarters (Generální ředitelství cel , 2006b) are the most important sources of information about drug 
production, trafficking, and distribution on the territory of the Czech Republic. 
The number of cases and the quantity of marijuana seized by customs bodies are decreasing, according to the 
Annual Report of the General Customs Headquarters. There were 54 cases of marijuana seizures during import 
checks by the Customs Administration, 89 cases in 2003, and 126 cases in 200236 (Generální ředitelství cel, 
2006a). Marijuana is mostly smuggled into the Czech Republic from the Netherlands. According to to the General 
Customs Headquarters, the vast majority of the demand for this drug is covered by domestic production; hydroponic 
marijuana growing has expanded at the same time.  
According to information from the branch office of the National Drug Squad in Hradec Králové (which covers the 
Hradec Králové and Pardubice regions), a large quantity of small marijuana growing rooms was recorded in 2005. 
However, most of them served for marijuana growing for personal use. Nevertheless, the number of marijuana 
growing rooms detected in the Czech Republic decreased from 14 in 2004 to 11 in 2005 (Národní protidrogová 
centrála , 2006a). 
Hashish production has not been recorded in the Czech Republic. Hashish is imported in small consignments, 
especially from the Netherlands, and, to a smaller extent, also from India or Spain. The General Customs 
Headquarters reported 53 cases of hashish seizures with a total volume of 696 g (15.7 g on the average, and the 
median is 4.4 g). 
Pervitin (metamphetamine) is a traditional stimulant drug in the Czech Republic, and it comes exclusively from 
domestic production. The number of pervitin laboratories detected in 2005 increased to 261, compared to 248 in 
2004 and 188 in 2003. The proportion of pervitin seized that was produced from medicaments which contain 
pseudoephedrine has been increasing in recent years. The Annual Report of the National Drug Squad mentions 
that approximately 90% of the cases of pervitin production examined involve pseudoephedrine from freely available 
medicaments as the source raw material.37 However, most of the cases involved the production of small quantities. 
When ephedrine is used as the source raw material, large quantities (dozens of grams or several kilograms) are 
usually produced and the pervitin produced is then of higher purity. The ephedrine used for pervitin production is 
usually imported into the Czech Republic, most commonly from the countries of the former Yugoslavia and 
Germany. Organised groups from the former Yugoslavia not only provide for ephedrine transportation, they also 
organise pervitin production and distribution in the Czech Republic38 (Národní protidrogová centrála , 2006a). 
According to the reports of the National Drug Squad and the Customs Administration, the number of cases of 
pervitin exports, especially to Germany, is increasing. They usually involve pervitin with a high level of purity made 
                                                          
35 However, as average wages are increasing, it is rather possible to argue that the real prices of the basic types of drugs have been 
decreasing in recent years. 
36  No data for the year 2004 are available. 
37 Neither the volume of pervitin made from medicaments nor its proportion in the total volume of pervitin produced is known. 
38 It was, for instance, recorded by a branch office of the National Drug Squad in Usti nad Labem. 
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directly from ephedrine. Illegal export often has links to organised crime. Germany has recorded cases of ephedrine 
trafficking in volumes of dozens of kilograms and export to the Czech Republic. An organised group which imported 
ephedrine from Germany to the Czech Republic and produced pervitin there was arrested. A large part of the 
pervitin produced was reexported for distribution to German drug users.  
Ecstasy is imported into the Czech Republic, most commonly in small consignments in buses from the Netherlands, 
Belgium, or Poland. Ecstasy production in the Czech Republic has not been recorded. Two cases of seizures of 
tablets which contained mCPP (1,3-chlorphenylpiperazine) were reported in 2005; the seizures were reported in the 
Early Warning System on new psychoactive substances.39  
Cocaine use still has a low prevalence in the Czech Republic and it is mostly imported from Western Europe (the 
Netherlands or Germany), and sporadically directly from South America. Crack has not yet been seized in the 
Czech Republic. 
Heroin is mostly smuggled into the Czech Republic via the so-called Balkan route. Some information is available 
that it is also transported via the so-called silk route from Afghanistan via post-Soviet countries and Poland and then 
to Central and Western Europe. This route has a marginal role in the imports to the Czech Republic. Most heroin 
consignments found in the Czech Republic are on their way to Western Europe; a small part of them stays in the 
domestic market. 
The National Drug Squad recorded a further increase in the illegal distribution of Subutex, a substance which is 
used for substitution therapy for opiates addiction – see the chapter on Substitution and Maintenance Programmes, 
page 36.  
10.3 Drug Seizures 
A slight decline in the number of cannabis seizures (i.e. seizures of marijuana and/or hashish) occurred in 2005. 
However, cannabis continues to be the most commonly seized type of drug – see Table 10-1, Figure 10-1 and 
Figure 10-2. A slight decline in the number of seizures and a marked decline in the quantity of hashish seized 
confirm that there is a trend for this drug to be imported in small volumes – see the chapter on Drugs Production 
and Trafficking, page 66. The number and volume of pervitin seizures has remained stable in the last three years. A 
considerable increase in cocaine-related crime was not associated with any corresponding increase in cocaine 
seizures; the figure is only slightly higher than in the last year and it is only a half of that in 2003. The number of 
ecstasy seizures continues to be low in comparison with the high prevalence of ecstasy use. 
As far as other illicitly possessed psychoactive substances are concerned, 145 grams of magic mushrooms, 
287 Subutex tablets, and 500 ml of GHB were, for instance, seized in 2005. At the same time, 27.3 kg of illicitly 
possessed ephedrine, a precursor for pervitin production, was also seized (Národní protidrogová centrála , 2006a).  
Table 10-1: Numbers and volumes of seizures of main types of drugs in 2002–2005 (Národní protidrogová centrála, 
2006c) 
2002 2003 2004 2005 Drug type  Units (volume) Number  Volume Number Volume Number Volume Number Volume 
Marijuana kg 293 100.7 465 77.82 423 168.53 397 103.34
Hashish  kg 58 11.4 96 64.81 149 22.69 116 4.63
Cannabis plants piece 93 3,173 117 3,125 46 1,617 46 1,780
Heroin kg 55 34.34 54 9.14 42 35.90 69 36.34
Cocaine kg 12 6.04 20 2.62 7 3.28 11 10.20
Pervitin kg 304 4.30 193 9.63 201 3.42 209 5.31
Ecstasy tablets 42 88,391 31 51,692 39 108,379 32 19,010
LSD doses 3 107 3 65 3 326 4 3,067
 
                                                          
39 The Early Warning System in the EU works on the basis of Council Decision 2005/387/JHA of 10 May 2005 on the information 
exchange, risk assessment and control of new psychoactive substances. 
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444 678 618 559
Pervitin 304 193 201 209
Heroin 55 54 42 69
Ecstasy 42 31 39 32
2002 2003 2004 2005
 
The National Drug Squad has been providing a classification of seizures of the main types of drugs by volume since 
2003. Pervitin and heroin seizures of quantities under one gram represent 45% and 46% respectively of the cases, 
and quantities up to five grams represent 76% and 69% respectively of the cases – see Figure 10-3 (Národní 
protidrogová centrála, 2006b).  
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> 100 g 15% 3% 9%
20-100 g 13% 8% 8%
5-20 g 22% 13% 13%
1-5 g 32% 31% 23%




10.4 Drug Prices and Drug Purity 
10.4.1 Drug Prices 
The National Drug Squad is responsible for the collection of data on drug prices.40 Average drug prices in 2005 
remained on approximately the same level as in the previous year – see Table 10-2. It is hard to make a long-term 
comparison because data on drug prices were acquired in a different manner in the previous years.  
Table 10-2: Average drug prices in 2004 and 2005 (€) (Národní protidrogová centrála, 2006c) 
Drug 2004 2005 
Ecstasy (tbl) 7.70 7.00 
Hashish (g) 9.40 8.20 
Heroin (g) 35.30 36.60 
Cocaine (g) 77.20 75.90 
LSD (dose) 5.70 6.00 
Marijuana (g) 5.70 5.70 
Methamphetamine (g) 36.90 34.30 
Subutex (8mg tbl) 9.20 12.60 
Note: Figures for 2004 were re-calculated by the 2005 exchange rate (1 € = CZK 29,784). 
The text part of the Annual Report of the National Drug Squad contains some other information on drug prices 
which were recorded in individual regions of the Czech Republic or during specific police actions, e.g.: 
• Pervitin prices in the Czech Republic vary according to quality and the quantity taken, from CZK 600–1,200 (€ 20 
to € 40) per gram, while the same drug (sold as Crystal) sells for approximately € 65 per gram (National Drug 
Squad branch office in Ústí nad Labem). 
• The price of imported ephedrine was around € 3,500 per kilogram. Approximately 800 g of pervitin can be made 
from this quantity of ephedrine. The price of pervitin made from this substance would then be around € 25,000 
per kilogram (National Drug Squad branch office in  Ústí nad Labem). 
• The importing of ephedrine from former Yugoslavian countries was reported. The purchasing price in the former 
Yugoslavia was approximately € 2,000 per kilogram and it was sold for approximately € 6,000–7,000 per 
kilogram (National Drug Squad branch office in Ostrava). 
• An ecstasy tablet costs CZK 45 to 80 (€ 1.50 to € 2,70) in large deliveries, and CZK 120 to 200 (€ 4.00 to € 6.70) 
when individual tablets are sold (National Drug Squad branch office in Hradec Králové). 
• The quality of distributed heroin is often low, around 10%; in such cases, the price is usually CZK 800 to 1,000 
(€ 27 to € 34) per gram (National Drug Squad branch office in Ostrava).  
                                                          
40 The National Drug Squad receives data on drug prices from district headquarters of the Police of the Czech Republic. 62 district 
police headquarters provided data on drug prices in 2005. Only minimum and maximum prices are reported, and so it is only possible to 
calculate average minimum and maximum prices in individual regions or in the entire Czech Republic. Other possibilities involve 
averaging all price ranges repoted by each district (for instance, when the minimum price per gram of hashish is € 6.70 and the 
maximum price is € 11.80, € 9.25 is considered as the average price) and then calculating national or regional averages from the 
values. This is exactly the method by which the National Drug Squad obtains the values which it reports as the average prices of drugs 
in the Czech Republic in its annual report or in reports to international organisations. 
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• The price of cocaine varies from CZK 1,600 to 2,500 (€ 54 to 84) per gram; imported cocaine costs € 35 per 
gram (National Drug Squad branch office in Brno). 
10.4.2 Drug Purity 
The National Drug Squad obtains data on the purity of seized and analysed drugs from the Institute of Criminology 
in Prague and from reports from individual units of the Criminal Police and Investigation Service. 
The Institute of Criminology in Prague provides a list of analyses which were carried out during the year, and so it 
makes it possible to track time trends. Data on the purity of drugs which were analysed by the Institute of 
Criminology in Prague during the last two years are included in Table 10-3; despite the year-on-year differences 
mentioned in the table, drug purity has remained relatively stable during the last two years. 
Table 10-3: Drug purity in 2004 and 2005 (Národní protidrogová centrála, 2006c) 
2004 2005 
Drug Sample 
size Min. Max. Average Modus 
Sample 
size Min. Max. Average Modus 
Hashish  n.a. 5.4 20 10 n.a. 10 4 17.3 7.4 10
Marijuana n.a. 0.4 18 3 n.a. 108 0.1 20.6 3.8 1.6
Heroin  n.a. 0.8 26.9 12 n.a. 19 4.7 89 41.5 17
Cocaine n.a. 21.7 88 65 n.a. 25 12.1 99.8 55.9 54
Pervitin n.a. 23.3 80 50 n.a. 65 3.4 86 62.9 66
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PART B: SPECIAL CHAPTERS 
Three special chapters are included in the Annual Report every year. The EMCDDA assigns the topics in 
collaboration with focal points in individual countries of the Reitox network with regard to their topicality and research 
needs.  
11 Drug Use and Related Problems among Very Young People (Under 15 Years)  
It has often been discussed in recent years that substance use – and its onset in particular – is occurring among 
very young age groups and drug use among children aged under 15 is becoming a problem. School surveys show 
that smoking and, especially, alcohol drinking are relatively common among Czech children. This is related to a high 
degree of social tolerance towards alcohol drinking and its high availability. Approximately a third of those aged 15 
reported experiences with the use of illicit drugs, mostly with cannabis; however, it also applies to approximately 13–
14% of children aged 13 and as many as 2–3% of children aged 11. Inhalants are the second most commonly used 
illicit drug among children. It is alarming that as many as half of the children who have tried a drug would like to use 
it again, and more than 10% of the children who have never used a drug would like to try one. 
The number of children aged under 15 who have been in treatment is very low – AT clinics register approximately 
100 children every year. Every year, approximately 120 children are hospitalised in relation to illicit drug use. Most of 
the hospitalisations of patients aged 14–15 were due to polydrug use and cannabis use, while inhalants were the 
most common cause of hospitalisation among younger children. The use of inhalants, as well as the use of 
psychoactive medicines among children, must not be underestimated – one or two deaths in relation to the use of 
inhalants occur every year. 
There is a limited number of specialised treatment facilities for children aged under 15; they are poorly interlinked 
and the poor indication of children for treatment has also appeared to be problematic. The course and the success 
of the treatment are then also complicated by the fact that the treatment of children aged under 15 is not voluntary. 
Nearly 100 cases of drug-related crime committed by children aged under 15 have been recorded every year; 
however, the prosecution is usually suspended because of their low age. The cases most commonly involve the 
unauthorised production of narcotic and psychotropic substances (Section 187), mostly cannabis. 
11.1 Extent of Drug Use among Children Aged Under 15 
The most recent national representative survey which targeted substance use among school pupils aged under 15  
was carried out within the framework of the HBSC (Health Behaviour in School-aged Children) international survey. 
It focused on the health and lifestyles of children aged 11, 13, and 15; the questions regarding the use of illicit drugs 
were only included in the questionnaires for pupils aged 15 (in the 9th grade of basic schools).  
29.7% of students aged 15 (28.6% of boys and 30.6% of girls) were regular smokers in 2002, i.e. they smoked at 
least once a week. They consumed an average of 33.6 cigarettes per person per week (Csémy et al.  2005). 9% of 
the respondents were heavy smokers (more than 40 cigarettes per week). 2% of those aged 11 (3% of boys and 
1% of girls) and 11.1% of those aged 13 (13.8% of boys and 8.6% of girls) were regular smokers.  
Besides their first experiences with smoking cigarettes, children aged 11 also get their first experiences with alcohol. 
9% of boys and 4% of girls aged 11 and 21% of boys and 8% of girls aged 13 were regular beer drinkers, i.e. they 
drank beer at least once a week. Among those aged 15, 36.9% of boys and 23.1% of girls regularly drink beer, 
10.9% of boys and 12.1% of girls drink wine and approximately 9% of the respondents drink spirits and mixed 
drinks (Csémy et al.  2005). 44.4% of those aged 15 reported drinking excessive amounts of alcohol, i.e. five or 
more glasses of alcohol, on one occasion at least once within the last 30 days, and 16.2% of the respondents 
(19.0% of boys and 13.5% of girls) three or more times within the last month.  
31.0% of those aged 15 mentioned that they have tried an illicit drug in their lifetime, mostly marijuana (34.6% of 
boys and 26.7% of girls). Next, ecstasy (4.2% of respondents) and LSD (3.0%) were reported most commonly, and 
approximately 1–2% of respondents reported experiences with opiates and amphetamines – see Table 11-1. 
A high prevalence of the use of inhalants (7.3%) and the use of medicines with a sedative effect without 
a prescription (7.0%) is alarming. Similarly, the last-year prevalence of the use of the substances monitored is also 
high, and so it is possible to say that a considerable proportion of the experiences with drugs occurred exactly 







Table 11-1: Lifetime and last-year prevalence of substance use among children aged 15 in the HBSC 2002 survey (%) 
(Csémy et al.  2005) 
Lifetime prevalence Last-year prevalence  Drug Total Boys Girls Total Boys Girls 
Any illicit drug 31.0 35.3 27.0 27.4 31.4 23.6 
Cannabis  30.5 34.6 26.7 26.9 30.9 23.2 
Inhalants  7.3 8.2 6.4 3.9 4.9 3.0 
Hypnotics and sedatives 7.0 5.9 7.9 4.4 3.4 5.4 
Ecstasy  4.5 5.0 4.2 3.2 3.0 3.3 
LSD 3.0 3.7 2.5 2.1 2.2 2.0 
Amphetamines 2.0 1.8 2.1 1.3 0.9 1.7 
Opiates 1.2 1.7 0.7 1.0 1.3 0.7 
 
The above-mentioned frequency of illicit drug use in the last year shows that 14.7% of boys (11.3% of girls) are 
experimental cannabis users (i.e. they have used cannabis once or twice). 12.9% of boys (9.5% of girls) belong in 
the category of recreational users (they have used it 3–39 times in the last year). 3.3% of boys (2.4% of girls) belong 
in the category of regular users (they have used cannabis 40 or more times during the last year). Experimental use 
prevails markedly as far as other illicit drugs are concerned; less than 1% of the respondents are recreational or 
even regular users (Csémy et al.  2005). 
Data on young pupils were acquired within the framework of the Project on Evaluation of Primary Prevention 
Community Programme. It is a five-year project which targets especially the evaluation of the quality and efficiency 
of a preventive programme implemented by NGO Prev-Centrum in 25 basic schools in Prague 6. The situation 
among pupils aged 11 (in the 5th grade) was mapped in 2003, with a follow-up in 2005, i.e. when they were 13 years 
old (and in the 7th grade). Two groups of pupils were monitored within the project – an experimental sample of 
classes which participate in the preventive programme of the Prev-Centrum (Sample A, 619 pupils) and two control 
groups of classes which do not participate in the programme (Samples B and C, 559 pupils) (Miovský et al.  2004).  
The prevalence of illicit drug use among those aged 11 was very low in 2003; cannabis was the most commonly 
reported illicit drug used (1.6% of respondents from the experimental sample and 3.4% of respondents from the 
control sample). Ecstasy and pervitin were the second most commonly reported drugs (nearly 1% of pupils in the 
control sample); the prevalence in the experimental sample was approaching zero. The prevalence of experiences 
with inhalants is high (2–3%); in the experimental sample, the prevalence of the use of inhalants was even higher 
than the prevalence of cannabis use (Figure 11-1).  










Cannabis 1.6 13.3 3.4 14.2
Inhalants 2.8 6.7 2.5 8.5
Ecstasy 0.3 0.5 0.9 1.3
Pervitin 0.2 0.5 0.7 0.8
Heroin 0.0 0.7 0.5 0.4
2003 - 11-years-olds 2005 - 13-years-olds 2003 - 11-years-olds 2005 - 13-years-olds
Sample A (experimental) Samples B+C (control)
 
Data on pupils aged 13 show significantly higher prevalence of cannabis – 13–14% of respondents have tried 
marijuana or hashish at least once in their lifetime. Ecstasy continued to be the second favourite drug in the control 
sample (1.3% of respondents); however, heroin prevailed over ecstasy in the experimental sample (0.7%). The 
prevalence of the use of inhalants also increased considerably. 7–8% of respondents aged 13 have experience with 
sniffing inhalants (Miovská, 2006).  
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The 2005 survey of the Regional Hygiene Station of the Liberec region, ‘Lifestyles of Children and Young People 
(Experiences and Attitudes in the Field of Smoking, Alcohol, and Drugs)’ also provided comparable results at a 
regional level. It involved 1,430 pupils of the 8th grade of basic schools (aged 13–14). 76.2% of children of this age 
have experience with smoking, 23.9% are currently smokers (20.8% of boys and 26.7% of girls). 95.7% of 
respondents have tried alcohol, 6.4% of the children drink alcohol at least once a week (7.7% of boys and 5.2% of 
girls), and 9.5% of the respondents reported drunkenness in the last month (KHS Libereckého kraje, 2005).  
Altogether, 31.2% of the children had been offered an illicit drug, 15.7% of the respondents (17.5% of boys and 
14.4% of girls) have tried one at least once. 4.5% of the children reported repeated use, most commonly the use of 
cannabis. 50.2% of the children who have tried a drug will definitely or probably try it again; 10.8% of those who 
have not tried a drug would like to try one (KHS Libereckého kraje, 2005).  
11.2 Treatment and Treatment Demands 
84 patients aged under 15 were registered in outpatient AT clinics in 2004; 70 of them (49 boys and 21 girls) were 
registered in relation to illicit drug use, one in relation to tobacco. Half of all reported cases (36 persons) involved 
cannabis use, 20 cases involved the use of inhalants, and 10 involved the use of stimulants. The trends show that 
approximately 60–100 patients have been registered in AT clinics every year since 2000; another 20–50 have been 
registered every year in relation to the use of licit drugs (see Table 11-2). Similarly, cannabis and inhalants were the 
most commonly used drugs in the previous years; the significant representation of the users of sedatives and 
hypnotics in 2003 was an exception (47 cases). 
Table 11-2: Patients aged 0–14 registered in outpatient AT clinics (Ústav zdravotnických informací a statistiky, 2005d) 
Diagnosis (ICD-10) – drug 2000 2001 2002 2003 2004 
F11 – opiates opioids 1 4 6 1 3 
F12 – cannabinoids 32 43 46 45 36 
F13 – sedatives, hypnotics 1 3 1 47 1 
F14 – cocaine 0 0 0 0 0 
F15 – stimulants  6 5 11 2 10 
F16 – hallucinogens 1 0 3 1 0 
F18 – inhalants 12 24 14 8 20 
F19 – multiple drug use and other substances 9 12 1 1 0 
Drugs total 62 91 82 105 70 
F17 – tobacco 30 22 4 17 1 
F10 – alcohol 7 31 15 8 13 
Psychoactive substances total 99 144 101 130 84 
 
Outpatient psychiatric facilities reported 95,098 examinations of persons aged under 15 in 2004; 84 of the 
examinations were due to the use of illicit drugs (diagnoses F11–F16 and F18–F19 according to ICD-10), and 18 
examinations were due to the use of alcohol (F10) (Ústav zdravotnických informací a statistiky, 2005d). 
152 children aged 10–15 were hospitalised for behavioural disorders related to drug use in 2005; 78 of them were 
boys and 74 were girls. A third of them (51 persons) were hospitalised as in relation to multiple drug use and the 
use of other psychoactive substances (F19), 33 in relation to the use of cannabis, 24 in relation to the use of 
stimulants, and 22 in relation to the use of inhalants (Figure 11-2). The number of hospitalised patients aged under 
15 has been increasing continually since 2002, from 95 in 2002 to 152 in 2005. The structure of the drugs used 
remains approximately the same; hospitalisations related to the use of opiates (F11) and the use of inhalants (F18) 
were reported more commonly in 2004 than hospitalisations related to the use of cannabis (F12) and multiple drug 
use and the use of other psychoactive substances (F19).  
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Figure 11-2: Patients aged 11–15 hospitalised for behavioural disorders resulting from drug use (Ústav zdravotnických 










F19 - polydrug use, other drugs 43 32 37 29 51
F18 - inhalants 11 11 21 27 22
F16 - hallucinogens 2 3 5 5 4
F15 - stimulants 11 15 24 28 24
F14 - cocaine 0 1 2 1 1
F13 - sedatives, hypnotics 5 2 8 6 6
F12 - cannabis 13 15 25 20 33
F11 - opiates 43 16 7 17 11
2001 2002 2003 2004 2005
 
 
Table 11-3 shows the structure of the hospitalised children by age and diagnoses. 82 of the 152 children were aged 
15, 55 were aged 14, and 10 were aged 13; one patient aged 12 and four patients aged 11 were also reported. The 
use of cannabis, stimulants, and drug combinations prevails in the group of those aged 14–15, while the use of 
inhalants is the most common reason for hospitalisation among the youngest age groups (aged 11–13) (Ústav 
zdravotnických informací a statistiky, 2006a).  
Table 11-3: Hospitalised patients aged 11–15 in 2005 by age and diagnoses (Ústav zdravotnických informací a statistiky, 
2006a) 
Age/diagnosis F11 F12 F13 F14 F15 F16 F18 F19 Total 
11 0 1 0 0 1 0 2 0 4 
12 0 0 0 0 0 0 1 0 1 
13 0 1 2 0 0 0 5 2 10 
14 7 12 2 0 5 1 9 19 55 
15 4 19 2 1 18 3 5 30 82 
Total 11 33 6 1 24 4 22 51 152 
Note: Diagnoses F11–F19 – see Table 11-2 a Figure 11-2. 
According to the data of the Prague Hygiene Service, 100 children aged under 15 (67 boys and 33 girls) sought 
treatment in 2005. It corresponds to approximately 1% of treatment demands in 2005 (Polanecký et al.  2006). More 
than half of them (53 persons) sought treatment in relation to cannabis use, 21 in relation to pervitin, and 18 in 
relation to the use of opiates; in total there were 37 injecting drug users. 76 persons (53 boys and 23 girls) sought 
treatment for the first time; 47 of them reported cannabis as their primary drug, 14 reported pervitin, and 9 reported 
opiates in this context – see Figure 11-3. In contrast to the prevalence of use, the number of patients in AT clinics, 
and the number of those hospitalised, users of inhalants are very rare among treatment demands – 7 out of all 
treatment demands and 6 out of first treatment demands were reported in 2005.  
An obvious decline in the number of reported treatment demands among those aged under 15 occurred between 
2002 and 2004. The number of all and first treatment demands decreased from 121 to 77 persons and from 108 to 
59 persons respectively. It rose again in 2005. The increase in the number of treatment demands is especially 
apparent in relation to the use of opiates and pervitin (the number of injecting drug users increased from 7 in 2004 
to 37 in 2005). The cause of this increase is uncertain. 41  
                                                          
41 Recent data show that the number of opiates users aged under 15 is again at a nearly zero level in 2006.  
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cannabinoids 82 73 79 67 50 41 53 47
inhalants 22 21 18 13 12 7 7 6
hallucinogens 1 1 0 0 0 0 1 0
sedatives 0 0 1 1 0 0 0 0
ecstasy 0 0 0 0 0 0 0 0
pervitin 14 11 9 9 13 10 21 14
cocaine 0 0 1 1 0 0 0 0
opiates 1 1 1 1 1 1 18 9
All demands First demandAll demands First demandAll demands First demandAll demands First demand
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A limited number of specialised treatment facilities dealing with the treatment of children aged under 15 operate in 
the Czech Republic. AT clinics, psychiatric departments in hospitals, and three psychiatric hospitals (for children 
and young people aged under 18) provide these services. A detoxification centre for children and adolescents 
started to operate in Prague (at the Sisters of Mercy of St Karel Boromejsky Hospital). Selected educational 
institutions, especially children’s homes with a school, also have departments with an educational-treatment regime 
which target children at risk of drug addiction and preventive-educational departments (for children aged under 15). 
The residential department Alternativa in Kostelec nad Labem of the Klíčov Centre for Educational Care works on 
the basis of voluntariness and with the consent of the legal guardians of the child. It works with children aged 10–15 
who are at risk of drugs. 
The Centre for Addictology of the Psychiatric Clinic at the 1st Faculty of Medicine of Charles University in Prague 
drew up an Analysis of Needs and Current State of Addictological Services in Prague for Children Aged Under 15 in 
2005. The Prague Magistrate’s Office commissioned it. The analysis assessed school facilities and special facilities 
which work with children aged under 15. The results of the analysis were not available at the time of the drawing up 
of this report.  
The factors which complicate drug treatment for children aged under 15 were identified. Specialised outpatient 
facilities are not available, individual types of facilities are not sufficiently interlinked, and the wrong indication of 
children for treatment (especially by social workers) takes place often. The treatment of children aged under 15 is 
often involuntary, and this negatively influences the course of treatment and its results. The Centre of Research into 
Drug Services and Public Health (CEPROS) drew up the Manual for Drug Prevention in the Practice of a General 
Practitioner for Children and Young People in 2004 (Centrum výzkumu protidrogových služeb a veřejného 
zdravotnictví, 2006). It is hoped that it could contribute to an improvement in the diagnostics of problems with 
addictive substances among children and consecutive referrals for treatment.  
11.3 Health Consequences 
One overdose-related death of a person aged under 15 was recorded in 2005 – a boy aged 12 died as a result of 
an overdose on an inhalant (butane from a lighter). Altogether, 218 overdoses were recorded in the Czech Republic 
– see the chapter on Drug-Related Deaths and Mortality of Drug Users, page 40, for more information. Four fatal 
overdoses have been reported in recent years; two cases involved overdoses on psychoactive medicines in 2003, 
and there was one case of an overdose on inhalants and one overdose on psychoactive medicines in 2004 
(Národní monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2005). 
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11.4 Drug-Related Crime 
According to the data from the Police Statistical System of Criminality, criminal prosecutions were launched against 
2,209 persons suspected of drug offences in 2005; 91 (4.1%) of them were children aged under 15. 72 cases 
involved the unauthorised production and distribution of narcotic and psychotropic substances (Section 187 of the 
Penal Code), one case involved the unauthorised possession of narcotic and psychotropic substances for personal 
use (Section 187a), and 18 cases involved offences of the promotion of drug addiction (Section 188a). Children 
aged under 15 are not criminally liable, and so their prosecution is suspended as a result of the low age of the 
perpetrators. 
Statistics on drug offences in 2000-2005 reported 60–120 offences committed by children every year. The number 
of perpetrators aged under 15 declined in 2001–2004, but it rose again in 2005. A similar trend occurred in the 
development of the proportion of persons aged under 15 among all drug offences (Figure 11-4).  
Figure 11-4: Development in the total number of all persons prosecuted and persons aged under 15 prosecuted 
(Ministerstvo vnitra ČR, 2006) 
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A total of 2,6000 persons were accused in 2005; 120 of them were children, and their prosecution was suspended 
because of the low age (Section 159a paragraph 2, Section 11 paragraph 1 letter d) of the Code of Criminal 
Procedure). 89 cases involved the unauthorised production and distribution of narcotic and psychotropic 
substances (Section 187 of the Penal Code), 2 cases concerned the unauthorised possession of narcotic and 
psychotropic substances for personal use (Section 187a of the Penal Code), and 4 cases involved the production or 
possession of equipment for the production of narcotic and psychotropic substances (Section 188 of the Penal 
Code). 25 persons were accused of the promotion of drug addiction (Section 188a of the Penal Code). Cannabis 
was involved in 20 of the 21 cases which involved children and for which the type of the drug was recorded; one 
case involved pervitin. 
11.5 Prevention Focused on At-Risk Groups of Children 
As far as specific primary prevention is concerned, the Strategy for the Prevention of Socially Pathological 
Phenomena Among Children and Young People (Ministerstvo školství, mládeže a tělovýchovy, 2004b) places an 
emphasis on the prevention of drug use and its further development and it mentions that it is necessary to focus 
explicitly on target groups of more endangered or at-risk individuals – however, it does not provide a detailed 
definition of the groups. Accordingly, strategies and activities targeting individual at-risk groups of children and 
young people have not been formulated.  
A study which targeted addictive behaviour and its context among groups of children at high risk was carried out in 
2003; two groups of children aged 10–15 were monitored within the study: the first group consisted of children from 
families in which one of the parents had been treated for alcohol addiction, and the second group consisted of 
children who had been placed in the hands of a health care or educational facility as a consequence of behavioural 
disorders and who had records of running away from home in their anamnesis. Altogether 75 children participated 
in the study (the average age was 13.2); 45 of them had a behavioural disorder and 30 children lived with addicted 
parents (Csémy et al.  2003).  
Approximately half of the children with a behavioural disorder who were monitored and a third of the children of 
addicted parents are regular tobacco smokers; a quarter of the children mentioned frequent alcohol drinking. 
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A restaurant (29%) or home (25%) was the most common place for alcohol consumption; it indicates a high 
tolerance of alcohol drinking in society and its availability even for children aged under 15. 
Approximately a fourth of the children of addicted parents and two thirds of children with a behavioural disorder 
have experience with cannabis; the same applies to just under a third of 15-year-old pupils of normal basic schools. 
Experiences with other illicit drugs are markedly higher in the monitored groups of children than in the randomly 
selected sample of basic school pupils who were surveyed within the framework of the HBSC study in 2002, even 
though the respondents of the HBSC study were older. Experiences with hallucinogens, amphetamines, and 
inhalants were mentioned by 13.3%, 16.7%, and 13.3% respectively of the children of addicted parents and 27.9%, 
37.2%, and 34.9% respectively of the children with a behavioural disorder (see Figure 11-5).  
Figure 11-5: Experiences with illicit drugs among children of addicted parents and children with a behavioural disorder in 
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There are significant differences between the groups with regard to the perception of the risks of the given drug. 
53.5% of the children with a behavioural disorder and 76.7% of the children of addicted parents regard smoking 
cigarettes as risky (medium or high risk). 79.1% of the children with a behavioural disorder and 90% of the children 
of addicted parents regard drinking alcohol as risky. Both groups perceive marijuana use as less risky than alcohol 
consumption (58.1% of the children with a behavioural disorder and 83.3% of the children of addicted parents); the 
use of heroin or other drugs is perceived as very risky (86% of the children with a behavioural disorder and 96.7% of 
the children of addicted parents). The prevailing perception of the high risks of alcohol use among the children of 
addicted parents may be influenced by the presence of alcoholism in the family and direct confrontation with its 
consequences (Csémy et al.  2003). Gambling on slot machines is also very common among the children with 
behavioural disorders (a quarter of them reported frequent gambling).  
The survey also tracked family structure, problems in the family, the habits of parents with regard to alcohol, and the 
behaviour of friends and peers. It has shown that only 40% and 30% of the children of addicted parents and 
children with behavioural disorders, respectively, live in a complete family with both parents (compare with 74% of 
children in the general school population). More than 30% of the children with behavioural disorders live in a 
different family configuration than with parents (their own parents or step-parents). A higher incidence of crime, 
addictions, and disturbed relationships was monitored in the groups of children with behavioural disorders. 
Nearly 70% of the children with behavioural disorders and just under 25% of the children of addicted parents 
mentioned that their best friend is a regular smoker; approximately 25% of the best friends of the children with 
behavioural disorders and 10–12% of children of addicted parents consume alcohol on a regular basis. Nearly 20% 
of the friends of the children with behavioural disorders and 4% of the friends of the children of addicted parents use 
illicit drugs on an occasional or a regular basis (Csémy et al.  2003).  
11.6 Policy and Legal Framework 
11.6.1 Offences Committed by Children Aged Under 15 
Persons aged under 15 are not criminally responsible according to the Czech legislation and the provisions of the 
Penal Code are not applicable to them. When children aged under 15 commit an offence which is otherwise 
page 78 
punishable by law42, action is taken according to the provisions of Act 218/2003 Coll. on Juvenile Justice. Upon the 
proposal of the Public Prosecutor’s Office or upon an initiative of the court, proceedings regarding imposing a 
measure on a child aged under 15 who has committed an offence which is otherwise punishable by law are 
launched. According to Section 93, the court for juveniles may impose the following measures in these proceedings: 
• supervision by a probation officer, 
• therapeutic, psychological, or other suitable educational programme in a educational care centre, 
• protective education. 
Protective education can only be imposed on children who were 12 years old at the time of the commission of the 
offence, and it can only be imposed for offences for which the Penal Code allows the imposition of an exceptional 
sentence, when justified by the nature of the crime, and only when it is necessary in order to provide for the due 
education of the child. The supervising probation officer regularly visits the child at school or his or her place of 
residence. 
A juvenile court is a special senate, its presiding judge, or a single judge of a competent court of the place of 
domicile of the defendant. The participants in the proceedings on imposing a measure on a child aged under 15 
always involve the juvenile him/herself, a body for the social and legal protection of children, and the legal guardians 
of the child. If what happened can be reliably proved otherwise, the child does not have to be examined during the 
proceedings; however, its opinion on the matter must always be ascertained. 
During the proceedings and when imposing a measure according to Act 218/2003 Coll. on children aged under 15, 
the court always takes into consideration the personality of the child, including its age and intellectual and moral 
maturity, health, and personal, family, and social situation. It also pays attention to ensuring an educational influence 
on children and monitors the preventive effects of the measure. The personal data and privacy of the child are 
protected to a greater extent during the proceedings. Judges, public prosecutors, members of police bodies, and 
officers of the Probation and Mediation Service who deal with criminal cases which involve young people must 
undergo special training in handling young people. 
11.6.2 Restricting Availability of Alcohol and Tobacco Products for Persons Aged Under 18 
The legislation of the Czech Republic restricts the availability of tobacco and alcohol for those aged under 18; there 
is no special legislative arrangement for children aged under 15. Restrictions on the availability of alcohol and 
tobacco products are regulated by Act 379/2005 Coll. on Measures for Protection from Harm Caused by Tobacco 
Products, Alcohol, and Other Addictive Substances.  
It is prohibited to sell tobacco products and alcohol to persons aged under 18. Tobacco products cannot be sold at 
cultural, social, and sport events for persons aged under 18; the ban on the serving and sales of alcohol applies to 
all events for persons aged under 18 and also in all types of schools and school facilities. The seller is obliged to 
place a clearly visible sign which bans sales to persons aged under 18 in places where tobacco products are sold. 
At the same time, it is also forbidden to sell tobacco products or alcoholic beverages in vending machines if it is not 
possible to restrict their sales to persons aged under 18. Even other forms of sales are banned when it is impossible 
to verify the age of the buyer. Other restrictions on the sales, serving, and consumption of alcoholic beverages can 
be laid down by an ordinance issued by a municipality with its own powers. 
The Municipal Police, Police of the Czech Republic, and a municipality with delegated powers are especially 
responsible for monitoring adherence to the above-mentioned restrictions. A fine of up to CZK 50,000 (€ 1,680) can 
be imposed to a physical entity for a failure to observe the ban on the sales of tobacco products and alcohol and up 
to CZK 500,000 to a legal entity. The fine goes to the state budget or (when a municipality imposed it) to the 
municipal budget. 
The sale, serving, or any other manner of facilitation of the consumption of alcohol to a person aged under 18 can 
also be prosecuted according to Act 200/1990 Coll. on Misdemeanours. The misdemeanour can be punished by 
a fine of up to CZK 3,000 (Section 30, paragraph 1, letter a)), or (Section 30, paragraph 1, letter e)) or by a fine of up 
to 5,000 and prohibition of activities for up to one year. 
According to Act 40/1995 Coll. on the Regulation of Advertising, alcohol and tobacco advertisements must not be 
targeted at persons aged under 18, especially by depicting such persons or using elements or events which mostly 
appeal to such persons. 
11.6.3 Penalties for Drug Offences Committed against Minors 
The Penal Code (Act 40/1961 Coll.) increasingly protects minors against the negative effects of illicit drug use. It 
stipulates more stringent sanctions for some drug offences, if they were committed against persons aged under 15 
or 18. 
                                                          
42 When a child aged under 15 commits an act against the law other than those specified in the Penal Code, action is taken according to 
general regulations (for instance, according to the Act on Misdemeanours). 
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Section 187 penalises the unauthorised production and distribution and other forms of unauthorised handling of 
narcotic and psychotropic substances. Paragraph 3, letter b) stipulates a higher sentence of 8–12 years of 
imprisonment for offenders who committed the offence against a person aged under 15 (the basic range for an 
offence according to Section 187 is 1–5 years).  
Even the penalty for the criminal offence of the promotion of drug addiction (Section 188a of the Penal Code), which 
penalises the incitement or promotion of the use of addictive substances, is higher when it is committed against 
a person aged under 18 (1–5 years of imprisonment as opposed to the basic range of up to 3 years). 
11.6.4 Policy Targeting Drug Use among Children Aged Under 15 
Two of the six main goals of the 2005–2009 National Strategy target the field of primary prevention, and therefore, 
also the target group of children aged under 15. The goals involve stopping the increase in experimental and 
occasional use of licit and illicit drugs and stabilisation or reduction of consumption of licit and illicit substances 
among society and especially among juveniles. According to the 2005–2006 Action Plan, one of the goals in the 
field of primary prevention is to provide for availability of quality and effective primary prevention programmes and 
targeted primary prevention programmes which will target the most endangered target groups. Concrete activities in 
the field for instance involve drawing up standards of professional competency of primary prevention providers and 
putting them into practice, introduction of a system for certification of the services and creation of a database of 
certified programmes.   
The Ministry of Education has been given the task of coordinating primary prevention of drug use. The ministry drew 
up a 2005–2008 Strategy for the Prevention of Socially Pathological Phenomena among Children and Juveniles 
within the Sphere of Competence of the Ministry of Education in 2004.  
More detailed information on the above-mentioned strategy of the Ministry of Education and on the goals of the 
2005–2006 Action Plan is included in the chapter on Primary Prevention Coordination, page 19. 
Another main goal of the 2005–2006 National Strategy is to reduce availability of licit and illicit drugs among the 
general population, especially among juveniles.  As far as the field of supply reduction and law enforcement is 
concerned, the 2005–2006 Action Plan includes a goal of reducing alcohol and tobacco availability among the 
general population and juveniles. One of the activities to meet this goal involves more efficient and sound 




12 Cocaine and Crack 
The lifetime prevalence of cocaine and crack use among the general and the school population is almost impossible 
to measure. Approximately a fifth of the respondents in the specific population of “dance drug” users have 
experience with cocaine. Several dozens of cocaine users are in contact with treatment facilities every year; most of 
them use it as their secondary drug. Sporadic deaths resulting from cocaine overdoses have been identified in 
recent years; at the same time, the number of cocaine-related criminal offences is also increasing. However, 
cocaine occurrence and use in the Czech Republic is still low in comparison with other drugs; crack practically does 
not occur in the Czech Republic. 
12.1 Extent of Cocaine and Crack Use among the Population 
12.1.1 Use in the General Population 
The frequency of cocaine use (including crack) has been below the limit of sensitivity of population surveys in recent 
years. The Institute of Health Information and Statistics of the Czech Republic carried out a General Population 
Survey on the Health Status and Lifestyle of the Population of the Czech Republic in 2004; it focused on the use of 
licit and illicit substances (Ústav zdravotnických informací a statistiky, 2005b). It was a questionnaire survey among 
3,526 participants aged 18–64. 1.1% of the adult population had had at least one experience with the use of 
cocaine; only 0.2% of respondents have used this substance in the last 12 months, and zero prevalence of use in 
the last 30 days was reported. Cocaine use was most common in the group aged 18–24 and it decreased with the 
age of the participants – see Figure 12-1 (Ústav zdravotnických informací a statistiky, 2005a). 
Figure 12-1: Lifetime prevalence of cocaine use (including crack) by age groups in 2004 (%) (Ústav zdravotnických 































12.1.2 Use among the School Population 
Results of school surveys also show a very low prevalence of cocaine or crack among the entire population. 
Several surveys among young people of school age have been carried out in the Czech Republic in recent years; 
two of them were significant in terms of their extent and the opportunity they provided to monitor trends: the 
European School Survey on Alcohol and Other Drugs (ESPAD) and the Youth and Drugs survey. The international 
survey ESPAD was carried out in 1995, 1999, and 2003 and students aged 15–16 were targeted (the survey also 
involved 18-year-old students in 2003). The sample consisted of 2,962 students in 1995 and of 3,579 students in 
1999, and 3,172 students aged 15–16 and 3,388 students aged 17–18 participated in the survey in 2003 (Csémy et 
al.  2006b). The Prague Hygiene Service carried out the Youth and Drugs survey in 1994, 1997, and 2000, and it 
covered a wider age spectrum of respondents (aged 15–19). The sample consisted of 3,997 respondents in 1994, 
8,767 in 1997, and 6,340 high-school students in 2000 (Polanecký et al.  2001). 
The lifetime prevalence of cocaine and crack use was higher in the Youth and Drugs surveys; the reasons may 
involve the fact that these substances are especially used by older students. The results of the 2003 ESPAD survey 
among students aged 18 also confirm this statement. The lifetime prevalence of cocaine and crack use is given in 
Figure 12-2. The prevalence of cocaine and crack use in the last 12 months and last 30 days are below the limit of 
sensitivity of school surveys (i.e. under 0.5%). 
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Note: * Lifetime prevalence of the use of cocaine and crack together. 
12.1.3 Use among Specific Population Groups 
The prevalence of cocaine and crack use is significantly higher among those attending dance events than among 
the general population. According to the Dance and Drugs survey in 2003, at least 20% of respondents have used 
cocaine at least once in their lifetime, 12% have used it in the last year, and 4% in the last month. In comparison 
with the Semtex Dance survey from 2000, the prevalence of cocaine use on the dance scene has increased slightly 
– see Figure 12-3 (Kubů et al.  2006) 
Figure 12-3: Lifetime, last year and last month prevalence of cocaine and crack among those attending dance events in 
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A similar lifetime prevalence of cocaine use was also found in 2003 and 2004 in surveys among those attending 
dance events who used preventive and harm reduction services provided by NGOs – see Table 12-1 (Mravčík et al.  
2005; Mravčík and Valnoha, 2005). 
Table 12-1: Prevalence of cocaine use among those attending dance events who used preventive and harm reduction 






Lifetime  17.5 22.8
3 or more times during the last 30 days 2.1 3.3
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12.2 Problems Associated with Cocaine and Crack Use 
12.2.1 Cocaine- and Crack-Related Treatment Demands 
The register kept by the Hygiene Service provides information on treatment demands – see the chapter on Profile 
of Drug Users in Treatment, page 27, for more information. It has been gathering data on drug users who have 
visited a low-threshold or treatment facility for the first time in a given year since 1995, and it has been collecting 
data on all drug users who have used the services provided by these facilities since 2002. For the purposes of this 
chapter, an analysis of the data on cocaine and crack in the register was carried out (Trojáčková, 2006). 
The proportion of those who use cocaine as their primary drug in all and first treatment demands has been under 
0.5% since 1997. Their number and other characteristics (number of females and injecting drug users) are given in 
Table 12-2. It has been possible to monitor the average age of drug users demanding treatment in relation to the 
use of cocaine since 2002; it is higher than the average age of users of other drugs and it increases in a time line – 
see Figure 4-6 and Figure 4-7 on page 30 in the chapter on Profile of Drug Users in Treatment for more detailed 
information. 15 (22%) of all drug users demanding treatment in relation to the use of cocaine in 2002–2005 reported 
the daily use of cocaine – see Figure 12-4. 
Table 12-2: Number and basic characteristics of (first) treatment demands in relation to the use of cocaine and crack (%) 
(Trojáčková, 2006) 
First treatment demands  All treatment demands  









1995 17 3 20 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
1996 14 3 17 6 n.a. n.a. n.a. n.a. n.a. n.a.
1997 12 0 12 8 n.a. n.a. n.a. n.a. n.a. n.a.
1998 7 0 7 3 n.a. n.a. n.a. n.a. n.a. n.a.
1999 7 1 8 2 n.a. n.a. n.a. n.a. n.a. n.a.
2000 10 0 10 4 n.a. n.a. n.a. n.a. n.a. n.a.
2001 5 1 6 3 2 n.a. n.a. n.a. n.a. n.a.
2002 3 0 3 0 2 12 1 13 3 2
2003 14 1 15 8 1 21 1 22 10 1
2004 13 0 13 4 4 18 0 18 5 4
2005 3 2 5 1 1 13 2 15 5 2
Total 105 11 116 39 10 64 4 68 23 9
Figure 12-4: Average frequency of cocaine use (including crack) among all treatment demands in relation to cocaine use 
















Cocaine is more often used as a secondary drug in combination with other substances, most commonly with other 
stimulants (especially pervitin) and opiates – see Table 12-3. 
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Table 12-3: Number of drug users demanding treatment who report cocaine as their secondary drug (including crack) in 
2002–2005 (Trojáčková, 2006) 
First treatment demands  All treatment demands  Primary drug  2002 2003 2004 2005 2002 2003 2004 2005 
Stimulants  28 28 38 41 59 52 58 73 
Opiates  3 7 7 4 24 24 18 16 
Cannabis  1 4 7 6 2 6 11 10 
Cocaine* 0 0 1 0 0 2 1 0 
Inhalants 0 0 1 0 0 1 1 1 
Hypnotics, sedatives 0 0 0 0 0 1 0 0 
Hallucinogens  0 0 0 0 1 0 0 0 
Total  32 39 54 51 86 86 89 100 
Note: * Some cocaine users reported crack as their secondary drug, and vice versa. 
Reports on outpatient care in the field of psychiatry and obligatory reports on hospitalisations serve as other data 
sources. They are processed by the Institute of Health Information and Statistics of the Czech Republic. 
Three patients (two males) were hospitalised in relation to cocaine use (diagnosis F14) in 2005 in psychiatric 
facilities for adults, and ten patients (7 males) in all hospital departments (Ústav zdravotnických informací a 
statistiky, 2006b). 
Altogether 380 patients who used cocaine were registered in outpatient AT clinics43 in 2000–2004; 273 (72%) of 
them were males and 107 (28%) were females; most of them (203 patients) were aged 20–29, and no patient aged 
0–14 was registered. A higher year-on-year increase in the number of persons treated occurred in 2003; the 
number of patients treated in 2004 again corresponded to the stable increase of the previous years. The 
development copies the curve of all patients registered by outpatient AT clinics in 2000–2004 (Ústav zdravotnických 
informací a statistiky, 2002, 2003a, 2003b, 2005c, 2005d) – see Figure 12-5. 
Figure 12-5: Development in the number of patients who use cocaine (dg. F14) registered in outpatient AT clinics by age 
groups in 2000–2004 (Ústav zdravotnických informací a statistiky, 2002, 2003a, 2003b, 2005c, 2005d) 
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Total all patients dg. F11-F19
 
12.2.2 Drug-Related Deaths in Relation to Cocaine and Crack Use 
Data on drug overdoses have been available in the Czech Republic since 1998 – see the chapter on Drug-Related 
Deaths and Mortality of Drug Users, page 40, for more information. A single death resulting from a cocaine 
overdose among the total of 241 fatal drug overdoses (including overdoses on medicaments) and one death with 
the presence of cocaine out of the total number of 164 deaths with the presence of drugs was recorded for the first 
time in 2004. One death resulting from a cocaine overdose was also identified in 2005 (out of the total number of 
218 fatal overdoses) (Národní monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2005; 
Národní monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006). 
                                                          
43 This involves the facilities which filled in Appendix A013 of the AT psychiatric report. 
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An analysis of all autopsies carried out in forensic medicine and forensic toxicology departments in the Czech 
Republic was done in 2003–2005. The presence of cocaine was not confirmed in any of the cases – see the 
chapter on Drugs and Driving, page 85, for more information. 
12.2.3 Infections in Relation to Cocaine and Crack Use 
The number of cocaine and crack users who are infected with HIV and HBV and HCV is unknown. 
12.2.4 Non-Fatal Intoxications with Cocaine and Crack 
The Hygiene Service has been collecting data on non-fatal intoxications (i.e. on intoxications which do not result in 
a death) – see the chapter on Other Drug-Related Disorders, page 45, for more information. In recent years, they 
have involved 1 to 7 cases every year – see Table 6-12 in the chapter on Non-Fatal Drug Intoxications, page 48. 
12.3 Cocaine and Crack Demand Reduction  
In the Czech Republic, there are no harm reduction or treatment programmes which specifically focus on cocaine or 
crack users. 
Therapeutic interventions for those addicted to cocaine involve a wide spectrum of counselling approaches, 
outpatient and intensive outpatient treatment, and inpatient and residential treatment in therapeutic communities, 
including aftercare. The interventions are always part of abstinence-oriented treatment (Minařík, 2003). Supportive 
pharmacological treatment of acute intoxications, withdrawal states, the actual addiction, and accompanying 
psychopathological states is not usually necessary and often it is not even appropriate. Antiarhythmics are only 
administered in cases of cardiovascular complications (especially tachycardia), and benzodiazepines are 
administered in cases of marked restlessness. Antidepressants can be used in the event of strong attacks of 
depression and neuroleptics can be used in cases of protracted toxic psychosis (Minařík, 2003; Bayer, 2003). 
12.4 Drug-Related Crime and Drug Market 
By drug-related crime, we understand criminal offences of the unauthorised production and possession of narcotic 
and psychotropic substances (Section 187, Section 187a, Section 188 of the Penal Code) and criminal offences 
involving the promotion of drug addiction (Section 188a of the Penal Code), for which the term “drug offences” is 
used, and secondary drug-related crime – see the chapter on Drug-Related Crime, page 56, for more detailed 
information.  
2,128 persons suspected of the commission of drug offences44 were prosecuted in 2005. 50 (2.3%) of them were 
prosecuted for cocaine-related offences. One person was prosecuted for cocaine possession in a quantity greater 
than small for personal use. The development of the number of those prosecuted for cocaine-related offences is 
given in Table 12-4 (Národní protidrogová centrála, 2006c). 
Table 12-4: Perpetrators of cocaine-related offences prosecuted in 2002–2005 (Národní protidrogová centrála, 2006c) 
Criminal offences 2002 2003 2004 2005 
Section 187a of the Penal Code (drug 
possession for personal use) 1 3 0 1 
Section 187 and 188 of the Penal Code 
(production and distribution) 9 21 17 49 
Total  10 24 17 50 
 
Data on drug seizures in the Czech Republic are recorded centrally by the National Drug Squad and the General 
Customs Headquarters. The number of seizures and quantities of cocaine seized in 2002–2005 are given in Table 
12-5. Crack has not been seized in the Czech Republic. 
Table 12-5: Cocaine seizures in 2002–2005 (Mravčík et al.  2005; Národní protidrogová centrála, 2006) 
Year  Number  Volume in kg 
2002 12 6.0 
2003 20 2.6 
2004 7 3.3 
2005 11 10.2 
 
 
                                                          
44 Offences of the promotion of drug addiction (Section 188a of the Penal Code) are not included. 
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13 Drugs and Driving 
The prevalence of driving under the influence of cannabis in the Czech Republic is ten times lower than that under 
the influence of alcohol, according to available information. The prevalence of driving under the influence of other 
drugs is even lower. The frequency of driving under the influence of benzodiazepines is approximately the same as 
that under the influence of cannabis. 
During the last two years, the government and the Ministry of the Interior and the Ministry of Transport have 
adopted strategic documents that aim to increase road safety. The documents contain tasks which concern 
increasing the control and prevention of driving under the influence of alcohol and drugs. The Road Traffic Act and 
several provisions of the Act on Misdemeanours and the Penal Code relating to driving under the influence of 
addictive substances were amended. The Police of the Czech Republic have introduced pilot orientative testing for 
drivers for the presence of drugs; the testing is expected to be extended and methodological guidelines will be 
completed after an evaluation of the pilot phase. 
The implementation of preventive programmes during driver training is within the responsibility of individual driving 
schools; they are mostly uninterested, according to available information. The Ministry of Transport is implementing 
a preventive project promoting the strategy of a “designated driver” who abstains and takes his/her friends home 
from an event; the project targets recreational drug users at dance events, concerts etc.  
The practice of using visible labelling for packages for medicaments (pictograms or symbols which warn against the 
possibility of their influencing psychomotor functions and reducing the ability to drive) is not widespread in the Czech 
Republic.  
13.1 Legal Framework, Strategies and Policy 
13.1.1 Legal Framework 
Act 411/2005 Coll. amended Act 361/2000 Coll. on Traffic on Road Communications (Road Traffic Act), Act 
200/1990 Coll., on Misdemeanours and Acts 140/1961 Coll., Penal Code. Inter alia, it also changed the facts of the 
case of misdemeanours and offences involving driving motor vehicles under the influence of addictive substances 
and it established conditions for checks for driving under the influence of addictive substances other than alcohol – 
see the chapter on Legislation, page 3. 
13.1.2 Strategies and Policy 
The 2005–2006 Action Plan targets reducing drug use among road traffic participants, especially drivers. Its Goal 
No. 17, Increased Road Traffic Safety, includes two activities which must be carried out by June 30, 2006. The 
Ministry of the Interior is responsible for the activities: 
• To provide material and technical equipment for traffic police officers for orientative testing for the presence of 
narcotic and psychotropic substances among road users. 
• All police officers who are employed by the Traffic Police Service shall receive training in the identification of the 
external signs of drug use. 
The goal of introducing orientative drug testing for road users was already mentioned in the previous 2000–2004 
strategy; however, the goal was not met. 
The Government Resolution 883/2004 established the Governmental Council for Road Traffic Safety. The Minister 
of Transport is the chairman of the council. The council is a permanent advisory body of the government and a top 
coordinating body in the field of road traffic safety. The goal is provide maximum support for road safety, especially 
the fulfilment of the National Road Traffic Safety Strategy. The council coordinates the activities of central state 
administration bodies, the parliament, regions, municipalities, NGOs, and also entrepreneurs who are active in this 
field. The Road Safety Department of the Ministry of Transport deals with the everyday coordination of activities in 
the field of road safety. 
The National Road Traffic Safety Strategy, which was approved by the government, contains nine main goals. One 
of them is to reduce the number of accidents and the consequences of those accidents which were caused under 
the influence of alcohol and other drugs (Ministerstvo dopravy, 2005). Individual priorities and activities for the 
implementation of the goal are given in Table 13-1. 
The 2005 Road Safety and Traffic Flow Action Plan of the Ministry of the Interior (Ministerstvo vnitra, 2005) included 
three activities in the field of the prevention and control of alcohol and drug use in road traffic – see Table 13-2. 
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Table 13-1: Priorities and activities of the Road Safety Strategy relating to reducing the influence of alcohol and other 
drugs (Ministerstvo dopravy, 2005) 
Priority Activities Responsible Term 
C 1.1: Annual campaign targeting the 
dangers of driving under the influence of 
alcohol, medicaments, and other addictive 
substances, with an emphasis on the 
responsibility of the consumer. 
Ministry of Transport, 
Ministry of the Interior, 
Ministry of Health, Ministry 
of Labour and Social 
Affairs  
Every year 
C 1.2: Application of knowledge on the 
influence of alcohol and other addictive 
substances on the ability to drive motor and 
non-motor vehicles and road traffic safety in 
educational programmes in schools and 
driving schools. 
Ministry of Transport in 
collaboration with Ministry 
of Education, Ministry of 
Health, and Ministry of the 
Interior  
Continuously
C 1: Reducing the 
number of traffic 
accidents caused under 
the influence of alcohol 
and other drugs by way 
of educational influence  
C 1.3: Increasing informedness of patients 
about the influence of several medicaments 
on the ability to drive a motor vehicle and on 
the influence of the medicaments on the 
behaviour of other road users. 
Ministry of Health in 
collaboration with Ministry 
of Transport and bodies of 
the Czech Medical 
Chamber, Czech Dental 
Chamber, and Czech 
Chamber of Pharmacists 
Continuously
C 2: Reducing the 
number of accidents 
caused under the 
influence of alcohol 
through more intensive 
surveillance by the  
Police of the Czech 
Republic  
C 2.1: Increasing the number of drivers 
checked during operations targeting the 
detection of alcohol and other addictive 
substances among cyclists and drivers of 
motor vehicles; to carry out traffic safety 
operations at night and during weekends. 
Ministry of the Interior  Continuously
Note: Zkratky uvedené v tabulce viz kapitola Zkratky. 
Table 13-2: Activities of the 2005 Road Safety and Traffic Flow Action Plan of the Ministry of the Interior relating to 
reducing the influence of alcohol and other drugs (Ministerstvo vnitra, 2005) 
Activities Responsible Description 
C 1.1: Annual campaign 
targeting the dangers of driving 
under the influence of alcohol, 
medicaments, and other 
addictive substances, with an 
emphasis on the responsibility 





Ministry of the 
Interior, Ministry 
of Health, and 
Ministry of Labour 
and Social Affairs
– informing on specific cases and their consequences in the 
media and on the web pages of the Ministry of the Interior 
(nationwide presentation, presentation in local media) 
– collaboration during the preparation, publishing, and 
distribution of instructional videotapes which focus on traffic 
safety issues and during the implementation of 
accompanying contests 
– preventive educational activities  
C 1.2: Application of 
knowledge on the influence of 
alcohol and other addictive 
substances on the ability to 
drive motor and non-motor 
vehicles and road traffic safety 
in educational programmes in 







and Ministry of 
the Interior 
– according to agreements and requirements from driving 
schools 
C 2.1: Increasing the number 
of drivers checked during 
operations targeting the 
detection of alcohol and other 
addictive substances among 
cyclists and drivers of motor 
vehicles; to carry out traffic 
safety operations at night and 
during weekends. 
Ministry of the 
Interior 
– every year, at least three national traffic safety operations 
targeting the detection of alcohol and other addictive 
substances among drivers of motor vehicles and cyclists 
– every year, at least one traffic safety operation targeting the 
detection of alcohol and other addictive substances among 
drivers of motor vehicles and cyclists at the regional and 
district levels 
– to focus on periods of time and places where it is more 
likely that alcoholic beverages will be consumed according to 
assessments made by regional and district directors 
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13.2 Prevalence of Driving under the Influence of Drugs 
According to the official statistics of the Headquarters of the Traffic Police Service of the Police Presidium of the 
Czech Republic (Ředitelství služby dopravní policie Policejního prezidia ČR, 2004), 4–5% of traffic accidents took 
place under the influence of alcohol. 0.02–0.03% of accidents were caused by the use of medicaments and other 
drugs – see Table 13-3. The statistics do not distinguish between individual drugs. The rates of traffic accidents 
under the influence of alcohol in individual regions45 in 2005, including the rates of deaths in these accidents, are 
given in Table 13-4. 
Table 13-3: Rates of traffic accidents on road communications in the Czech Republic in 2003–2005 – influence of alcohol 
and drugs (Ředitelství služby dopravní policie Policejního prezidia ČR, 2004; Ředitelství služby dopravní policie 
Policejního prezidia ČR, 2005; Ředitelství služby dopravní policie Policejního prezidia ČR, 2006a) 
Accidents Fatal accidents 
Total Under the 
influence of 
alcohol  
Under the influence of 
medicaments and 
other drugs 
Total Under the 
influence of 
alcohol 
Under the ifluence of 
medicaments and 
other drugs  
Year 
Abs. Abs. % Abs. % Abs. Abs. % Abs. % 
2003 195,851 9,076 4.6 39 0.02 1,215 111 9.1 0 0.00 
2004 196,484 8,445 4.3 53 0.03 1,215 59 4.9 1 0.08 
2005 199,262 8,192 4.1 60 0.03 1,127 59 5.2 0 0.00 
Table 13-4: Traffic accidents under the influence of alcohol and deaths in the accidents by regions in 2005 (Ředitelství 
služby dopravní policie Policejního prezidia ČR, 2006a) 
Region Number of accidents  





all deaths (%) 
Prague  748 2.3 6 9.8 
Central Bohemia  1,111 4.4 4 2.1 
Southern Bohemia  679 5.1 5 4.2 
Western Bohemia  802 4.7 10 10.2 
Northern Bohemia  1,119 5.4 11 8.7 
Eastern Bohemia 967 4.7 8 5.5 
Southern Moravia  1,312 4.4 11 5.0 
Northern Moravia 1,454 4.9 4 2.4 
Total Czech Rep.  8,192 4.3 59 5.2 
 
The police carry out periodic traffic safety operations in the Czech Republic. Some are carried out at the national 
level – the “Kryštof” operations are the best known. They involve checks on drivers and the technical state of 
vehicles and they aim to reduce the number of serious traffic accidents. Only alcohol tests are carried out within the 
framework of the operations; drug tests are not carried out – see Table 13-5. 
Table 13-5: Alcohol-impaired driving detected during the Kryštof police operation in 2003–2005 (Ředitelství služby 
dopravní policie Policejního prezidia ČR, 2006b) 





of alcohol  
Proportion  
in % 
September 29 –  
October 3, 2003 
361,685 952 0.26 
April 13 – April 16, 2004 206,846 210 0.10 
April 18 – April 21, 2005 150,601 186 0.12 
 
It is very likely (even considering the results of the toxicological examinations of the dead victims of traffic accidents 
– see below) that the official police data on driving under the influence of alcohol and narcotic and psychotropic 
substances are considerably underestimated. 
13.2.1 Presence of Alcohol and Other Drugs among Dead Victims of Traffic Accidents 
Detections of alcohol and other drugs among dissected victims of traffic accidents in all thirteen departments of 
forensic medicine and forensic toxicology in the Czech Republic have been analysed since 2003 – see the chapter 
on Drug-Related Deaths and Mortality of Drug Users, page 40, for more information; the 2003 data were published 
in professional journals (Mravčík et al.  2005). As far as alcohol is concerned, cases with an alcohol level higher 
than 0.2 g/kg are regarded as positive (Společnost soudního lékařství a soudní toxikologie, 1999). As far as 
                                                          
45 The Police of the Czech Republic (as well as Public Prosecutors’ Offices and courts) are divided according to the regional 
arrangement which was applicable before the public administration reform in 2000 (8 regions instead of the current 14). 
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cannabinoids are concerned, positive cases involved those cases where THC or its active metabolite (therefore, 
not, for instance, THC-COOH) were found, and positive cases of inhalants involve the detection of substances 
which do not develop post mortem or are not indicated in several physiological or pathological conditions (e.g. 
acetone, acetaldehyde, n-propanole, n-butanole). Blood alcohol level examinations are carried out according to the 
Guidelines for Ethanol Level Determination issued by the Professional Association of Forensic Medicine and 
Toxicology of the Czech Medical Association of J. E. Purkyně (Společnost soudního lékařství a soudní toxikologie, 
1998). At the minimum, toxicological examinations involve urine screening by means of immunochemical methods 
and confirmation by means of a specific analytic method after previous extrapolation from blood or organs, and they 
focus on medicaments and other drugs. The entire sample was divided into four categories: pedestrians, cyclists, 
drivers of motor vehicles, and others. The category “others” especially involved co-passengers in motor vehicles 
and those who died and do not belong in any of the three above-mentioned categories (other than traffic accidents, 
e.g. plane crashes, accidents at building sites, etc.). 
Approximately 50% of the dead victims of traffic accidents were tested toxicologically in 2003–200546 – see Table 
13-6. The highest proportion of positive results involved alcohol; however, this proportion has a declining trend – 
from 40% in 2003 to 30% in 2005 among all active participants in traffic accidents (and from 32% to 19% among 
drivers). Every year, approximately 7% of the active participants in traffic accidents tested were positive for some 
drug besides alcohol; the cases most commonly involved benzodiazepines (3–4%), cannabis (1–3%), and 
stimulants (1–2% of active participants in traffic accidents) – see Table 13-7. 
Table 13-6: Overview of those dissected in forensic medicine departments in the Czech Republic in 2003–2005 (Národní 
monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006) 
Year  Total number 
of dissected 
bodies 





2003 9,960 1,035 554 
2004 12,731 1,255 590 
2005 11,358 1,047 561 
                                                          
46 I.e. tested for the presence of ethanol or some of the drugs belonging to the following groups: inhalants, opiates, stimulants, cannabis, 
cocaine, benzodiazepines, barbiturates 
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Table 13-7: Detection of alcohol and narcotic and psychotropic substances among victims of traffic accidents (Národní 
monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006) 
Category of victims of traffic accidents 
Pedestrians Cyclists Drivers Total 





































2003 141 51.8 50 40.0 203 32.0 394 40.1 
2004 150 48.7 44 29.5 209 23.9 403 33.7 Alcohol 
2005 148 45.3 35 34.3 198 18.7 381 30.4 
2003 141 0.7 50 0.0 203 0.5 394 0.5 
2004 77 1.3 9 0.0 101 0.0 187 0.5 Inhalants 
2005 67 3.0 7 0.0 68 0.0 142 1.4 
2003 92 0.0 28 3.6 153 0.7 273 0.7 
2004 109 0.0 23 4.3 172 0.0 304 0.3 
Opiates (including 
heroin) 
2005 103 0.0 17 0.0 149 0.7 269 0.4 
2003 91 1.1 27 0.0 152 3.3 270 2.2 
2004 109 1.8 23 0.0 170 1.8 302 1.7 
Stimulants (including 
pervitin and ecstasy) 
2005 103 1.9 17 0.0 148 0.7 268 1.1 
2003 39 0.0 8 0.0 54 0.0 101 0.0 
2004 50 0.0 13 0.0 75 0.0 138 0.0 Cocaine 
2005 45 0.0 10 0.0 71 0.0 126 0.0 
2003 70 2.9 21 0.0 101 4.0 192 3.1 
2004 44 2.3 14 0.0 100 0.0 158 0.6 
Cannabis (active 
metabolites of THC) 
2005 54 1.9 11 0.0 94 3.2 159 2.5 
2003 89 3.4 28 7.1 150 2.0 267 3.0 
2004 109 5.5 23 4.3 172 2.9 304 3.9 Benzodiazepines 
2005 103 2.9 17 5.9 147 4.1 267 3.7 
2003 88 0.0 28 3.6 149 0.0 265 0.4 
2004 109 1.8 23 0.0 169 1.2 301 1.3 Barbiturates 
2005 101 2.0 15 0.0 131 0.8 247 1.2 
2003 108 7.4 35 11.4 171 6.4 314 7.3 
2004 117 9.4 26 7.7 181 5.5 324 7.1 
Any drug besides 
alcohol 
2005 110 8.2 19 5.3 158 7.0 287 7.3 
2003 106 3.8 35 5.7 170 0.6 311 2.3 
2004 154 3.2 44 0.0 219 0.5 417 1.4 
Combination of 
alcohol and any other 
drug  2005 104 2.9 19 0.0 147 2.0 270 2.2 
 
Positive findings of ethanole were significantly more common among males than among females; on the other 
hand, benzodiazepines were detected much more frequently among females than among males – see Table 13-8. 
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Table 13-8: Positive detection of alcohol and other narcotic and psychotropic substances among victims of traffic 
accidents by gender (Národní monitorovací středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006) 
Males  Females  Total Substance Year Tests Positive (%) Tests  Positive (%) Tests Positive (%) 
2003** 335 44.8 59 13.6 394 40.1 
2004** 348 36.2 55 18.2 403 33.7 Alcohol 
2005** 325 33.5 56 12.5 381 30.4 
2003 335 0.6 59 0.0 394 0.5 
2004 165 0.6 22 0.0 187 0.5 Inhalants  
2005 121 1.7 21 0.0 142 1.4 
2003* 238 0.0 35 5.7 273 0.7 
2004 265 0.4 39 0.0 304 0.3 
Opiates (including 
heroin)  
2005 228 0.4 41 0.0 269 0.4 
2003 236 2.1 34 2.9 270 2.2 
2004 263 1.5 39 2.6 302 1.7 
Stimulants 
(including pervitin 
and ecstasy) 2005 227 1.3 41 0.0 268 1.1 
2003 91 0.0 10 0.0 101 0.0 
2004 117 0.0 21 0.0 138 0.0 Cocaine  
2005 105 0.0 21 0.0 126 0.0 
2003 167 3.6 25 0.0 192 3.1 
2004 141 0.7 17 0.0 158 0.6 
Cannabis (active 
metabollites of 
THC) 2005 135 3.0 24 0.0 159 2.5 
2003* 233 2.1 34 8.8 267 3.0 
2004 265 3.4 39 7.7 304 3.9 Benzodiazepines  
2005 226 3.1 41 7.3 267 3.7 
2003 231 0.4 34 0.0 265 0.4 
2004 262 1.1 39 2.6 301 1.3 Barbiturates 
2005 209 1.0 38 2.6 247 1.2 
Note: * difference at significance level of p < 0.05, **difference at significance level of p < 0.01(chi-quadrate test).  
The age of those who tested positive was lower than the age of those who tested negative in the case of all drugs, 
with the exception of medicaments; the most significant differences involve ethanol and cannabis – see Table 13-9. 
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Table 13-9: Average age of toxicologically positive and negative participants in traffic accidents (Národní monitorovací 
středisko pro drogy a drogové závislosti and SSLST ČLS JEP, 2006) 
Substance Year Positive Negative  Total 
2003* 39.1 43.3 41.6 
2004** 40.4 46.3 44.3 Alcohol  
2005 41.1 42.9 42.4 
2003 40.5 41.6 41.6 
2004 25.0 42.3 42.2 Inhalants  
2005 18.5 41.5 41.1 
2003 28.0 39.3 39.2 
2004 53.0 42.0 42.0 
Opiates (including 
heroin) 
2005 40.0 39.3 39.3 
2003 29.2 39.2 39.0 
2004 28.2 42.2 42.0 
Stimulants (including 
pervitin and ecstasy) 
2005 22.3 39.5 39.3 
2003 – 36.1 36.1 
2004 – 42.0 42.0 Cocaine 
2005 – 38.1 38.1 
2003* 20.5 38.7 38.2 
2004 20.0 38.7 38.6 
Cannabis (active 
metabollites of THC) 
2005 22.5 35.7 35.4 
2003 46.3 39.1 39.3 
2004 51.6 41.7 42.1 Benzodiazepines 
2005 40.6 39.3 39.4 
2003 65.0 38.9 39.0 
2004 50.5 42.1 42.2 Barbiturates 
2005** 66.0 39.5 39.8 
Note: * difference at significance level of p < 0.05, **difference at significance level of p < 0.01(ANOVA test). 
A study was carried out in the Southern Bohemia region in 1998–2002 on a sample of 200 drivers who died in traffic 
accidents (166 of them were toxicologically examined). An illicit drug was detected in 2 of them (1.2%, pervitin in 
one case and THC in the second one). 4.8% of them were under the influence of pharmaceutical psychotropic 
substances at the moment of the fatal traffic accident, 4.8% were under the influence of other medicaments, and 
37% were under the influence of alcohol (Vorel, 2003).  
13.3 Drug Testing among Road Users 
The traffic police carry out drink-driving checks on drivers within the framework of the so-called traffic safety 
operations and also during regular checks. Four national traffic safety operations targeted driving under the 
influence of alcohol and other drugs, 34 operations were carried out at a regional level, and 573 operations were 
carried out at a district level. Police officers also paid closer attention to cyclists during their operations in 2005. 
15,077 cases of the consumption of alcoholic beverages were detected during checks on the drivers of motor 
vehicles (the influence of narcotic and psychotropic substances was not monitored). 
Lately, the police have been abandoning extensive operations and adapting checks to local conditions; they 
especially target sport and other social events (Ministerstvo dopravy, 2006). 
The traffic police have been practically testing four types of detection sets for saliva or sweat testing. Concurrently 
with the introduction of testing sets, training for traffic police officers on orientative testing for narcotics and 
recognising the signs of drug use has been taking place since December 2005. Altogether, 2,000 detection aids 
have been delivered, 500 of them from each manufacturer (Nováková, 2006). It is expected that pilot testing will be 
evaluated by the end of August 2006; no official interim results are available.  
A sample for sweat testing is taken from objects which the person being tested has touched (e.g. driver's license, 
steering wheel). A sample for saliva testing is taken by means of inserting an absorption device into the mouth. 
Orientative testing in both of the above-mentioned manners is carried out in situ; the results are available within 
a few minutes. A reactive result must be confirmed by a forensic toxicology laboratory. 
The experimental testing follows on from a methodological guideline of the Police Presidium. It stipulates that testing 
for drug use should be carried out in the following instances: 
• When a driver shows external signs of drug use. 
• When a driver answers positively a question whether he had used a drug before driving. 
• When a driver committed a misdemeanour or caused a traffic accident in a manner which indicates drug use. 
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• In connection with holding an event at which an increased level of drug use can be expected (e.g. some dance 
parties etc.). 
When the orientative test for the presence of drugs is positive, the police officer takes the following action:  
• Notice of a misdemeanour with a detailed description of the actual detection of a sign of drug influence. 
• Call for medical (confirmation) examination with advice. 
• Submitting the driver to a medical examination. 
• Drawing up a protocol on the medical examination. 
Furthermore, the methodological guideline places the following obligations upon police officers: 
• To conclusively prohibit further driving until the effects of the drug wear off. 
• To draw up a detailed official record on the course of the reaction of the orientative test and the conditions under 
which it was administered. 
• To describe the result of the intervention and which measures were taken. 
• To announce the misdemeanour to an appropriate administrative body and make a proposal to invite an expert to 
determine whether the detected quantity of the drug in the body precludes the ability to drive a motor vehicle.  
13.4 Prevention of Drug Use among Road Users 
The Ministry of Transportation launched the campaign “Domluvený (Designated Driver)” at the Summer of Love 
festival in Pardubice, the Hip-Hop festival in Hradec Králové, and the Trnkobraní music festival in Slušovice in 2005. 
The philosophy of this campaign is based on the status of a designated driver who abstains during an event so that 
he/she can safely take his/her friends home. The campaign “Domluvený” is a parallel of the European Designated 
Driver Campaign and it is supported by the European Commission. Several interactive thematic activities were 
prepared for those attending the events and they targeted road traffic safety. These were, for instance, an impact 
simulator, computer games, first aid demonstrations, and counselling on the risks of the consumption of alcohol and 
other drugs in connection with driving.  
Within the framework of the campaign, a new service, PROMILE SMS (www.promilesms.cz), was localised, verified 
in a pilot project, and launched. It makes it possible to check blood alcohol levels and find out when the alcohol 
consumer will be “sober” again, i.e. when he/she will be capable of driving a car again. The SANANIM Charity 
Services is implementing the project. It is based on the principle of entering basic parameters which influence the 
blood alcohol level into a text message and sending it. A text message reply is sent back almost immediately and it 
contains information on the current alcohol concentration in the blood, the time when the person will be sober once 
more, and a short preventive message. During the first three months of its full operation (September November 
2005), the Promile SMS service replied to more than 11,460 queries. Males used the service markedly more often 
(82%), and the average age of clients was 32. Approximately 31% of clients had a zero blood alcohol level at the 
time of sending the text message. It is likely that these customers used the service the day after they had been 
drinking so that they could check whether they could carry out activities which it is forbidden to perform under the 
influence of alcohol. The average blood alcohol level was 1.03‰. The service is used the most between 9 and 
12 p.m. 
The issues of the influence of alcohol and other drugs on driving are included in several primary prevention projects 
which are implemented by the Police of the Czech Republic. For instance, they involve debates with secondary-
school students during which the students watch a videotape, A Car Is a Gun (Auto je zbraň), produced by the 
Malina foundation (www.nadace-malina.cz), and documentary shots of traffic accidents. With a few exceptions, 
driving schools were not interested in the debates, although they received an offer from the Police of the Czech 
Republic (Ministerstvo dopravy, 2006).  
The project ‘The Action’ was implemented in Pilsen in September 2005. It targeted the use of alcohol and its 
consequences for road traffic. Most secondary schools in Pilsen participated in the project (Ministerstvo dopravy, 
2006). 
13.4.1 Labelling of Medicines 
According to the registration ordinance on medicinal preparations (ordinance No. 288/2004 Coll.), a special 
notification is mentioned on a patient package leaflet or on the labelling of the package; it involves especially the 
possibility of the medication influencing the ability to drive or operate machinery. From this point of view, the 
ordinance classifies preparations into three groups: (1) safe preparations or preparations which are unlikely to have 
any influence; (2) preparations with the probability of a slight influence, and (3) preparations with the probability of a 
considerable influence, and that are potentially dangerous. The patient package leaflet or labelling of the outer 
package may also include symbols or pictograms or other data, e.g. a warning against the contents impairing the 
ability to drive a car (for instance, an exclamation mark or an exclamation mark in a triangle). However, the symbols 
are only used exceptionally in practice, even for medicaments with a considerable influence on psychomotor 
functions. 
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SELECTED DRUG-RELATED WEB PAGES ON THE CZECH INTERNET 
An extensive list of (not only) Czech websites that deal with drug issues is available at http://www.drogy-
info.cz/index.php/web_a_drogy/. The following list provides selected official pages of key Czech institutions in the 
field of prevention, treatment and monitoring of drug use. 
Adiktologie (Addictology – a professional journal for 
prevention, treatment and research of addiction): 
http://www.adiktologie.cz/  
A.N.O. – Asociace nestátních organizací zabývajících 
se prevencí a léčbou drogových závislostí (Association 
of NGOs Dealing with Prevention and Treatment of 
Drug Addiction ): http://www.asociace.org/  
Antidopingový výbor ČR (Antidoping Committee of the 
Czech Republic): http://www.antidoping.cz/  
Celní správa ČR (Customs Administration of the Czech 
Republic): http://www.cs.mfcr.cz/  
Centrum adiktologie – Psychiatrická klinika I. LF a VFN, 
Univerzita Karlova v Praze (Centre for Addictology, 
Psychiatric Clinic, 1st Faculty of Medicine, Charles 
University in Prague): http://www.adiktologie.cz/ 
Centrum epidemiologie a mikrobiologie SZÚ (Centre of 
Epidemiology and Microbiology of the National Institute 
of Public Health): http://www.szu.cz/cem/hpcem.htm  
Centrum pro výzkum veřejného mínění – Sociologický 
ústav AV ČR (Public Opinion Research Centre of the 
Institute of Sociology of the Academy of Sciences of the 
Czech Republic): http://www.cvvm.cas.cz/  
Česká asociace streetwork (Czech Streetwork 
Association): http://streetwork.ecn.cz/  
Česká lékařská společnost JEP (Czech Medical 
Association of J. E. Purkyně): http://www.cls.cz/  
Česká lékařská společnost JEP (Czech Medical 
Association of J. E. Purkyně – search in journals): 
http://www.clsjep.cz/hledani.asp  
Česká neuropsychofarmakologická společnost (Czech 
Neuropsychopharmalogical Society): 
http://www.cnps.cz/  
Český statistický úřad (Czech Statistical Office): 
http://www.czso.cz/  
Drop-In, o.p.s.: http://www.dropin.cz/  
EXTC (web councelling and prevention of synthetic 
drug abuse): http://www.extc.cz/  
Informační centrum OSN v Praze (Information Centre of 
the UNO in Prague): http://www.osn.cz/  
Informační portál primární prevence (Primary 
Prevention Information Portal, operated by the 
SANANIM civic association): http://www.odrogach.cz/  
Institut pro kriminologii a sociální prevenci (Institute for 
Criminology and Social Prevention): 
http://www.ok.cz/iksp/  
Ministerstvo spravedlnosti (Ministry of Justice – portal 
for Czech justice): http://portal.justice.cz/  
Ministerstvo práce a sociálních věcí (Ministry of Labour 
and Social Affairs): http://www.mpsv.cz/  
Ministerstvo školství, mládeže a tělovýchovy (Ministry of 
Education): http://www.msmt.cz/  
Ministerstvo vnitra (Ministry of the Interior): 
http://www.mvcr.cz/  
Ministerstvo zdravotnictví (Ministry of Health): 
http://www.mzcr.cz/  
Národní monitorovací středisko pro drogy a drogové 
závislosti (National Monitoring Centre for Drugs and 
Drug Addiction): http://www.drogy-info.cz/ 
Národní program boje proti AIDS ČR (National 
Programme of Combating AIDS in the Czech Republic): 
http://www.aids-hiv.cz/  
Národní protidrogová centrála Služby kriminální policie 
a vyšetřování Policie ČR (Police National Drug Squad): 
http://www.mvcr.cz/policie/npdc.html  
Newton IT (press monitor and fulltext archives): 
http://www.newtonit.cz/  
Poslanecká sněmovna Parlamentu ČR (Lower House of 
the Parliament of the Czech Republic, 2002–2006 
electoral term, Committee for Social Policy and Health 
(it included the Subcommittee for Drugs and Addiction 
Issues): http://www.psp.cz/sqw/fsnem.sqw?id=669&o=4  
Probační a mediační služba ČR (Probation and 
Mediation Service of the Czech Republic): 
http://www.pmscr.cz/ 
Prev-Centrum, o.s.: http://www.prevcentrum.cz/  
Psychiatrické centrum Praha (Prague Psychiatric 
Centre): http://www.pcp.lf3.cuni.cz/pcpout/  
Rada vlády pro koordinaci protidrogové politiky (Council 
of the Government for Drug Policy Coordination): 
http://www.vlada.cz/cs/rvk/rkpp/rvkpp_uvod.html 
SANANIM, o.s. (drug information server, drug 
councelling: http://www.sananim.cz/ 
Sdružení Podané ruce, o.s. (civic association): 
http://www.podaneruce.cz/ 
Soudní lékařství v ČR (Forensic Medicine in the Czech 
Republic): http://www.nemcb.cz/soudni/  
Státní zdravotní ústav (National Institute of Public 
Health): http://www.szu.cz/  
Ústav farmakologie 3. LF UK – 
neuropsychofarmakologie a prevence drogových 
závislostí (Institute of Pharmacology of the 3rd Medical 
Faculty of Charles University in Prague – 
neuropsychopharmacology and prevention of drug 
addiction): http://www.lf3.cuni.cz/drogy/  
Ústav zdravotnických informací a statistiky (Institute for 
Health Information and Statistics): http://www.uzis.cz/  
Vězeňská služba ČR (Prison Service of the Czech 
Republic): http://www.vscr.cz/  
Výzkumný ústav práce a sociálních věcí (Research 





2005–2006 Action Plan – Action Plan of the National Drug Policy Strategy Implementation for the period 2005  
to 2006 
2005–2009 National Drug Strategy – National Drug Policy Strategy for the Period 2005 to 2009 
AT – Alcohol – toxicomania (designation of outpatient clinics dealing with addiction treatment) 
CGDCP – Council of the Government for Drug Policy Coordination  
ČLS JEP – Czech Medical Association of J.E. Purkyně 
EMCDDA – European Monitoring Centre for Drugs and Drug Addiction 
ESPAD – European School Survey on Alcohol and Other Drugs 
EU – European Union  
ICD-10 – International Classification of Diseases, Revision 10 
IDU – injecting drug user(s) 
IHIS – Institute of Health Information and Statistics 
NMC – National Monitoring Centre for Drugs and Drug Addiction  
NGO – non-governmental organisations  
SSLST – Professional Association of Forensic Medicine and Toxicology 
HAV – hepatitis A 
HBV – hepatitis B 
HCV – hepatitis C 
WHO – World Health Organisation 
 
 
MAIN INSTITUTIONS REFFERED-TO IN THE REPORT: 
Generální ředitelství cel – General Customs Headquarters 
Ministerstvo dopravy – Ministry of Transport 
Ministerstvo spravedlnosti – Ministry of Justice 
Ministerstvo vnitra – Ministry of the Interior 
Ministerstvo zdravotnictví – Ministry of Health 
Ministerstvo školství, mládeže a tělovýchovy – Ministry of Education 
Národní monitorovací středisko pro drogy a drogové závislosti – National Monitoring Centre for Drugs and Drug 
Addiction 
Národní protidrogová centrála – Police National Drug Squad 
Státní ústav pro kontrolu léčiv – State Institute for Drug (pharmaceuticals) Control 
Vězeňská služba – The Prison Service  
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